studyid,lead_author,year,harmonized_disease_name,study_disease_name,notes
1,Prados-Torres,2012,asthma,Asthma,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,cancer,"Low impact malignant neoplasms; High impact malignant neoplasms; Malignant neoplasms, colorectal; Malignant neoplasms, lymphomas; Malignant neoplasms, bladder; Malignant neoplasms of the skin; Malignant neoplasms, stomach; Malignant neoplasms, prostate; Malignant neoplasms, breast; Malignant neoplasms, cervix, uterus; Malignant neoplasms, kidney; Malignant neoplasms, lung; Malignant neoplasms, pancreas; Malignant neoplasms, ovary; Malignant neoplasms, oesophagus; Malignant neoplasms, liver and biliary tract; Acute leukaemia",ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,chronic kidney disease,Chronic renal failure,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,COPD,"Emphysema, chronic bronchitis, COPD",ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,dementia incl. alzheimers,Dementia and delirium,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,diabetes mellitus,Diabetes,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,epilepsy,Seizure disorder,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,gout,Gout,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,heart failure,Congestive heart failure,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,HIV/AIDS,"HIV, AIDS",ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,hypertension,Hypertension,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,ischemic heart disease,Ischemic heart disease (excluding acute myocardial infarction); Acute myocardial infarction,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,mood and anxiety disorders,"Anxiety, neuroses; Depression",ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,multiple sclerosis,Multiple sclerosis,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,osteoarthritis,NA,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,osteoporosis,Osteoporosis,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,parkinsons,Parkinson's disease,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,rheumatoid arthritis,NA,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,schizophrenia,Schizophrenia and affective psychosis,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,stroke,Cerebrovascular disease,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,"Anxiety, neuroses",ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Arthropathy,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Behaviour problems,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Cervical pain syndromes,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Chronic liver disease,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,"Deafness, hearing loss",ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Depression,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Disorders of lipid metabolism,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Diverticular disease of colon,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Generalised atherosclerosis,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Glaucoma,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Low back pain,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Obesity,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,"Peripheral neuropathy, neuritis",ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Prostatic hypertrophy,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Psoriasis,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Substance use,ACG EDCs (chronic diseases defiend from Salisbury list)
1,Prados-Torres,2012,NA,Thyroid disease,ACG EDCs (chronic diseases defiend from Salisbury list)
2,Aubert,2019,asthma,NA,HCUP groups
2,Aubert,2019,cancer,Solid Malignancy; Haemotological malignancy,HCUP groups
2,Aubert,2019,chronic kidney disease,Chronic kidney disease,HCUP groups
2,Aubert,2019,COPD,COPD and bronchiectasis,HCUP groups
2,Aubert,2019,dementia incl. alzheimers,NA,HCUP groups
2,Aubert,2019,diabetes mellitus,NA,HCUP groups
2,Aubert,2019,epilepsy,Epilepsy – convulsions,HCUP groups
2,Aubert,2019,gout,NA,HCUP groups
2,Aubert,2019,heart failure,NA,HCUP groups
2,Aubert,2019,HIV/AIDS,NA,HCUP groups
2,Aubert,2019,hypertension,NA,HCUP groups
2,Aubert,2019,ischemic heart disease,Chronic heart disease,HCUP groups
2,Aubert,2019,mood and anxiety disorders,Mood disorders; Anxiety disorders,HCUP groups
2,Aubert,2019,multiple sclerosis,NA,HCUP groups
2,Aubert,2019,osteoarthritis,Arthropathy and arthritis,HCUP groups
2,Aubert,2019,osteoporosis,NA,HCUP groups
2,Aubert,2019,parkinsons,NA,HCUP groups
2,Aubert,2019,rheumatoid arthritis,NA,HCUP groups
2,Aubert,2019,schizophrenia,NA,HCUP groups
2,Aubert,2019,stroke,Cerebrovascular disease,HCUP groups
2,Aubert,2019,NA,Anxiety disorders,HCUP groups
2,Aubert,2019,NA,Diseases of white blood cells,HCUP groups
2,Aubert,2019,NA,Mood disorders (depression?),HCUP groups
2,Aubert,2019,NA,"Nephritis, nephrosis and renal sclerosis",HCUP groups
2,Aubert,2019,NA,Other nervous system disorders,HCUP groups
2,Aubert,2019,NA,Paralysis,HCUP groups
2,Aubert,2019,NA,Peripheral and visceral atherosclerosis,HCUP groups
2,Aubert,2019,NA,Pulmonary heart disease,HCUP groups
2,Aubert,2019,NA,Substance-related disorders,HCUP groups
3,Egan,2019,asthma,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,cancer,"Cancer (Lymphoma, metastatic cancer and solid tumors without metastasis)","Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,chronic kidney disease,Chronic Kidney Disease,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,COPD,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,dementia incl. alzheimers,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,diabetes mellitus,Diabetes,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,epilepsy,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,gout,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,heart failure,Congestive Heart Failure,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,HIV/AIDS,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,hypertension,Hypertension (complicated and uncomplicated hypertension),"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,ischemic heart disease,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,mood and anxiety disorders,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,multiple sclerosis,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,osteoarthritis,Osteoarthritis,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,osteoporosis,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,parkinsons,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,rheumatoid arthritis,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,schizophrenia,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,stroke,NA,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,NA,"Behavioral Health (depression, psychosis, drug and alchohol abuse)","Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,NA,"Cardiovascular Disease (myocardial infarction; cerebrovascular disease, artherosclerosis and peripheral vascular disease)","Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,NA,Chronic pulmonary disease,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,NA,Lipid Metabolism Disorders,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,NA,"Neurological conditions (inclds dementia, paralysis (most from CVD) and other neurological conditions like CP or hydrocephalus)","Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
3,Egan,2019,NA,Obesity,"Charlson/Exlihauser; excluded from meta-analysis- no assignment of diseases to clusters, just reported prevalence of diseases in each cluster. I reported top 3 most prevalent diseases per cluster"
4,Lu,2023,asthma,asthma,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,cancer,cancer,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,chronic kidney disease,chronic kidney disease,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,COPD,COPD,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,dementia incl. alzheimers,dementia incl. alzheimers,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,diabetes mellitus,diabetes mellitus,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,epilepsy,epilepsy,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,gout,NA,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,heart failure,heart failure,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,HIV/AIDS,HIV/AIDS,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,hypertension,hypertension,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,ischemic heart disease,ischemic heart disease,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,mood and anxiety disorders,mood and anxiety disorders,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,multiple sclerosis,multiple sclerosis,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,osteoarthritis,NA,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,osteoporosis,NA,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,parkinsons,parkinsons,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,rheumatoid arthritis,rheumatoid arthritis,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,schizophrenia,schizophrenia,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,stroke,stroke,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Alcohol abuse,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Cardiac arrhythmias,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Chronic pulmonary disease,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Depression,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Drug abuse,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Obesity,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,"Peripheral vascular disorders,","ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Psychosis,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Pulmonary circulation disorders,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Smoking,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
4,Lu,2023,NA,Valvular disease,"ICD codes mapped onto our CDSS-based definitions, but they also list elizhauser conditions in their study methods (though cluster results are by ICD code, not elixhauser categories)"
5,Roso-Llorach,2022,asthma,Asthma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,cancer,Hematological neoplasms; ﻿solid neoplasms,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,chronic kidney disease,Chronic kidney diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,COPD,"COPD, Emphysema, Chronic Bronchitis","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,dementia incl. alzheimers,Dementia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,diabetes mellitus,Diabetes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,epilepsy,epilepsy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,gout,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,heart failure,heart failure,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,HIV/AIDS,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,hypertension,Hypertension,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,ischemic heart disease,Ischemic heart disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,mood and anxiety disorders,Depression and mood diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,multiple sclerosis,Multiple Sclerosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,osteoarthritis,Osteoarthritis and other degenerative joint disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,osteoporosis,Osteoporosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,parkinsons,Parkinson and parkinsonism,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,rheumatoid arthritis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,schizophrenia,﻿schizophrenia and delusional diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,stroke,cerebrovascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Anemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Atrial fibrillation,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Autoimmune diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Bradycardias and conduction diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Chronic infectious diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,"Chronic pancreas, biliary tract and gallbladder diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Colitis and related diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,"Esophagus, stomach and duodenum diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Glaucoma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Hearing impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Hypercholesterolemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Inflammatory arthropathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Inflammatory bowel diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Migraine and facial pain syndromes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Obesity,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Other psychiatric and behavioral diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Peripheral vascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Prostate diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Thyroid diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
5,Roso-Llorach,2022,NA,Visual impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
6,Baré,2021,asthma,Asthma,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,cancer,"Neoplasia (including leukaemia, lymphoma, metastatic solid tumour)","Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,chronic kidney disease,Moderate or severe renal disease,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,COPD,Chronic obstructive pulmonary disease (COPD),"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,dementia incl. alzheimers,Dementia,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,diabetes mellitus,"Diabetes with complication, Diabetes without complication","Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,epilepsy,NA,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,gout,Gout,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,heart failure,Heart failure,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,HIV/AIDS,NA,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,hypertension,Hypertension,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,ischemic heart disease,Ischaemic heart disease without infarction; Myocardial infarction,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,mood and anxiety disorders,Depression or Anxiety,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,multiple sclerosis,NA,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,osteoarthritis,NA,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,osteoporosis,Osteoporosis,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,parkinsons,Parkinson's disease,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,rheumatoid arthritis,NA,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,schizophrenia,NA,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,stroke,Cerebrovascular disease (including hemiplegia),"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Acute confusional syndrome/delirium,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Amputation,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Anaemia,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Cardiac arrhythmia,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Chronic gastritis or gastrooesophageal reflux,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Chronic pain,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Chronic thyroid disease,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Cognitive/Intellectual impairment,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Constipation,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Degenerative arthropathy,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Drug-related conditions,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Dyslipidaemia,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Dysphagia,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Frailty,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Gallstones,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Haematologic disorders,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Immobility,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Incontinence (Urinary/faecal),"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Inflammatory osteoarticular disease,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Instability/falls,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Malnutrition,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Mild liver disease (including chronic hepatitis B or C),"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Moderate or severe liver disease,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Neurologic disorder of the CNS,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Non-ischaemic heart disease,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Obesity,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Peptic ulcer disease,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Peripheral neuropathy or neuritis,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Peripheral vascular disease,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Polypharmacy,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Pressure ulcers,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Previous fracture (not hip),"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Previous hip fracture,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Rheumatologic disease,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Sensorial deficit,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Sleep apnoea,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Sleep disorders/Insomnia,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Varicose veins of lower extremities,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
6,Baré,2021,NA,Vertigo,"Diseases from clinical charts. Select list of chronic conditions, defined by physician teams."
7,Bisquera,2021,asthma,Asthma,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,cancer,Cancer,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,chronic kidney disease,Chronic Kidney Disease (CKD) - Stages 3-5,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,COPD,Chronic obstructive pulmonary disease (COPD),UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,dementia incl. alzheimers,Dementia (includes Alzheimer's),UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,diabetes mellitus,Diabetes mellitus,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,epilepsy,Epilepsy,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,gout,NA,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,heart failure,Heart Failure,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,HIV/AIDS,HIV/AIDS,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,hypertension,Hypertension,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,ischemic heart disease,"Coronary Heart Disease (CHD) (includes Angina, MI)",UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,mood and anxiety disorders,Anxiety Disorders ; Depression,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,multiple sclerosis,Multiple Sclerosis,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,osteoarthritis,Osteoporosis,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,osteoporosis,Osteoarthritis,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,parkinsons,Parkinson's disease,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,rheumatoid arthritis,Rheumatoid Arthritis,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,schizophrenia,NA,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,stroke,Stroke and Transient Ischemic Attack (TIA),UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Alcohol Dependence,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Anxiety Disorders,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Atrial Fibrillation,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Chronic Pain (Chronic pain &/or analgesic opioid prescribing),UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Depression,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Inflammatory Bowel Disease (IBD),UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Learning Disabilities,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Liver Disease,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Lupus,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Morbid Obesity (BMI ≥40),UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Peripheral Arterial Disease (PAD),UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Serious Mental Illness,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Sickle-Cell Anaemia,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Substance dependency,UK standardized disease categories from SNODMED and READ codes
7,Bisquera,2021,NA,Viral Hepatitis (B & C),UK standardized disease categories from SNODMED and READ codes
8,Hajat,2021,asthma,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,cancer,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,chronic kidney disease,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,COPD,COPD,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,dementia incl. alzheimers,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,diabetes mellitus,Diabetes,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,epilepsy,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,gout,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,heart failure,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,HIV/AIDS,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,hypertension,Hypertension,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,ischemic heart disease,Coronary Artery Disease,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,mood and anxiety disorders,Anxiety; Depression,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,multiple sclerosis,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,osteoarthritis,Osteoarthritis,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,osteoporosis,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,parkinsons,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,rheumatoid arthritis,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,schizophrenia,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,stroke,NA,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Alcohol Abuse,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Allergy,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Anxiety,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Back Pain,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Cardiac Arrythmia,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Cardiomyopathy,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Chronic Pain,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Depression,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Eye Problems,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,High Cholesterol,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Obesity,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Other Endocrine,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Other Endocrine Disease,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Other Neurological Disease,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Other Neurological Disorder,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Peptic Ulcer Disease Excluding Bleed,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
8,Hajat,2021,NA,Weight Loss,ICD 9/10 codes grouped into chronic disease categories by AHQR CCS/CCI list.
9,Van Cleave,2016,asthma,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,cancer,"any malignancy, including leukemia and lymphoma, metastasis, or solid tumor",ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,chronic kidney disease,renal diseases,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,COPD,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,dementia incl. alzheimers,dementia,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,diabetes mellitus,diabetes with/without chronic complications,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,epilepsy,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,gout,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,heart failure,congestive heart failure,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,HIV/AIDS,﻿AIDS/HIV,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,hypertension,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,ischemic heart disease,myocardial infarction,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,mood and anxiety disorders,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,multiple sclerosis,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,osteoarthritis,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,osteoporosis,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,parkinsons,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,rheumatoid arthritis,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,schizophrenia,NA,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,stroke,cerebrovascular disease,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,NA,chronic pulmonary disease,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,NA,﻿hemiplegia or paraplegia,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,NA,"mild, moderate, or severe liver disease",ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,NA,peptic ulcer disease,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,NA,peripheral vascular disease,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
9,Van Cleave,2016,NA,rheumatologic disease,ICD-10 codes grouped into Charlson Comorbidity Index categories (15)
10,Zhu,2020,asthma,Asthma,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,cancer,Cancer,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,chronic kidney disease,Chronic kidney disease,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,COPD,COPD,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,dementia incl. alzheimers,Dementia,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,diabetes mellitus,Diabetes,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,epilepsy,NA,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,gout,NA,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,heart failure,Heart failure,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,HIV/AIDS,NA,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,hypertension,Hypertension,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,ischemic heart disease,Coronary heart disease,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,mood and anxiety disorders,Anxiety; Depression,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,multiple sclerosis,multiple sclerosis,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,osteoarthritis,NA,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,osteoporosis,NA,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,parkinsons,Parkinson's disease,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,rheumatoid arthritis,Rheumatoid arthritis,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,schizophrenia,Schizophrenia,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,stroke,Stroke & transient ischaemic attack,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Alcohol problems,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Anorexia bulimia,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Anxiety,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Atrial fibrillation,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Blindness and low vision,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Bronchiectasis,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Chronic liver disease,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Chronic sinusitis,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Constipation,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Depression,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Diverticular disease of intestine,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Epilepsy,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Hearing loss,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Inflammatory bowel disease,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Irritable bowel syndrome,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Learning disability,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Migraine,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Painful conditions,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Peptic ulcer disease,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Peripheral vascular disease,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Prostate disorders,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Psoriasis or eczema,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Psychoactive substance misuse (NOT ALCOHOL),UK READ codes grouped into standardized conditions for Clinical Practice Research Database
10,Zhu,2020,NA,Thyroid disorders,UK READ codes grouped into standardized conditions for Clinical Practice Research Database
11,Schafer,2010,asthma,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,cancer,"Cancers [C00-26, C30-41, C43-58, C60-97, D00-09, D37-48]","ICD-10 3-digit codes, select list"
11,Schafer,2010,chronic kidney disease,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,COPD,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,dementia incl. alzheimers,"Dementias [F00-03, F05.1, G30-31, R54]","ICD-10 3-digit codes, select list"
11,Schafer,2010,diabetes mellitus,Diabetes mellitus [E10-14],"ICD-10 3-digit codes, select list"
11,Schafer,2010,epilepsy,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,gout,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,heart failure,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,HIV/AIDS,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,hypertension,Hypertension [I10-15],"ICD-10 3-digit codes, select list"
11,Schafer,2010,ischemic heart disease,"Chronic ischemic heart diseases [I20-21, I25]","ICD-10 3-digit codes, select list"
11,Schafer,2010,mood and anxiety disorders,Anxiety [F40-41]; Depression [F32-33],"ICD-10 3-digit codes, select list"
11,Schafer,2010,multiple sclerosis,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,osteoarthritis,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,osteoporosis,Osteoporosis [M80-82],"ICD-10 3-digit codes, select list"
11,Schafer,2010,parkinsons,Parkinson’s disease [G20-22],"ICD-10 3-digit codes, select list"
11,Schafer,2010,rheumatoid arthritis,"Rheumatoid arthritis/Chronic polyarthritis [M05-06, M79.0]","ICD-10 3-digit codes, select list"
11,Schafer,2010,schizophrenia,NA,"ICD-10 3-digit codes, select list"
11,Schafer,2010,stroke,"Cerebral ischemia/Chronic stroke [G45, I60-64, I69]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Allergies [H01.1, J30, K52.2, K90.0, L23, L27.2, L56.4, T78.1, T78.4, T88.7]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Anemias [D50-53, D55-58, D59.0-.2, D59.4-.9, D60.0, D60.8-.9, D61, D63-64]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Anxiety [F40-41],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Asthma/Chronic obstructive pulmonary disease [J40-45, J47]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Atherosclerosis/Peripheral arterial occlusive disease [I65-66, I67.2, I70, I73.9]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Cardiac arrhythmias [I44-45, I46.0, I46.9, I47-48, I49.1-.9]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Cardiac insufficiency [I50],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Cardiac valve disorders [I34-I37],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Chronic cholecystitis/Gallstones [K80, K81.1]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Chronic gastritis/Gastroesophageal reflux disease [K21, K25.4-.9, K26.4-.9, K27.4-.9, K28.4-.9, K29.2-.9]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Chronic low back pain [M40-45, M47, M48.0-.2, M48.5-.9, M50-54]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Depression [F32-33],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Dizziness [H81-82, R42]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Hemorrhoids [I84],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Hypotension [I95],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Insomnia [F51, G47]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Intestinal diverticulosis [K57],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Joint arthrosis [M15-19],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Lipid metabolism disorders [E78],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Liver diseases [K70, K71.3-.5, K71.7, K72.1, K72.7, K72.9, K73-74, K76]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Lower limb varicosis [I83, I87.2]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Migraine/Chronic headache [G43-44],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Neuropathies [G50-64],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Noninflammatory gynecological problems [N81, N84-90, N93, N95]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Obesity [E66],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Prostatic hyperplasia [N40],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Psoriasis [L40],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Purine/pyrimidine metabolism disorders/Gout [E79, M10]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Renal insufficiency [N18-N19],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Severe hearing loss [H90, H91.0-.1, H91.3, H91.8-.9]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Severe vision reduction [H17-18, H25-28, H31, H33, H34.1-.2, H34.8-.9, H35-36, H40, H43, H47, H54]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Sexual dysfunction [F52, N48.4]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Somatoform disorders [F45],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Thyroid dysfunction [E01-05, E06.1-.3, E06.5, E06.9, E07]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Tobacco abuse [F17],"ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,"Urinary incontinence [N39.3-.4, R32]","ICD-10 3-digit codes, select list"
11,Schafer,2010,NA,Urinary tract calculi [N20],"ICD-10 3-digit codes, select list"
12,Roso-Llorach,2018,asthma,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,cancer,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,chronic kidney disease,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,COPD,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,dementia incl. alzheimers,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,diabetes mellitus,E10-E14: Diabetes mellitus,ICD-10 block disease categories
12,Roso-Llorach,2018,epilepsy,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,gout,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,heart failure,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,HIV/AIDS,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,hypertension,I10-I15: Hypertensive diseases,ICD-10 block disease categories
12,Roso-Llorach,2018,ischemic heart disease,I20-I25: Ischaemic heart diseases,ICD-10 block disease categories
12,Roso-Llorach,2018,mood and anxiety disorders,F30-F39: Mood [affective] disorders,ICD-10 block disease categories
12,Roso-Llorach,2018,multiple sclerosis,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,osteoarthritis,M15-M19: Arthrosis,ICD-10 block disease categories
12,Roso-Llorach,2018,osteoporosis,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,parkinsons,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,rheumatoid arthritis,NA,ICD-10 block disease categories
12,Roso-Llorach,2018,schizophrenia,"F20-F29: Schizophrenia, schizotypal and delusional disorders",ICD-10 block disease categories
12,Roso-Llorach,2018,stroke,I60-I69: Cerebrovascular diseases,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,A00-A09: Intestinal infectious diseases,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,B00-B09: Viral infections characterized by skin and mucous membrane lesions,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,B15-B19: Viral hepatitis,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,B25-B34: Other viral diseases,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,B35-B49: Mycoses,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,D10-D36: Benign neoplasms,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,D50-D53: Nutritional anaemias,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,D70-D77: Other diseases of blood and blood-forming organs,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,E00-E07: Disorders of thyroid gland,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,E65-E68: Obesity and other hyperalimentation,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,E70-E90: Metabolic disorders,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,F10-F19: Mental and behavioural disorders due to psychoactive substance use,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"F40-F48: Neurotic, stress-related and somatoform disorders",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,F50-F59: Behavioural syndromes associated with physiological disturbances and physical factors,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,G40-G47: Episodic and paroxysmal disorders,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"G50-G59: Nerve, nerve root and plexus disorders",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"H00-H06: Disorders of eyelid, lacrimal system and orbit",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H10-H13: Disorders of conjunctiva,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H25-H28: Disorders of lens,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H30-H36: Disorders of choroid and retina,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H40-H42: Glaucoma,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"H49-H52: Disorders of ocular muscles, binocular movement, accommodation and refraction",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H53-H54: Visual disturbances and blindness,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H55-H59: Other disorders of eye and adnexa,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H60-H62: Diseases of external ear,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H65-H75: Diseases of middle ear and mastoid,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H80-H83: Diseases of inner ear,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,H90-H95: Other disorders of ear,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,I30-I52: Other forms of heart disease,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"I70-I79: Diseases of arteries, arterioles and capillaries",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"I80-I89: Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,J00-J06: Acute upper respiratory infections,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,J09-J18: Influenza and pneumonia,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,J20-J22: Other acute lower respiratory infections,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,J30-J39: Other diseases of upper respiratory tract,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,J40-J47: Chronic lower respiratory diseases,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"K00-K14: Diseases of oral cavity, salivary glands and jaws",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"K20-K31: Diseases of oesophagus, stomach and duodenum",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,K40-K46: Hernia,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,K50-K52: Noninfective enteritis and colitis,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,K55-K63: Other diseases of intestines,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,K70-K77: Diseases of liver,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"K80-K87: Disorders of gallbladder, biliary tract and pancreas",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,L00-L08: Infections of the skin and subcutaneous tissue,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,L20-L30: Dermatitis and eczema,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,L40-L45: Papulosquamous disorders,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,L50-L54: Urticaria and erythema,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,L60-L75: Disorders of skin appendages,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,L80-L99: Other disorders of the skin and subcutaneous tissue,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,M05-M14: Inflammatory polyarthropathies,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,M20-M25: Other joint disorders,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,M40-M43: Deforming dorsopathies,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,M45-M49: Spondylopathies,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,M50-M54: Other dorsopathies,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,M60-M63: Disorders of muscles,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,M65-M68: Disorders of synovium and tendon,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,M70-M79: Other soft tissue disorders,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,M80-M85: Disorders of bone density and structure,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,N17-N19: Renal failure,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,N20-N23: Urolithiasis,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,N30-N39: Other diseases of urinary system,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,N40-N51: Diseases of male genital organs,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,N60-N64: Disorders of breast,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,N80-N98: Noninflammatory disorders of female genital tract,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,Q38-Q45: Other congenital malformations of the digestive system,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,S00-S09: Injuries to the head,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,S60-S69: Injuries to the wrist and hand,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,S80-S89: Injuries to the knee and lower leg,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,S90-S99: Injuries to the ankle and foot,ICD-10 block disease categories
12,Roso-Llorach,2018,NA,"T08-T14: Injuries to unspecified part of trunk, limb or body region",ICD-10 block disease categories
12,Roso-Llorach,2018,NA,T51-T65: Toxic effects of substances chiefly nonmedicinal as to source,ICD-10 block disease categories
13,Moran,2017,asthma,Asthma,Charlson/Elixhauser
13,Moran,2017,cancer,Lymphoma; Metastatic cancer; Solid tumour without metastasis,Charlson/Elixhauser
13,Moran,2017,chronic kidney disease,Renal failure,Charlson/Elixhauser
13,Moran,2017,COPD,Chronic obstructive pulmonary disease,Charlson/Elixhauser
13,Moran,2017,dementia incl. alzheimers,Dementia,Charlson/Elixhauser
13,Moran,2017,diabetes mellitus,"Diabetes, complicated; Diabetes, uncomplicated",Charlson/Elixhauser
13,Moran,2017,epilepsy,NA,Charlson/Elixhauser
13,Moran,2017,gout,NA,Charlson/Elixhauser
13,Moran,2017,heart failure,Congestive heart failure,Charlson/Elixhauser
13,Moran,2017,HIV/AIDS,AIDS/HIV,Charlson/Elixhauser
13,Moran,2017,hypertension,"Hypertension, complicated; Hypertension, uncomplicated",Charlson/Elixhauser
13,Moran,2017,ischemic heart disease,Myocardial infarction,Charlson/Elixhauser
13,Moran,2017,mood and anxiety disorders,Depression,Charlson/Elixhauser
13,Moran,2017,multiple sclerosis,NA,Charlson/Elixhauser
13,Moran,2017,osteoarthritis,NA,Charlson/Elixhauser
13,Moran,2017,osteoporosis,NA,Charlson/Elixhauser
13,Moran,2017,parkinsons,NA,Charlson/Elixhauser
13,Moran,2017,rheumatoid arthritis,Rheumatoid arthritis/collagen vascular diseases,Charlson/Elixhauser
13,Moran,2017,schizophrenia,NA,Charlson/Elixhauser
13,Moran,2017,stroke,Cerebrovascular disease,Charlson/Elixhauser
13,Moran,2017,NA,Alcohol Abuse,Charlson/Elixhauser
13,Moran,2017,NA,Blood loss anaemia,Charlson/Elixhauser
13,Moran,2017,NA,Coagulopathy,Charlson/Elixhauser
13,Moran,2017,NA,Deficiency anaemia,Charlson/Elixhauser
13,Moran,2017,NA,Drug abuse,Charlson/Elixhauser
13,Moran,2017,NA,Fluid and electrolyte disorders,Charlson/Elixhauser
13,Moran,2017,NA,Hyperlipidaemia,Charlson/Elixhauser
13,Moran,2017,NA,Hypothyroidism,Charlson/Elixhauser
13,Moran,2017,NA,Liver disease,Charlson/Elixhauser
13,Moran,2017,NA,Lymphoma,Charlson/Elixhauser
13,Moran,2017,NA,Metastatic cancer,Charlson/Elixhauser
13,Moran,2017,NA,Obesity,Charlson/Elixhauser
13,Moran,2017,NA,Other neurological disorders,Charlson/Elixhauser
13,Moran,2017,NA,Paralysis,Charlson/Elixhauser
13,Moran,2017,NA,Peptic ulcer disease excluding bleeding,Charlson/Elixhauser
13,Moran,2017,NA,Peripheral vascular disorders,Charlson/Elixhauser
13,Moran,2017,NA,Psychoses,Charlson/Elixhauser
13,Moran,2017,NA,Pulmonary circulation disorders,Charlson/Elixhauser
13,Moran,2017,NA,Renal failure,Charlson/Elixhauser
13,Moran,2017,NA,Sickle cell,Charlson/Elixhauser
13,Moran,2017,NA,Solid tumour without metastasis,Charlson/Elixhauser
13,Moran,2017,NA,Valvular disease,Charlson/Elixhauser
13,Moran,2017,NA,Weight loss,Charlson/Elixhauser
14,Nicolet,2022,asthma,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,cancer,Cancer,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,chronic kidney disease,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,COPD,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,dementia incl. alzheimers,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,diabetes mellitus,Diabetes,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,epilepsy,Epilepsy,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,gout,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,heart failure,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,HIV/AIDS,HIV/AIDS,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,hypertension,Hypertension related,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,ischemic heart disease,Heart disease,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,mood and anxiety disorders,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,multiple sclerosis,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,osteoarthritis,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,osteoporosis,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,parkinsons,Parkinson,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,rheumatoid arthritis,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,schizophrenia,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,stroke,NA,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,NA,Glaucoma,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,NA,Immune,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,NA,Inflammatory,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,NA,Mental,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,NA,Other,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,NA,Pain,"Pharmacy-based cost groupes, grouped into 15 disease categories"
14,Nicolet,2022,NA,Thyroid,"Pharmacy-based cost groupes, grouped into 15 disease categories"
15,Wang,2020,asthma,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,cancer,﻿Malignancy,ICD-10 codes grouped into disease categories
15,Wang,2020,chronic kidney disease,Chronic kidney disease,ICD-10 codes grouped into disease categories
15,Wang,2020,COPD,COPD,ICD-10 codes grouped into disease categories
15,Wang,2020,dementia incl. alzheimers,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,diabetes mellitus,Diabetes mellitus,ICD-10 codes grouped into disease categories
15,Wang,2020,epilepsy,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,gout,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,heart failure,Heart failure,ICD-10 codes grouped into disease categories
15,Wang,2020,HIV/AIDS,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,hypertension,Hypertension,ICD-10 codes grouped into disease categories
15,Wang,2020,ischemic heart disease,Ischemic heart disease,ICD-10 codes grouped into disease categories
15,Wang,2020,mood and anxiety disorders,Depressive disorders,ICD-10 codes grouped into disease categories
15,Wang,2020,multiple sclerosis,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,osteoarthritis,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,osteoporosis,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,parkinsons,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,rheumatoid arthritis,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,schizophrenia,NA,ICD-10 codes grouped into disease categories
15,Wang,2020,stroke,Cerebrovascular disease,ICD-10 codes grouped into disease categories
15,Wang,2020,NA,Cataract,ICD-10 codes grouped into disease categories
15,Wang,2020,NA,Depressive disorders,ICD-10 codes grouped into disease categories
15,Wang,2020,NA,Glaucoma,ICD-10 codes grouped into disease categories
15,Wang,2020,NA,Osteoarthritis and rheumatoid arthritis,ICD-10 codes grouped into disease categories
15,Wang,2020,NA,﻿Peptic ulcer disease,ICD-10 codes grouped into disease categories
16,Caballero,2023,asthma,Asthma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,cancer,Solid neoplasms,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,chronic kidney disease,Chronic kidney diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,COPD,"COPD, Emphysema, Chronic Bronchitis","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,dementia incl. alzheimers,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,diabetes mellitus,Diabetes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,epilepsy,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,gout,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,heart failure,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,HIV/AIDS,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,hypertension,Hypertension,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,ischemic heart disease,Ischemic heart disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,mood and anxiety disorders,Depression and mood diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,multiple sclerosis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,osteoarthritis,Osteoarthritis and other degenerative joint disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,osteoporosis,Osteoporosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,parkinsons,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,rheumatoid arthritis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,schizophrenia,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,stroke,cerebrovascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Anemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Atrial fibrillation,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Chronic infectious diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,"Chronic pancreas, biliary tract and gallbladder diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Colitis and related diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,"Esophagus, stomach and duodenum diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Glaucoma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Migraine and facial pain syndromes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Obesity,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Other genitourinary diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Other musculoskeletal and joint diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Other psychiatric and behavioral diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Peripheral vascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Prostate diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,sleep disorders,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Thyroid diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
16,Caballero,2023,NA,Visual impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016- reduced to 36 diseases with > 5% prevalence"
17,Corsonello,2022,asthma,NA,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,cancer,Cancer,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,chronic kidney disease,CKD,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,COPD,COPD,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,dementia incl. alzheimers,Dementia,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,diabetes mellitus,Diabetes,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,epilepsy,Epilepsy,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,gout,NA,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,heart failure,Heart failure,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,HIV/AIDS,NA,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,hypertension,Hypertension,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,ischemic heart disease,Ischemic cardiomyopathy,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,mood and anxiety disorders,NA,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,multiple sclerosis,NA,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,osteoarthritis,NA,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,osteoporosis,Osteoporosis,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,parkinsons,Parkinson's,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,rheumatoid arthritis,NA,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,schizophrenia,NA,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,stroke,Stroke,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,NA,Anemia,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,NA,Atrial fibrillation,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,NA,Cerebrovascular disease,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,NA,Dyslipidemia,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,NA,Prostate disease,ICD-9 codes: no info on how codes were grouped to diseases
17,Corsonello,2022,NA,Thyroid dysfunction,ICD-9 codes: no info on how codes were grouped to diseases
18,Dong,2013,asthma,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,cancer,Malignancy,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,chronic kidney disease,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,COPD,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,dementia incl. alzheimers,Dementia,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,diabetes mellitus,Diabetes,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,epilepsy,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,gout,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,heart failure,Heart failure,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,HIV/AIDS,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,hypertension,﻿Hypertension,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,ischemic heart disease,Myocardial infarction,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,mood and anxiety disorders,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,multiple sclerosis,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,osteoarthritis,Osteoarthritis,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,osteoporosis,Osteoporosis,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,parkinsons,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,rheumatoid arthritis,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,schizophrenia,NA,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,stroke,Stroke,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,NA,Affective diseases,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,NA,Arrhythmia,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,NA,Asthma or COPD,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,NA,Hyperlipidemia,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,NA,Thrombosis or PVD,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,NA,Thyroid dysfunction,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
18,Dong,2013,NA,Urinary incontinence,"ICD-10 codes, grouped into chronic disease categories with >5% prevalence"
19,Franti,2022,asthma,NA,ICD-10 block disease categories
19,Franti,2022,cancer,"C00-C14: Malignant neoplasms of lip, oral cavity and pharynx
C15-C26: Malignant neoplasms of digestive organs
C30-C39: Malignant neoplasms of respiratory and intrathoracic organs
C40-C41: Malignant neoplasms of bone and articular cartilage
C43-C44: Melanoma and other malignant neoplasms of skin
C45-C49: Malignant neoplasms of mesothelial and soft tissue
C50-C50: Malignant neoplasm of breast
C51-C58: Malignant neoplasms of female genital organs
C60-C63: Malignant neoplasms of male genital organs
C64-C68: Malignant neoplasms of urinary tract
C69-C72: Malignant neoplasms of eye, brain and other parts of central nervous system
C73-C75: Malignant neoplasms of thyroid and other endocrine glands
C76-C80: Malignant neoplasms of ill-defined, secondary and unspecified sites
C81-C96: Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
C97-C97: Malignant neoplasms of independent (primary) multiple sites",ICD-10 block disease categories
19,Franti,2022,chronic kidney disease,NA,ICD-10 block disease categories
19,Franti,2022,COPD,NA,ICD-10 block disease categories
19,Franti,2022,dementia incl. alzheimers,NA,ICD-10 block disease categories
19,Franti,2022,diabetes mellitus,E10-E14: Diabetes mellitus,ICD-10 block disease categories
19,Franti,2022,epilepsy,NA,ICD-10 block disease categories
19,Franti,2022,gout,NA,ICD-10 block disease categories
19,Franti,2022,heart failure,NA,ICD-10 block disease categories
19,Franti,2022,HIV/AIDS,B20-B24: Human immunodeficiency virus [HIV] disease,ICD-10 block disease categories
19,Franti,2022,hypertension,I10-I15: Hypertensive diseases,ICD-10 block disease categories
19,Franti,2022,ischemic heart disease,I20-I25: Ischaemic heart diseases,ICD-10 block disease categories
19,Franti,2022,mood and anxiety disorders,F30-F39: Mood [affective] disorders,ICD-10 block disease categories
19,Franti,2022,multiple sclerosis,NA,ICD-10 block disease categories
19,Franti,2022,osteoarthritis,M15-M19: Arthrosis,ICD-10 block disease categories
19,Franti,2022,osteoporosis,NA,ICD-10 block disease categories
19,Franti,2022,parkinsons,NA,ICD-10 block disease categories
19,Franti,2022,rheumatoid arthritis,NA,ICD-10 block disease categories
19,Franti,2022,schizophrenia,"F20-F29: Schizophrenia, schizotypal and delusional disorders",ICD-10 block disease categories
19,Franti,2022,stroke,I60-I69: Cerebrovascular diseases,ICD-10 block disease categories
19,Franti,2022,NA,A00-A09: Intestinal infectious diseases,ICD-10 block disease categories
19,Franti,2022,NA,A15-A19: Tuberculosis,ICD-10 block disease categories
19,Franti,2022,NA,A20-A28: Certain zoonotic bacterial diseases,ICD-10 block disease categories
19,Franti,2022,NA,A30-A49: Other bacterial diseases,ICD-10 block disease categories
19,Franti,2022,NA,A50-A64: Infections with a predominantly sexual mode of transmission,ICD-10 block disease categories
19,Franti,2022,NA,A65-A69: Other spirochaetal diseases,ICD-10 block disease categories
19,Franti,2022,NA,A70-A74: Other diseases caused by chlamydiae,ICD-10 block disease categories
19,Franti,2022,NA,A75-A79: Rickettsioses,ICD-10 block disease categories
19,Franti,2022,NA,A80-A89: Viral infections of the central nervous system,ICD-10 block disease categories
19,Franti,2022,NA,A90-A99: Arthropod-borne viral fevers and viral haemorrhagic fevers,ICD-10 block disease categories
19,Franti,2022,NA,B00-B09: Viral infections characterized by skin and mucous membrane lesions,ICD-10 block disease categories
19,Franti,2022,NA,B15-B19: Viral hepatitis,ICD-10 block disease categories
19,Franti,2022,NA,B25-B34: Other viral diseases,ICD-10 block disease categories
19,Franti,2022,NA,B35-B49: Mycoses,ICD-10 block disease categories
19,Franti,2022,NA,B50-B64: Protozoal diseases,ICD-10 block disease categories
19,Franti,2022,NA,B65-B83: Helminthiases,ICD-10 block disease categories
19,Franti,2022,NA,"B85-B89: Pediculosis, acariasis and other infestations",ICD-10 block disease categories
19,Franti,2022,NA,B90-B94: Sequelae of infectious and parasitic diseases,ICD-10 block disease categories
19,Franti,2022,NA,"B95-B98: Bacterial, viral and other infectious agents",ICD-10 block disease categories
19,Franti,2022,NA,B99-B99: Other infectious diseases,ICD-10 block disease categories
19,Franti,2022,NA,D00-D09: In situ neoplasms,ICD-10 block disease categories
19,Franti,2022,NA,D10-D36: Benign neoplasms,ICD-10 block disease categories
19,Franti,2022,NA,D37-D48: Neoplasms of uncertain or unknown behaviour,ICD-10 block disease categories
19,Franti,2022,NA,D50-D53: Nutritional anaemias,ICD-10 block disease categories
19,Franti,2022,NA,D55-D59: Haemolytic anaemias,ICD-10 block disease categories
19,Franti,2022,NA,D60-D64: Aplastic and other anaemias,ICD-10 block disease categories
19,Franti,2022,NA,"D65-D69: Coagulation defects, purpura and other haemorrhagic conditions",ICD-10 block disease categories
19,Franti,2022,NA,D70-D77: Other diseases of blood and blood-forming organs,ICD-10 block disease categories
19,Franti,2022,NA,D80-D89: Certain disorders involving the immune mechanism,ICD-10 block disease categories
19,Franti,2022,NA,E00-E07: Disorders of thyroid gland,ICD-10 block disease categories
19,Franti,2022,NA,E15-E16: Other disorders of glucose regulation and pancreatic internal secretion,ICD-10 block disease categories
19,Franti,2022,NA,E20-E35: Disorders of other endocrine glands,ICD-10 block disease categories
19,Franti,2022,NA,E40-E46: Malnutrition,ICD-10 block disease categories
19,Franti,2022,NA,E50-E64: Other nutritional deficiencies,ICD-10 block disease categories
19,Franti,2022,NA,E65-E68: Obesity and other hyperalimentation,ICD-10 block disease categories
19,Franti,2022,NA,E70-E90: Metabolic disorders,ICD-10 block disease categories
19,Franti,2022,NA,"F00-F09: Organic, including symptomatic, mental disorders",ICD-10 block disease categories
19,Franti,2022,NA,F10-F19: Mental and behavioural disorders due to psychoactive substance use,ICD-10 block disease categories
19,Franti,2022,NA,"F40-F48: Neurotic, stress-related and somatoform disorders",ICD-10 block disease categories
19,Franti,2022,NA,F50-F59: Behavioural syndromes associated with physiological disturbances and physical factors,ICD-10 block disease categories
19,Franti,2022,NA,F60-F69: Disorders of adult personality and behaviour,ICD-10 block disease categories
19,Franti,2022,NA,F70-F79: Mental retardation,ICD-10 block disease categories
19,Franti,2022,NA,F80-F89: Disorders of psychological development,ICD-10 block disease categories
19,Franti,2022,NA,F90-F98: Behavioural and emotional disorders with onset usually occurring in childhood and adolescence,ICD-10 block disease categories
19,Franti,2022,NA,F99-F99: Unspecified mental disorder,ICD-10 block disease categories
19,Franti,2022,NA,G00-G09: Inflammatory diseases of the central nervous system,ICD-10 block disease categories
19,Franti,2022,NA,G10-G14: Systemic atrophies primarily affecting the central nervous system,ICD-10 block disease categories
19,Franti,2022,NA,G20-G26: Extrapyramidal and movement disorders,ICD-10 block disease categories
19,Franti,2022,NA,G30-G32: Other degenerative diseases of the nervous system,ICD-10 block disease categories
19,Franti,2022,NA,G35-G37: Demyelinating diseases of the central nervous system,ICD-10 block disease categories
19,Franti,2022,NA,G40-G47: Episodic and paroxysmal disorders,ICD-10 block disease categories
19,Franti,2022,NA,"G50-G59: Nerve, nerve root and plexus disorders",ICD-10 block disease categories
19,Franti,2022,NA,G60-G64: Polyneuropathies and other disorders of the peripheral nervous system,ICD-10 block disease categories
19,Franti,2022,NA,G70-G73: Diseases of myoneural junction and muscle,ICD-10 block disease categories
19,Franti,2022,NA,G80-G83: Cerebral palsy and other paralytic syndromes,ICD-10 block disease categories
19,Franti,2022,NA,G90-G99: Other disorders of the nervous system,ICD-10 block disease categories
19,Franti,2022,NA,"H00-H06: Disorders of eyelid, lacrimal system and orbit",ICD-10 block disease categories
19,Franti,2022,NA,H10-H13: Disorders of conjunctiva,ICD-10 block disease categories
19,Franti,2022,NA,"H15-H22: Disorders of sclera, cornea, iris and ciliary body",ICD-10 block disease categories
19,Franti,2022,NA,H25-H28: Disorders of lens,ICD-10 block disease categories
19,Franti,2022,NA,H30-H36: Disorders of choroid and retina,ICD-10 block disease categories
19,Franti,2022,NA,H40-H42: Glaucoma,ICD-10 block disease categories
19,Franti,2022,NA,H43-H45: Disorders of vitreous body and globe,ICD-10 block disease categories
19,Franti,2022,NA,H46-H48: Disorders of optic nerve and visual pathways,ICD-10 block disease categories
19,Franti,2022,NA,"H49-H52: Disorders of ocular muscles, binocular movement, accommodation and refraction",ICD-10 block disease categories
19,Franti,2022,NA,H53-H54: Visual disturbances and blindness,ICD-10 block disease categories
19,Franti,2022,NA,H55-H59: Other disorders of eye and adnexa,ICD-10 block disease categories
19,Franti,2022,NA,H60-H62: Diseases of external ear,ICD-10 block disease categories
19,Franti,2022,NA,H65-H75: Diseases of middle ear and mastoid,ICD-10 block disease categories
19,Franti,2022,NA,H80-H83: Diseases of inner ear,ICD-10 block disease categories
19,Franti,2022,NA,H90-H95: Other disorders of ear,ICD-10 block disease categories
19,Franti,2022,NA,I00-I02: Acute rheumatic fever,ICD-10 block disease categories
19,Franti,2022,NA,I05-I09: Chronic rheumatic heart diseases,ICD-10 block disease categories
19,Franti,2022,NA,I26-I28: Pulmonary heart disease and diseases of pulmonary circulation,ICD-10 block disease categories
19,Franti,2022,NA,I30-I52: Other forms of heart disease,ICD-10 block disease categories
19,Franti,2022,NA,"I70-I79: Diseases of arteries, arterioles and capillaries",ICD-10 block disease categories
19,Franti,2022,NA,"I80-I89: Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified",ICD-10 block disease categories
19,Franti,2022,NA,I95-I99: Other and unspecified disorders of the circulatory system,ICD-10 block disease categories
19,Franti,2022,NA,J00-J06: Acute upper respiratory infections,ICD-10 block disease categories
19,Franti,2022,NA,J09-J18: Influenza and pneumonia,ICD-10 block disease categories
19,Franti,2022,NA,J20-J22: Other acute lower respiratory infections,ICD-10 block disease categories
19,Franti,2022,NA,J30-J39: Other diseases of upper respiratory tract,ICD-10 block disease categories
19,Franti,2022,NA,J40-J47: Chronic lower respiratory diseases,ICD-10 block disease categories
19,Franti,2022,NA,J60-J70: Lung diseases due to external agents,ICD-10 block disease categories
19,Franti,2022,NA,J80-J84: Other respiratory diseases principally affecting the interstitium,ICD-10 block disease categories
19,Franti,2022,NA,J85-J86: Suppurative and necrotic conditions of lower respiratory tract,ICD-10 block disease categories
19,Franti,2022,NA,J90-J94: Other diseases of pleura,ICD-10 block disease categories
19,Franti,2022,NA,J95-J99: Other diseases of the respiratory system,ICD-10 block disease categories
19,Franti,2022,NA,"K00-K14: Diseases of oral cavity, salivary glands and jaws",ICD-10 block disease categories
19,Franti,2022,NA,"K20-K31: Diseases of oesophagus, stomach and duodenum",ICD-10 block disease categories
19,Franti,2022,NA,K35-K38: Diseases of appendix,ICD-10 block disease categories
19,Franti,2022,NA,K40-K46: Hernia,ICD-10 block disease categories
19,Franti,2022,NA,K50-K52: Noninfective enteritis and colitis,ICD-10 block disease categories
19,Franti,2022,NA,K55-K64: Other diseases of intestines,ICD-10 block disease categories
19,Franti,2022,NA,K65-K67: Diseases of peritoneum,ICD-10 block disease categories
19,Franti,2022,NA,K70-K77: Diseases of liver,ICD-10 block disease categories
19,Franti,2022,NA,"K80-K87: Disorders of gallbladder, biliary tract and pancreas",ICD-10 block disease categories
19,Franti,2022,NA,K90-K93: Other diseases of the digestive system,ICD-10 block disease categories
19,Franti,2022,NA,L00-L08: Infections of the skin and subcutaneous tissue,ICD-10 block disease categories
19,Franti,2022,NA,L10-L14: Bullous disorders,ICD-10 block disease categories
19,Franti,2022,NA,L20-L30: Dermatitis and eczema,ICD-10 block disease categories
19,Franti,2022,NA,L40-L45: Papulosquamous disorders,ICD-10 block disease categories
19,Franti,2022,NA,L50-L54: Urticaria and erythema,ICD-10 block disease categories
19,Franti,2022,NA,L55-L59: Radiation-related disorders of the skin and subcutaneous tissue,ICD-10 block disease categories
19,Franti,2022,NA,L60-L75: Disorders of skin appendages,ICD-10 block disease categories
19,Franti,2022,NA,L80-L99: Other disorders of the skin and subcutaneous tissue,ICD-10 block disease categories
19,Franti,2022,NA,M00-M03: Infectious arthropathies,ICD-10 block disease categories
19,Franti,2022,NA,M05-M14: Inflammatory polyarthropathies,ICD-10 block disease categories
19,Franti,2022,NA,M20-M25: Other joint disorders,ICD-10 block disease categories
19,Franti,2022,NA,M30-M36: Systemic connective tissue disorders,ICD-10 block disease categories
19,Franti,2022,NA,M40-M43: Deforming dorsopathies,ICD-10 block disease categories
19,Franti,2022,NA,M45-M49: Spondylopathies,ICD-10 block disease categories
19,Franti,2022,NA,M50-M54: Other dorsopathies,ICD-10 block disease categories
19,Franti,2022,NA,M60-M63: Disorders of muscles,ICD-10 block disease categories
19,Franti,2022,NA,M65-M68: Disorders of synovium and tendon,ICD-10 block disease categories
19,Franti,2022,NA,M70-M79: Other soft tissue disorders,ICD-10 block disease categories
19,Franti,2022,NA,M80-M85: Disorders of bone density and structure,ICD-10 block disease categories
19,Franti,2022,NA,M86-M90: Other osteopathies,ICD-10 block disease categories
19,Franti,2022,NA,M91-M94: Chondropathies,ICD-10 block disease categories
19,Franti,2022,NA,M95-M99: Other disorders of the musculoskeletal system and connective tissue,ICD-10 block disease categories
19,Franti,2022,NA,N00-N08: Glomerular diseases,ICD-10 block disease categories
19,Franti,2022,NA,N10-N16: Renal tubulo-interstitial diseases,ICD-10 block disease categories
19,Franti,2022,NA,N17-N19: Renal failure,ICD-10 block disease categories
19,Franti,2022,NA,N20-N23: Urolithiasis,ICD-10 block disease categories
19,Franti,2022,NA,N25-N29: Other disorders of kidney and ureter,ICD-10 block disease categories
19,Franti,2022,NA,N30-N39: Other diseases of urinary system,ICD-10 block disease categories
19,Franti,2022,NA,N40-N51: Diseases of male genital organs,ICD-10 block disease categories
19,Franti,2022,NA,N60-N64: Disorders of breast,ICD-10 block disease categories
19,Franti,2022,NA,N70-N77: Inflammatory diseases of female pelvic organs,ICD-10 block disease categories
19,Franti,2022,NA,N80-N98: Noninflammatory disorders of female genital tract,ICD-10 block disease categories
19,Franti,2022,NA,N99-N99: Other disorders of the genitourinary system,ICD-10 block disease categories
19,Franti,2022,NA,O00-O08: Pregnancy with abortive outcome,ICD-10 block disease categories
19,Franti,2022,NA,"O10-O16: Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",ICD-10 block disease categories
19,Franti,2022,NA,O20-O29: Other maternal disorders predominantly related to pregnancy,ICD-10 block disease categories
19,Franti,2022,NA,O30-O48: Maternal care related to the fetus and amniotic cavity and possible delivery problems,ICD-10 block disease categories
19,Franti,2022,NA,O60-O75: Complications of labour and delivery,ICD-10 block disease categories
19,Franti,2022,NA,O80-O84: Delivery,ICD-10 block disease categories
19,Franti,2022,NA,O85-O92: Complications predominantly related to the puerperium,ICD-10 block disease categories
19,Franti,2022,NA,"O94-O99: Other obstetric conditions, not elsewhere classified",ICD-10 block disease categories
19,Franti,2022,NA,"P00-P04: Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery",ICD-10 block disease categories
19,Franti,2022,NA,P05-P08: Disorders related to length of gestation and fetal growth,ICD-10 block disease categories
19,Franti,2022,NA,P10-P15: Birth trauma,ICD-10 block disease categories
19,Franti,2022,NA,P20-P29: Respiratory and cardiovascular disorders specific to the perinatal period,ICD-10 block disease categories
19,Franti,2022,NA,P35-P39: Infections specific to the perinatal period,ICD-10 block disease categories
19,Franti,2022,NA,P50-P61: Haemorrhagic and haematological disorders of fetus and newborn,ICD-10 block disease categories
19,Franti,2022,NA,P70-P74: Transitory endocrine and metabolic disorders specific to fetus and newborn,ICD-10 block disease categories
19,Franti,2022,NA,P80-P83: Conditions involving the integument and temperature regulation of fetus and newborn,ICD-10 block disease categories
19,Franti,2022,NA,P90-P96: Other disorders originating in the perinatal period,ICD-10 block disease categories
19,Franti,2022,NA,Q00-Q07: Congenital malformations of the nervous system,ICD-10 block disease categories
19,Franti,2022,NA,"Q10-Q18: Congenital malformations of eye, ear, face and neck",ICD-10 block disease categories
19,Franti,2022,NA,Q20-Q28: Congenital malformations of the circulatory system,ICD-10 block disease categories
19,Franti,2022,NA,Q30-Q34: Congenital malformations of the respiratory system,ICD-10 block disease categories
19,Franti,2022,NA,Q35-Q37: Cleft lip and cleft palate,ICD-10 block disease categories
19,Franti,2022,NA,Q38-Q45: Other congenital malformations of the digestive system,ICD-10 block disease categories
19,Franti,2022,NA,Q50-Q56: Congenital malformations of genital organs,ICD-10 block disease categories
19,Franti,2022,NA,Q60-Q64: Congenital malformations of the urinary system,ICD-10 block disease categories
19,Franti,2022,NA,Q65-Q79: Congenital malformations and deformations of the musculoskeletal system,ICD-10 block disease categories
19,Franti,2022,NA,Q80-Q89: Other congenital malformations,ICD-10 block disease categories
19,Franti,2022,NA,"Q90-Q99: Chromosomal abnormalities, not elsewhere classified",ICD-10 block disease categories
19,Franti,2022,NA,S00-S09: Injuries to the head,ICD-10 block disease categories
19,Franti,2022,NA,S10-S19: Injuries to the neck,ICD-10 block disease categories
19,Franti,2022,NA,S20-S29: Injuries to the thorax,ICD-10 block disease categories
19,Franti,2022,NA,"S30-S39: Injuries to the abdomen, lower back, lumbar spine and pelvis",ICD-10 block disease categories
19,Franti,2022,NA,S40-S49: Injuries to the shoulder and upper arm,ICD-10 block disease categories
19,Franti,2022,NA,S50-S59: Injuries to the elbow and forearm,ICD-10 block disease categories
19,Franti,2022,NA,S60-S69: Injuries to the wrist and hand,ICD-10 block disease categories
19,Franti,2022,NA,S70-S79: Injuries to the hip and thigh,ICD-10 block disease categories
19,Franti,2022,NA,S80-S89: Injuries to the knee and lower leg,ICD-10 block disease categories
19,Franti,2022,NA,S90-S99: Injuries to the ankle and foot,ICD-10 block disease categories
19,Franti,2022,NA,T00-T07: Injuries involving multiple body regions,ICD-10 block disease categories
20,Hassaine,2020,asthma,NA,ICD-10 block disease categories
20,Hassaine,2020,cancer,C00-C97: cancer,ICD-10 block disease categories
20,Hassaine,2020,chronic kidney disease,NA,ICD-10 block disease categories
20,Hassaine,2020,COPD,NA,ICD-10 block disease categories
20,Hassaine,2020,dementia incl. alzheimers,NA,ICD-10 block disease categories
20,Hassaine,2020,diabetes mellitus,E10-E14: Diabetes mellitus,ICD-10 block disease categories
20,Hassaine,2020,epilepsy,NA,ICD-10 block disease categories
20,Hassaine,2020,gout,NA,ICD-10 block disease categories
20,Hassaine,2020,heart failure,NA,ICD-10 block disease categories
20,Hassaine,2020,HIV/AIDS,B20-B24: Human immunodeficiency virus [HIV] disease,ICD-10 block disease categories
20,Hassaine,2020,hypertension,I10-I15: Hypertensive diseases,ICD-10 block disease categories
20,Hassaine,2020,ischemic heart disease,I20-I25: Ischaemic heart diseases,ICD-10 block disease categories
20,Hassaine,2020,mood and anxiety disorders,F30-F39: Mood [affective] disorders,ICD-10 block disease categories
20,Hassaine,2020,multiple sclerosis,NA,ICD-10 block disease categories
20,Hassaine,2020,osteoarthritis,M15-M19: Arthrosis,ICD-10 block disease categories
20,Hassaine,2020,osteoporosis,NA,ICD-10 block disease categories
20,Hassaine,2020,parkinsons,NA,ICD-10 block disease categories
20,Hassaine,2020,rheumatoid arthritis,NA,ICD-10 block disease categories
20,Hassaine,2020,schizophrenia,"F20-F29: Schizophrenia, schizotypal and delusional disorders",ICD-10 block disease categories
20,Hassaine,2020,stroke,I60-I69: Cerebrovascular diseases,ICD-10 block disease categories
20,Hassaine,2020,NA,A00-A09: Intestinal infectious diseases,ICD-10 block disease categories
20,Hassaine,2020,NA,A30-A49: Other bacterial diseases,ICD-10 block disease categories
20,Hassaine,2020,NA,A50-A64: Infections with a predominantly sexual mode of transmission,ICD-10 block disease categories
20,Hassaine,2020,NA,B00-B09: Viral infections characterized by skin and mucous membrane lesions,ICD-10 block disease categories
20,Hassaine,2020,NA,B25-B34: Other viral diseases,ICD-10 block disease categories
20,Hassaine,2020,NA,B35-B49: Mycoses,ICD-10 block disease categories
20,Hassaine,2020,NA,"B85-B89: Pediculosis, acariasis and other infestations",ICD-10 block disease categories
20,Hassaine,2020,NA,"B95-B98: Bacterial, viral and other infectious agents",ICD-10 block disease categories
20,Hassaine,2020,NA,D00-D09: In situ neoplasms,ICD-10 block disease categories
20,Hassaine,2020,NA,D10-D36: Benign neoplasms,ICD-10 block disease categories
20,Hassaine,2020,NA,D37-D48: Neoplasms of uncertain or unknown behaviour,ICD-10 block disease categories
20,Hassaine,2020,NA,D50-D53: Nutritional anaemias,ICD-10 block disease categories
20,Hassaine,2020,NA,D60-D64: Aplastic and other anaemias,ICD-10 block disease categories
20,Hassaine,2020,NA,D70-D77: Other diseases of blood and blood-forming organs,ICD-10 block disease categories
20,Hassaine,2020,NA,E00-E07: Disorders of thyroid gland,ICD-10 block disease categories
20,Hassaine,2020,NA,E08-E14: NA,ICD-10 block disease categories
20,Hassaine,2020,NA,E15-E16: Other disorders of glucose regulation and pancreatic internal secretion,ICD-10 block disease categories
20,Hassaine,2020,NA,E20-E35: Disorders of other endocrine glands,ICD-10 block disease categories
20,Hassaine,2020,NA,E50-E64: Other nutritional deficiencies,ICD-10 block disease categories
20,Hassaine,2020,NA,E65-E68: Obesity and other hyperalimentation,ICD-10 block disease categories
20,Hassaine,2020,NA,E70-E90: Metabolic disorders,ICD-10 block disease categories
20,Hassaine,2020,NA,F10-F19: Mental and behavioural disorders due to psychoactive substance use,ICD-10 block disease categories
20,Hassaine,2020,NA,"F40-F48: Neurotic, stress-related and somatoform disorders",ICD-10 block disease categories
20,Hassaine,2020,NA,F50-F59: Behavioural syndromes associated with physiological disturbances and physical factors,ICD-10 block disease categories
20,Hassaine,2020,NA,G20-G26: Extrapyramidal and movement disorders,ICD-10 block disease categories
20,Hassaine,2020,NA,G30-G32: Other degenerative diseases of the nervous system,ICD-10 block disease categories
20,Hassaine,2020,NA,G40-G47: Episodic and paroxysmal disorders,ICD-10 block disease categories
20,Hassaine,2020,NA,"G50-G59: Nerve, nerve root and plexus disorders",ICD-10 block disease categories
20,Hassaine,2020,NA,G80-G83: Cerebral palsy and other paralytic syndromes,ICD-10 block disease categories
20,Hassaine,2020,NA,"H00-H06: Disorders of eyelid, lacrimal system and orbit",ICD-10 block disease categories
20,Hassaine,2020,NA,H10-H13: Disorders of conjunctiva,ICD-10 block disease categories
20,Hassaine,2020,NA,"H15-H22: Disorders of sclera, cornea, iris and ciliary body",ICD-10 block disease categories
20,Hassaine,2020,NA,H25-H28: Disorders of lens,ICD-10 block disease categories
20,Hassaine,2020,NA,H30-H36: Disorders of choroid and retina,ICD-10 block disease categories
20,Hassaine,2020,NA,H40-H42: Glaucoma,ICD-10 block disease categories
20,Hassaine,2020,NA,H43-H45: Disorders of vitreous body and globe,ICD-10 block disease categories
20,Hassaine,2020,NA,"H49-H52: Disorders of ocular muscles, binocular movement, accommodation and refraction",ICD-10 block disease categories
20,Hassaine,2020,NA,H53-H54: Visual disturbances and blindness,ICD-10 block disease categories
20,Hassaine,2020,NA,H55-H59: Other disorders of eye and adnexa,ICD-10 block disease categories
20,Hassaine,2020,NA,H60-H62: Diseases of external ear,ICD-10 block disease categories
20,Hassaine,2020,NA,H65-H75: Diseases of middle ear and mastoid,ICD-10 block disease categories
20,Hassaine,2020,NA,H80-H83: Diseases of inner ear,ICD-10 block disease categories
20,Hassaine,2020,NA,H90-H95: Other disorders of ear,ICD-10 block disease categories
20,Hassaine,2020,NA,I26-I28: Pulmonary heart disease and diseases of pulmonary circulation,ICD-10 block disease categories
20,Hassaine,2020,NA,I30-I52: Other forms of heart disease,ICD-10 block disease categories
20,Hassaine,2020,NA,"I70-I79: Diseases of arteries, arterioles and capillaries",ICD-10 block disease categories
20,Hassaine,2020,NA,"I80-I89: Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified",ICD-10 block disease categories
20,Hassaine,2020,NA,I95-I99: Other and unspecified disorders of the circulatory system,ICD-10 block disease categories
20,Hassaine,2020,NA,J00-J06: Acute upper respiratory infections,ICD-10 block disease categories
20,Hassaine,2020,NA,J09-J18: Influenza and pneumonia,ICD-10 block disease categories
20,Hassaine,2020,NA,J20-J22: Other acute lower respiratory infections,ICD-10 block disease categories
20,Hassaine,2020,NA,J30-J39: Other diseases of upper respiratory tract,ICD-10 block disease categories
20,Hassaine,2020,NA,J40-J47: Chronic lower respiratory diseases,ICD-10 block disease categories
20,Hassaine,2020,NA,J90-J94: Other diseases of pleura,ICD-10 block disease categories
20,Hassaine,2020,NA,"K00-K14: Diseases of oral cavity, salivary glands and jaws",ICD-10 block disease categories
20,Hassaine,2020,NA,"K20-K31: Diseases of oesophagus, stomach and duodenum",ICD-10 block disease categories
20,Hassaine,2020,NA,K40-K46: Hernia,ICD-10 block disease categories
20,Hassaine,2020,NA,K50-K52: Noninfective enteritis and colitis,ICD-10 block disease categories
20,Hassaine,2020,NA,K55-K64: Other diseases of intestines,ICD-10 block disease categories
20,Hassaine,2020,NA,K70-K77: Diseases of liver,ICD-10 block disease categories
20,Hassaine,2020,NA,"K80-K87: Disorders of gallbladder, biliary tract and pancreas",ICD-10 block disease categories
20,Hassaine,2020,NA,K90-K93: Other diseases of the digestive system,ICD-10 block disease categories
20,Hassaine,2020,NA,L00-L08: Infections of the skin and subcutaneous tissue,ICD-10 block disease categories
20,Hassaine,2020,NA,L20-L30: Dermatitis and eczema,ICD-10 block disease categories
20,Hassaine,2020,NA,L40-L45: Papulosquamous disorders,ICD-10 block disease categories
20,Hassaine,2020,NA,L50-L54: Urticaria and erythema,ICD-10 block disease categories
20,Hassaine,2020,NA,L55-L59: Radiation-related disorders of the skin and subcutaneous tissue,ICD-10 block disease categories
20,Hassaine,2020,NA,L60-L75: Disorders of skin appendages,ICD-10 block disease categories
20,Hassaine,2020,NA,L80-L99: Other disorders of the skin and subcutaneous tissue,ICD-10 block disease categories
20,Hassaine,2020,NA,M30-M36: Systemic connective tissue disorders,ICD-10 block disease categories
20,Hassaine,2020,NA,M60-M79: Soft tissue disorders,ICD-10 block disease categories
20,Hassaine,2020,NA,M80-M94: Osteopathies and chondropathies,ICD-10 block disease categories
20,Hassaine,2020,NA,N10-N16: Renal tubulo-interstitial diseases,ICD-10 block disease categories
20,Hassaine,2020,NA,N17-N19: Renal failure,ICD-10 block disease categories
20,Hassaine,2020,NA,N20-N23: Urolithiasis,ICD-10 block disease categories
20,Hassaine,2020,NA,N30-N39: Other diseases of urinary system,ICD-10 block disease categories
20,Hassaine,2020,NA,N40-N51: Diseases of male genital organs,ICD-10 block disease categories
20,Hassaine,2020,NA,N60-N64: Disorders of breast,ICD-10 block disease categories
20,Hassaine,2020,NA,N70-N77: Inflammatory diseases of female pelvic organs,ICD-10 block disease categories
20,Hassaine,2020,NA,N80-N98: Noninflammatory disorders of female genital tract,ICD-10 block disease categories
21,Ioakeim-Skoufa,2020,asthma,Asthma,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,cancer,Cancer,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,chronic kidney disease,Chronic renal failure,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,COPD,"Emphysema, chronic bronchitis, COPD","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,dementia incl. alzheimers,Dementia and delirium,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,diabetes mellitus,Diabetes,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,epilepsy,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,gout,Gout,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,heart failure,Congestive heart failure,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,HIV/AIDS,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,hypertension,Hypertension,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,ischemic heart disease,Ischemic heart disease,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,mood and anxiety disorders,"Depression; Anxiety, neuroses","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,multiple sclerosis,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,osteoarthritis,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,osteoporosis,Osteoporosis,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,parkinsons,Parkinson's disease,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,rheumatoid arthritis,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,schizophrenia,Schizophrenia and affective psychosis,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,stroke,Cerebrovascular disease,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Anxiety, neuroses","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Arthropathy,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Autoimmune and connective tissue diseases,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Behavior problems,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Blindness,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Cardiac arrhythmia,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Cardiac valve disorders,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Cardiovascular disorders, other","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Cataract, aphakia","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Cervical pain syndromes,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Chronic cystic disease of the breast,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Chronic ulcer of the skin,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Congenital anomalies of limbs, hands, and feet","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Deafness, hearing loss","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Depression,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Dermatitis and eczema,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Diabetic retinopathy,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Disease of hair and hair follicles,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Disorders of lipid metabolism,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Diverticular disease of colon,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Gastroesophageal reflux,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Generalized atherosclerosis,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Glaucoma,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Hematologic disorders, other","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Hypothyroidism,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Iron deficiency, other deficiency anemias","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Irritable bowel syndrome,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Kyphoscoliosis,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Low back pain,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Neurologic disorders, other","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Obesity,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Other endocrine disorders,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Peripheral neuropathy, neuritis","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Peripheral vascular disease,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Prostatic hypertrophy,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Psoriasis,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Renal calculi,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,"Respiratory disorders, other","EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Retinal disorders (excluding diabetic retinopathy),"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Seizure disorder,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Substance use,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Surgical aftercare,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Thrombophlebitis,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Utero-vaginal prolapse,"EDC AGCs, chronic conditions defined by Salisbury list"
21,Ioakeim-Skoufa,2020,NA,Varicose veins of lower extremities,"EDC AGCs, chronic conditions defined by Salisbury list"
22,Ioakeim-Skoufa,2022,asthma,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,cancer,neoplasms,CCS CCI diseases
22,Ioakeim-Skoufa,2022,chronic kidney disease,KD,CCS CCI diseases
22,Ioakeim-Skoufa,2022,COPD,﻿COPD,CCS CCI diseases
22,Ioakeim-Skoufa,2022,dementia incl. alzheimers,delirium and dementia,CCS CCI diseases
22,Ioakeim-Skoufa,2022,diabetes mellitus,DM,CCS CCI diseases
22,Ioakeim-Skoufa,2022,epilepsy,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,gout,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,heart failure,CHF,CCS CCI diseases
22,Ioakeim-Skoufa,2022,HIV/AIDS,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,hypertension,hypertension,CCS CCI diseases
22,Ioakeim-Skoufa,2022,ischemic heart disease,acute myocardial infarction,CCS CCI diseases
22,Ioakeim-Skoufa,2022,mood and anxiety disorders,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,multiple sclerosis,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,osteoarthritis,osteoarthritis,CCS CCI diseases
22,Ioakeim-Skoufa,2022,osteoporosis,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,parkinsons,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,rheumatoid arthritis,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,schizophrenia,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,stroke,NA,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,anaemias,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,cardiac arrhythmias,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,chronic ulcer of skin,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,coagulation/haemorrhagic disorders,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,﻿dyslipidaemia,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,endocrine–metabolic disorders,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,﻿genitourinary symptoms,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,ictus,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,prostate hyperplasia,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,thyroid disorders,CCS CCI diseases
22,Ioakeim-Skoufa,2022,NA,visual deficits,CCS CCI diseases
23,Lind,2020,asthma,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,cancer,Neoplasms,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,chronic kidney disease,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,COPD,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,dementia incl. alzheimers,Dementia,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,diabetes mellitus,Diabetes,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,epilepsy,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,gout,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,heart failure,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,HIV/AIDS,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,hypertension,Hypertension,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,ischemic heart disease,Heart disease,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,mood and anxiety disorders,Depression; Anxiety,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,multiple sclerosis,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,osteoarthritis,Arthritis,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,osteoporosis,Osteoporosis,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,parkinsons,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,rheumatoid arthritis,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,schizophrenia,NA,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,stroke,Cerebrovascular disease & stroke,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Anxiety,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Arrhythmias,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Cognitive impairment,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Constipation,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Depression,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Dyslipidaemia,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Eye issues including dry eyes,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Lower respiratory disease,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Pain,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Peptic ulcer disease or GERD,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Skin allergies,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
23,Lind,2020,NA,Urinary incontinence,"Custom groupings of HER records and ATC codes. Note: presented probabilities of class membership, I reported top 3 highest probability diseases for each cluster."
24,M﻿øller,2020,asthma,J45,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,cancer,"C43, C50, C15-C26, C51-C58, C60-C63, C30-C39, C00-C14, C40-C41, C45-C49, C64-C68, C69-C72, C73-C75, C81-C96","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,chronic kidney disease,N18,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,COPD,"J40, J41, J42, J43, J44, J47, J96","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,dementia incl. alzheimers,"F00, F01, F02, F03, G30, G31.0B, G31.8B, G31.8E, G31.9","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,diabetes mellitus,"E10, E11","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,epilepsy,"G40, G41","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,gout,NA,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,heart failure,NA,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,HIV/AIDS,"B20, B21, B22, B23, B24","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,hypertension,"I10, I12, I15","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,ischemic heart disease,NA,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,mood and anxiety disorders,"F40.1, F41.1, F06.32, F32, F33, F34.1","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,multiple sclerosis,G35,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,osteoarthritis,"M15, M16, M17, M18, M19","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,osteoporosis,"M80, M81, M82","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,parkinsons,"F02.3, G20, G21, G22","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,rheumatoid arthritis,NA,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,schizophrenia,"F20, F21, F22, F25, F28, F29","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,stroke,"G45, G46, I60, I61, I62, I63, I64, I65, I66, I67, I68, I69","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Alcohol attributable diseases (G31.2, G62.1, G72.1, K29.2, K70, K86.0)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Anxiety (F40.1, F41.1)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Aortic and mitral valve disease (I05, I06, I34, I35)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,Atherosclerosis (I70),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,Atrial fibrillation and flutter (I48),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Bipolar affective disorder (F30, F31)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,Blindness (H54),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Crohns‚Äôs disease and ulcerative colitis (K50, K51)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Depression (F06.32, F32, F33, F34.1)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Diseases of liver, biliary tract and pancreas (K71, K72, K73, K74, K75, K76, K77, K86.1, K87)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Disorders of lipoprotein metabolism and other lipidaemias (E78.0, E78.2, E78.4, E78.5)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,Eating disorders (F50),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,Fibromyalgia (M79.7),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Inflammatory polyarthropathies (M05, M06.0, M06.8, M07.0, M07.1, M07.3, M10.0, M10.9)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Injuries of nerves and spinal cord and paralytic syndromes (G81, G82, G83, S14, S24, S34, T09.3)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,Irritable bowel disease (K58),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Ischemic heart disease and heart failure (I11, I13, I20, I21, I23, I24, I25, I50)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Migraine and other headache syndromes (G43, G44)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,Obsessive-compulsive disorder (F42),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,Phlebitis and thrombophlebitis (I80),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,PTSD (F43.1),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Pulmonary heart disease and diseases of pulmonary circulation (I26, I27, I28)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Respiratory allergy (J30.1, J30.2, J30.3, J30.4)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Spondylopathies and other dorsopathies (M40, M41, M42, M43, M45, M46, M47, M48, M49, M50, M51, M53, M54)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,"Thyroid diseases (E00, E01, E02, E03, E04, E05, E06, E07)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
24,M﻿øller,2020,NA,Tinnitus (H93.1),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
25,Nichols,2022,asthma,Asthma,Select list of chronic conditions
25,Nichols,2022,cancer,All cancer,Select list of chronic conditions
25,Nichols,2022,chronic kidney disease,Chronic kidney disease,Select list of chronic conditions
25,Nichols,2022,COPD,COPD,Select list of chronic conditions
25,Nichols,2022,dementia incl. alzheimers,Alzheimers/dementia,Select list of chronic conditions
25,Nichols,2022,diabetes mellitus,Diabetes,Select list of chronic conditions
25,Nichols,2022,epilepsy,Epilepsy,Select list of chronic conditions
25,Nichols,2022,gout,Gout,Select list of chronic conditions
25,Nichols,2022,heart failure,Heart failure,Select list of chronic conditions
25,Nichols,2022,HIV/AIDS,NA,Select list of chronic conditions
25,Nichols,2022,hypertension,Hypertension,Select list of chronic conditions
25,Nichols,2022,ischemic heart disease,Ischemic heart disease,Select list of chronic conditions
25,Nichols,2022,mood and anxiety disorders,Anxiety; Depression,Select list of chronic conditions
25,Nichols,2022,multiple sclerosis,NA,Select list of chronic conditions
25,Nichols,2022,osteoarthritis,Osteoarthritis,Select list of chronic conditions
25,Nichols,2022,osteoporosis,Osteoporosis,Select list of chronic conditions
25,Nichols,2022,parkinsons,Parkinson’s disease,Select list of chronic conditions
25,Nichols,2022,rheumatoid arthritis,NA,Select list of chronic conditions
25,Nichols,2022,schizophrenia,NA,Select list of chronic conditions
25,Nichols,2022,stroke,Stroke/TIA,Select list of chronic conditions
25,Nichols,2022,NA,Age-related macular degeneration,Select list of chronic conditions
25,Nichols,2022,NA,Alcohol/substance misuse,Select list of chronic conditions
25,Nichols,2022,NA,Anxiety,Select list of chronic conditions
25,Nichols,2022,NA,Aortic aneurysm,Select list of chronic conditions
25,Nichols,2022,NA,Atrial fibrillation,Select list of chronic conditions
25,Nichols,2022,NA,Autoimmune disease of bowel,Select list of chronic conditions
25,Nichols,2022,NA,Autoimmune disease of connective tissue,Select list of chronic conditions
25,Nichols,2022,NA,Benign prostatic hypertrophy,Select list of chronic conditions
25,Nichols,2022,NA,Blindness,Select list of chronic conditions
25,Nichols,2022,NA,Bronchiectasis,Select list of chronic conditions
25,Nichols,2022,NA,Cataract,Select list of chronic conditions
25,Nichols,2022,NA,Chronic liver disease,Select list of chronic conditions
25,Nichols,2022,NA,Deafness,Select list of chronic conditions
25,Nichols,2022,NA,Depression,Select list of chronic conditions
25,Nichols,2022,NA,Diverticulitis,Select list of chronic conditions
25,Nichols,2022,NA,Eczema,Select list of chronic conditions
25,Nichols,2022,NA,Erectile dysfunction,Select list of chronic conditions
25,Nichols,2022,NA,Glaucoma,Select list of chronic conditions
25,Nichols,2022,NA,Heart valve disease,Select list of chronic conditions
25,Nichols,2022,NA,Hyperthyroid,Select list of chronic conditions
25,Nichols,2022,NA,Hypothyroid,Select list of chronic conditions
25,Nichols,2022,NA,Irritable bowel syndrome,Select list of chronic conditions
25,Nichols,2022,NA,Migraine,Select list of chronic conditions
25,Nichols,2022,NA,Obstructive sleep apnoea,Select list of chronic conditions
25,Nichols,2022,NA,Other autoimmune disease,Select list of chronic conditions
25,Nichols,2022,NA,Other heart disease,Select list of chronic conditions
25,Nichols,2022,NA,Peptic ulcer,Select list of chronic conditions
25,Nichols,2022,NA,Peripheral vascular disease,Select list of chronic conditions
25,Nichols,2022,NA,Psoriasis,Select list of chronic conditions
25,Nichols,2022,NA,Pulmonary embolism,Select list of chronic conditions
25,Nichols,2022,NA,Rhinitis/conjunctivitis,Select list of chronic conditions
25,Nichols,2022,NA,Serious mental illness,Select list of chronic conditions
25,Nichols,2022,NA,Sinusitis,Select list of chronic conditions
25,Nichols,2022,NA,Venous thromboembolism,Select list of chronic conditions
26,Planell-Morell,2020,asthma,NA,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,cancer,Cancer,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,chronic kidney disease,Chronic Kidney Disease (CKD),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,COPD,COPD,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,dementia incl. alzheimers,Dementia,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,diabetes mellitus,Diabetes,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,epilepsy,NA,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,gout,NA,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,heart failure,Heart Failure (HF),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,HIV/AIDS,NA,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,hypertension,NA,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,ischemic heart disease,Coronary Heart Disease (CHD),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,mood and anxiety disorders,Anxiety; Depression,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,multiple sclerosis,Multiple Sclerosis (MS),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,osteoarthritis,Osteoarthritis,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,osteoporosis,Osteoporosis (Osteo),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,parkinsons,Parkinson’s disease,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,rheumatoid arthritis,Rheumatoid Arthritis (RA),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,schizophrenia,NA,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,stroke,Stroke or TIA,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Alcohol problems,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Anxiety,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,﻿Atrial Fibrillation (AF),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Chronic liver disease (CLD),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Depression,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Diverticulitis of intestine (Div),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Epilepsy,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Glaucoma,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Hypothyroidism,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Inflammatory Bowel Disease (IBD),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Learning Disabilities (LD),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Motor Neurone Disease (MND),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Peripheral Arterial Disease (PAD),"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Prostate disorders,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Psoriasis,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Psychoactive substance misuse,"CPRD/CALIBER disease groupings, selected list for this study"
26,Planell-Morell,2020,NA,Severe Mental Illness (SMI),"CPRD/CALIBER disease groupings, selected list for this study"
27,Poblador-Plou,2014,asthma,Asthma,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,cancer,"Malignant neoplasms of the skin; Malignant neoplasms, bladder; Malignant neoplasms, colorectal; Malignant neoplasms, prostate; Mild malignant neoplasms; Malignant neoplasms, breast","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,chronic kidney disease,NA,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,COPD,NA,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,dementia incl. alzheimers,Dementia and delirium,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,diabetes mellitus,Diabetes,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,epilepsy,Seizure disorder,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,gout,Gout,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,heart failure,Congestive heart failure,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,HIV/AIDS,NA,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,hypertension,Hypertension,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,ischemic heart disease,Ischemic heart disease (excluding AMI); Acute myocardial infarction,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,mood and anxiety disorders,"Anxiety, neuroses; Depression","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,multiple sclerosis,NA,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,osteoarthritis,NA,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,osteoporosis,Osteoporosis,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,parkinsons,Parkinson’s disease,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,rheumatoid arthritis,NA,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,schizophrenia,NA,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,stroke,Cerebrovascular disease,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Anxiety, neuroses","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Arthropathy,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Attention deficit disorder,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Behaviour problems,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Cardiac arrhythmia,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Cardiac valve disorders,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Cardiovascular disorders, other","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Cataract, aphakia","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Cervical pain syndromes,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Chronic cystic disease of the breast,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Chronic liver disease,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Chronic ulcer of the skin,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Deafness, hearing loss","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Depression,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Dermatitis and eczema,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Developmental disorder,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Disease of hair and hair follicles,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Disorders of lipid metabolism,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Disorders of lipoid metabolism,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Diverticular disease of colon,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Emphysema, chronic bronchitis, COPD","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Gastro-oesophageal reflux,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Generalised atherosclerosis,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Glaucoma,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Hematologic disorders, other","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Inflammatory bowel disease,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Iron deficiency, other deficiency anaemias","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Iron deficiency, other deficiency anemias","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Irritable bowel syndrome,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Kyphoscoliosis,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Low back pain,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Neurologic disorders, other","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Obesity,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Other endocrine disorders,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,"Peripheral neuropathy, neuritis","EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Personality disorders,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Prostatic hypertrophy,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Prostatitis,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Psoriasis,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Renal calculi,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Retinal disorders (excluding diab. retin.),"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Retinal disorders (excluding diabetic retinopathy),"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Substance use,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Thrombophlebitis,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Thyroid disease,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Utero-vaginal prolapse,"EDC AGCs, chronic conditions similar to Salisbury list"
27,Poblador-Plou,2014,NA,Varicose veins of lower extremities,"EDC AGCs, chronic conditions similar to Salisbury list"
28,Robertson,2022,asthma,Asthma,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,cancer,"Cancer, lymphoma; Cancer, metastatic; cancer, non-metastatic","ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,chronic kidney disease,Chronic kidney disease,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,COPD,NA,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,dementia incl. alzheimers,Dementia,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,diabetes mellitus,Diabetes,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,epilepsy,Epilepsy,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,gout,NA,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,heart failure,Chronic heart failure,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,HIV/AIDS,NA,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,hypertension,Hypertension,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,ischemic heart disease,Myocardial infarction,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,mood and anxiety disorders,Depression,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,multiple sclerosis,Multiple sclerosis,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,osteoarthritis,NA,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,osteoporosis,NA,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,parkinsons,Parkinson’s disease,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,rheumatoid arthritis,Rheumatoid arthritis,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,schizophrenia,Schizophrenia,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,stroke,Stroke or TIA,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Alcohol misuse,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Atrial fibrillation,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,"Cancer, lymphoma","ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,"Cancer, metastatic","ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,"Cancer, non-metastatic (breast, cervical, colorectal, lung, prostate)","ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Chronic pain,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Chronic pulmonary disease,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Chronic viral hepatitis B,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Cirrhosis,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Depression,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Hypothyroidism,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Inflammatory bowel disease,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Irritable bowel syndrome,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Peptic ulcer disease,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Peripheral vascular disease,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Psoriasis,"ICD codes grouped by Tonelli, 2015"
28,Robertson,2022,NA,Severe constipation,"ICD codes grouped by Tonelli, 2015"
29,Siah,2022,asthma,asthma,READ codes grouped by clinicians into disease categories
29,Siah,2022,cancer,"Bladder Cancer, Breast Cancer, Cervix Cancer, Colorectal Cancer, Leukemias, Liver Cancer, Lung Cancer, Melanoma, Osophageal Cancer, Ovarian Cancer, Pancreas Cancer, Prostate Cancer, Stomach Cancer, Testicular Cancer, Uterus Cancer, Thyroid Cancer",READ codes grouped by clinicians into disease categories
29,Siah,2022,chronic kidney disease,Kidney Disease,READ codes grouped by clinicians into disease categories
29,Siah,2022,COPD,COPD,READ codes grouped by clinicians into disease categories
29,Siah,2022,dementia incl. alzheimers,Dementia,READ codes grouped by clinicians into disease categories
29,Siah,2022,diabetes mellitus,Diabetes,READ codes grouped by clinicians into disease categories
29,Siah,2022,epilepsy,NA,READ codes grouped by clinicians into disease categories
29,Siah,2022,gout,NA,READ codes grouped by clinicians into disease categories
29,Siah,2022,heart failure,Heart Failure,READ codes grouped by clinicians into disease categories
29,Siah,2022,HIV/AIDS,HIV/AIDS,READ codes grouped by clinicians into disease categories
29,Siah,2022,hypertension,Hypertension,READ codes grouped by clinicians into disease categories
29,Siah,2022,ischemic heart disease,Ml,READ codes grouped by clinicians into disease categories
29,Siah,2022,mood and anxiety disorders,NA,READ codes grouped by clinicians into disease categories
29,Siah,2022,multiple sclerosis,Multiple Sclerosis,READ codes grouped by clinicians into disease categories
29,Siah,2022,osteoarthritis,NA,READ codes grouped by clinicians into disease categories
29,Siah,2022,osteoporosis,NA,READ codes grouped by clinicians into disease categories
29,Siah,2022,parkinsons,Parkinson's Disease,READ codes grouped by clinicians into disease categories
29,Siah,2022,rheumatoid arthritis,NA,READ codes grouped by clinicians into disease categories
29,Siah,2022,schizophrenia,NA,READ codes grouped by clinicians into disease categories
29,Siah,2022,stroke,Stroke,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Angina,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Aortic Aneurysm,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Atrial Flbrlllation,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Cancer-related,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Cardiac Arrhythmia,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Cardiac-related,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Coronary Artery Disease,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Encephalitis,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Heart Valve Disorder,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Kidney-related,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Liver Disease,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Liver-related,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Lupus,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,other Aneurysms,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Peripheral Artery Disease,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Respiratory-related,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,Stroke-related,READ codes grouped by clinicians into disease categories
29,Siah,2022,NA,TIA,READ codes grouped by clinicians into disease categories
31,Vetrano,2020,asthma,Asthma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,cancer,Hematological neoplasms; ﻿solid neoplasms,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,chronic kidney disease,Chronic kidney diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,COPD,"COPD, Emphysema, Chronic Bronchitis","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,dementia incl. alzheimers,Dementia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,diabetes mellitus,Diabetes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,epilepsy,epilepsy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,gout,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,heart failure,heart failure,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,HIV/AIDS,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,hypertension,Hypertension,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,ischemic heart disease,Ischemic heart disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,mood and anxiety disorders,Depression and mood diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,multiple sclerosis,Multiple Sclerosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,osteoarthritis,Osteoarthritis and other degenerative joint disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,osteoporosis,Osteoporosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,parkinsons,Parkinson and parkinsonism,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,rheumatoid arthritis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,schizophrenia,﻿schizophrenia and delusional diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,stroke,cerebrovascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,Anemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,Atrial fibrillation,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,Autoimmune diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿blood and blood forming organ diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,Bradycardias and conduction diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,cardiac valve diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,cataract and other lens diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,chromosomal abnormalities,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,chronic infectious diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,chronic liver diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,"chronic pancreas, biliary tract and gallbladder diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,chronic ulcer of the skin,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,colitis and related diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,dorsopathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,dyslipidemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,"ear, nose, throat diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,"esophagus, stomach and duodenum diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,glaucoma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,hearing impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,hypercholesterolemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,inflammatory arthropathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,inflammatory bowel diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,migraine and facial pain syndromes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,"﻿neurotic, stress-related and somatoform diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,obesity,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿other cardiovascular diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿other digestive diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,other eye diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿other genitourinary diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿other metabolic diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿other musculoskeletal and joint diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿other neurological diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿other psychiatric and behavioral diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿other respiratory diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿other skin diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿peripheral neuropathy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,peripheral vascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,prostate diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿sleep disorders,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,thyroid diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,﻿venous and lymphatic diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
31,Vetrano,2020,NA,visual impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Excluded from meta-analysis b/c no info provided on diseases distributions in each cluster."
32,Violan,2019,asthma,Asthma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,cancer,Hematological neoplasms; ﻿solid neoplasms,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,chronic kidney disease,Chronic kidney diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,COPD,"COPD, Emphysema, Chronic Bronchitis","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,dementia incl. alzheimers,Dementia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,diabetes mellitus,Diabetes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,epilepsy,epilepsy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,gout,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,heart failure,heart failure,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,HIV/AIDS,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,hypertension,Hypertension,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,ischemic heart disease,Ischemic heart disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,mood and anxiety disorders,Depression and mood diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,multiple sclerosis,Multiple Sclerosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,osteoarthritis,Osteoarthritis and other degenerative joint disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,osteoporosis,Osteoporosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,parkinsons,Parkinson and parkinsonism,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,rheumatoid arthritis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,schizophrenia,﻿schizophrenia and delusional diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,stroke,cerebrovascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,Anemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,Atrial fibrillation,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,Autoimmune diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿blood and blood forming organ diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,Bradycardias and conduction diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,cardiac valve diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,cataract and other lens diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,chromosomal abnormalities,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,chronic infectious diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,chronic liver diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,"chronic pancreas, biliary tract and gallbladder diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,chronic ulcer of the skin,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,colitis and related diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,dorsopathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,dyslipidemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,"ear, nose, throat diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,"esophagus, stomach and duodenum diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,glaucoma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,hearing impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,hypercholesterolemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,inflammatory arthropathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,inflammatory bowel diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,migraine and facial pain syndromes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,"﻿neurotic, stress-related and somatoform diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,obesity,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿other cardiovascular diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿other digestive diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,other eye diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿other genitourinary diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿other metabolic diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿other musculoskeletal and joint diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿other neurological diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿other psychiatric and behavioral diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿other respiratory diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿other skin diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿peripheral neuropathy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,peripheral vascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,prostate diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿sleep disorders,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,thyroid diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,﻿venous and lymphatic diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
32,Violan,2019,NA,visual impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,asthma,Asthma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,cancer,Hematological neoplasms; ﻿solid neoplasms,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,chronic kidney disease,Chronic kidney diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,COPD,"COPD, Emphysema, Chronic Bronchitis","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,dementia incl. alzheimers,Dementia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,diabetes mellitus,Diabetes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,epilepsy,epilepsy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,gout,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,heart failure,heart failure,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,HIV/AIDS,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,hypertension,Hypertension,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,ischemic heart disease,Ischemic heart disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,mood and anxiety disorders,Depression and mood diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,multiple sclerosis,Multiple Sclerosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,osteoarthritis,Osteoarthritis and other degenerative joint disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,osteoporosis,Osteoporosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,parkinsons,Parkinson and parkinsonism,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,rheumatoid arthritis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,schizophrenia,﻿schizophrenia and delusional diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,stroke,cerebrovascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,Anemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,Atrial fibrillation,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,Autoimmune diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿blood and blood forming organ diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,Bradycardias and conduction diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,cardiac valve diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,cataract and other lens diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,chromosomal abnormalities,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,chronic infectious diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,chronic liver diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,"chronic pancreas, biliary tract and gallbladder diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,chronic ulcer of the skin,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,colitis and related diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,dorsopathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,dyslipidemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,"ear, nose, throat diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,"﻿esophagus, stomach and duodenum diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,glaucoma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,hearing impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,hypercholesterolemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,inflammatory arthropathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,inflammatory bowel diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,migraine and facial pain syndromes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,"﻿neurotic, stress-related and somatoform diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,obesity,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿other cardiovascular diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿other digestive diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,other eye diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿other genitourinary diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿other metabolic diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿other musculoskeletal and joint diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿other neurological diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿other psychiatric and behavioral diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿other respiratory diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿other skin diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿peripheral neuropathy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,peripheral vascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,prostate diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿sleep disorders,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,thyroid diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,﻿venous and lymphatic diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
33,Violan,2020,NA,visual impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016"
34,Webster,2021,asthma,J45,3- and some 4-digit ICD-10 codes
34,Webster,2021,cancer,"C25, C34, C44, C67",3- and some 4-digit ICD-10 codes
34,Webster,2021,chronic kidney disease,"E112, N18",3- and some 4-digit ICD-10 codes
34,Webster,2021,COPD,"J440, J441",3- and some 4-digit ICD-10 codes
34,Webster,2021,dementia incl. alzheimers,NA,3- and some 4-digit ICD-10 codes
34,Webster,2021,diabetes mellitus,E11,3- and some 4-digit ICD-10 codes
34,Webster,2021,epilepsy,NA,3- and some 4-digit ICD-10 codes
34,Webster,2021,gout,NA,3- and some 4-digit ICD-10 codes
34,Webster,2021,heart failure,I50,3- and some 4-digit ICD-10 codes
34,Webster,2021,HIV/AIDS,NA,3- and some 4-digit ICD-10 codes
34,Webster,2021,hypertension,I10,3- and some 4-digit ICD-10 codes
34,Webster,2021,ischemic heart disease,I20,3- and some 4-digit ICD-10 codes
34,Webster,2021,mood and anxiety disorders,NA,3- and some 4-digit ICD-10 codes
34,Webster,2021,multiple sclerosis,NA,3- and some 4-digit ICD-10 codes
34,Webster,2021,osteoarthritis,M15,3- and some 4-digit ICD-10 codes
34,Webster,2021,osteoporosis,M81,3- and some 4-digit ICD-10 codes
34,Webster,2021,parkinsons,G20,3- and some 4-digit ICD-10 codes
34,Webster,2021,rheumatoid arthritis,NA,3- and some 4-digit ICD-10 codes
34,Webster,2021,schizophrenia,NA,3- and some 4-digit ICD-10 codes
34,Webster,2021,stroke,"I63, I64",3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,A045,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,A08,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,A41,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,B34,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,D12,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,D649,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,E16,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,E871,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,E875,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,G473,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,H250,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,H251,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,H258,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,H33,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,I26,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,I35,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,I48,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,I70,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,I74,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,I83,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,I85,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,I95,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,J06,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,J18,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,J22,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,J47,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,J84,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,K29,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,K42,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,K590,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,K61,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,K621,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,K80,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,K81,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,K900,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,L02,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,L03,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,L97,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,M25,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,M47,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,M48,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,M51,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,M54,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,M653,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,M750,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,M754,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,M796,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,N17,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,N390,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R042,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R060,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R073,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R104,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R11,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R194,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R296,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R634,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R69,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,R91,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,S72,3- and some 4-digit ICD-10 codes
34,Webster,2021,NA,S82,3- and some 4-digit ICD-10 codes
35,Tan,2020,asthma,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,cancer,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,chronic kidney disease,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,COPD,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,dementia incl. alzheimers,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,diabetes mellitus,Diabetes,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,epilepsy,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,gout,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,heart failure,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,HIV/AIDS,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,hypertension,Hypertension,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,ischemic heart disease,IHD,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,mood and anxiety disorders,Depression or anxiety,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,multiple sclerosis,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,osteoarthritis,Arthritis,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,osteoporosis,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,parkinsons,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,rheumatoid arthritis,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,schizophrenia,NA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,stroke,Stroke or TIA,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Anemia,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Asthma or COPD,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Dementia or osteoporosis,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Heart disease,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Hyperlipidemia,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Kidney disease or failure,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Liver or gallbladder disease,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Obesity,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Peripheral vascular disease,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Poor circulation of lower limbs,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Pre-diabetes,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Schizophrenia or psychosis,ICD-10 codes grouped into disease entities by an exploratory factor analysis
35,Tan,2020,NA,Thyroid disorder,ICD-10 codes grouped into disease entities by an exploratory factor analysis
37,Machon,2020,asthma,Asthma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,cancer,Hematological neoplasms; ﻿solid neoplasms,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,chronic kidney disease,Chronic kidney diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,COPD,"COPD, Emphysema, Chronic Bronchitis","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,dementia incl. alzheimers,Dementia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,diabetes mellitus,Diabetes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,epilepsy,epilepsy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,gout,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,heart failure,heart failure,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,HIV/AIDS,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,hypertension,Hypertension,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,ischemic heart disease,Ischemic heart disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,mood and anxiety disorders,Depression and mood diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,multiple sclerosis,Multiple Sclerosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,osteoarthritis,Osteoarthritis and other degenerative joint disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,osteoporosis,Osteoporosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,parkinsons,Parkinson and parkinsonism,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,rheumatoid arthritis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,schizophrenia,﻿schizophrenia and delusional diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,stroke,cerebrovascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Anemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Atrial fibrillation,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Autoimmune diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Bradycardias and conduction diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Chronic infectious diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,"Chronic pancreas, biliary tract and gallbladder diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Colitis and related diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,"Esophagus, stomach and duodenum diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Glaucoma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Hearing impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Hypercholesterolemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Inflammatory arthropathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Inflammatory bowel diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Migraine and facial pain syndromes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Obesity,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Other psychiatric and behavioral diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Peripheral vascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Prostate diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Thyroid diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
37,Machon,2020,NA,Visual impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. I reported top-3 most prevalence diseases for each cluster"
38,Profili,2020,asthma,NA,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,cancer,NA,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,chronic kidney disease,kidney failure,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,COPD,chronic obstructive pulmonary disease (COPD),ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,dementia incl. alzheimers,dementia,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,diabetes mellitus,﻿diabetes,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,epilepsy,epilepsy,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,gout,NA,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,heart failure,heart failure,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,HIV/AIDS,NA,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,hypertension,hypertension,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,ischemic heart disease,ischemic heart disease (IHD),ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,mood and anxiety disorders,NA,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,multiple sclerosis,multiple sclerosis,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,osteoarthritis,NA,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,osteoporosis,NA,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,parkinsons,Parkinson’s disease,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,rheumatoid arthritis,NA,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,schizophrenia,NA,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,stroke,stroke,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,NA,atrial fibrillation,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,NA,dyslipidaemia,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,NA,inflammatory bowel diseases (IBD),ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,NA,inflammatory rheumatic diseases (IRD),ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,NA,mental disorders,ICD-9 codes grouped into case algorithms developed in Tuscany health region
38,Profili,2020,NA,peripheral arterial disease (PAD),ICD-9 codes grouped into case algorithms developed in Tuscany health region
39,Srinivasan,2018,asthma,"49391, 49390, 49320, 49322, 49392","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,cancer,"185, 193, 220, 1500, 1509, 1519, 1533, 1534, 1536, 1539, 1540, 1541, 1550, 1551, 1570, 1579, 1623, 1625, 1629, 1704, 1707, 1727, 1729, 1744, 1748, 1749, 1809, 1820, 1830, 1889, 1890, 1940, 1960, 1961, 1962, 1963, 1965, 1966, 1969, 1970, 1971, 1972, 1974, 1975, 1976, 1977, 1978, 1980, 1981, 1983, 1984, 1985, 1986, 1987, 1991, 2111, 2113, 2114, 2144, 2148, 2180, 2181, 2182, 2189, 2252, 2271, 2273, 2384, 2396, 19882, 19889, 20280, 20300, 20400, 20401, 20410, 20500, 20501, 20502, 20920, 20921, 20929, 20930, 20971, 20972, 20973, 20974, 20979, 22801, 23871, 23875, 23877","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,chronic kidney disease,"587, 5819, 5839, 5845, 5849, 5851, 5852, 5853, 5854, 5855, 5856, 5859, 7534, 25040, 25041, 25042, 25043, 28521, 40300, 40301, 40310, 40311, 40390, 40391, 40490, 40491, 40492, 40493, 58181, 58281, 58381, 75329","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,COPD,"496, 4918, 4920, 4928, 49120, 49121, 49122","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,dementia incl. alzheimers,"29040, 29411, 29041, 29421, 29420, 29410, 3310, 33182, 3315, 2900","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,diabetes mellitus,"25000, 25001, 25002, 25012, 25013, 25040, 25041, 25042, 25043, 25050, 25051, 25052, 25053, 25060, 25061, 25062, 25063, 25070, 25071, 25072, 25073, 25080, 25081, 25082, 25083, 25092","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,epilepsy,"3453, 34541, 34590, 34591","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,gout,"2749, 27400, 27401, 71226, 71230, 71233, 71236","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,heart failure,"4280, 42820, 42821, 42822, 42823, 42830, 42831, 42832, 42833, 42840, 42841, 42842, 42843","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,HIV/AIDS,NA,"ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,hypertension,"4010, 4011, 4019, 40290, 40291, 40300, 40301, 40310, 40311, 40390, 40391, 40490, 40491, 40492, 40493, 40591","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,ischemic heart disease,"412, 4110, 4111, 4139, 4142, 4144, 4148, 4149, 41011, 41041, 41071, 41072, 41091, 41189, 41400, 41401, 41402, 41404, 41406, 41410, 41412","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,mood and anxiety disorders,"311, 2967, 3003, 3004, 3009, 29620, 29622, 29623, 29630, 29632, 29633, 29634, 29650, 29664, 29680, 29689, 29690, 30000, 30001, 30002, 30021, 30023, 30029","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,multiple sclerosis,340,"ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,osteoarthritis,"71515, 71516, 71531, 71535, 71536, 71589, 71590, 71591, 71595, 71596","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,osteoporosis,"73300, 73313, 73319, 73342, 73381, 73382, 73390, 73392","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,parkinsons,3320,"ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,rheumatoid arthritis,7140,"ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,schizophrenia,"29530, 29570, 29590","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,stroke,"430, 431, 4329, 43310, 43311, 43320, 43330, 43331, 43411, 43491","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
39,Srinivasan,2018,NA,"1760 other unmatched ICD-9 codes (haven't listed them all here, but they are saved in a spreadsheet in the data_extraction folder)","ICD-9 codes (2025 codes to 5-digits level, I've rolled these up into CCDSS definitions)"
41,Jiang,2018,asthma,NA,"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,cancer,"155.1, 155.1, 155.1, 155.1, 155.1","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,chronic kidney disease,"250.22, 401.22, 401.22, 401.2, 401.2, 401.2, 401.2, 401.2, 585.3, 585.3, 585.3, 585.2","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,COPD,"496.21, 496.21, 496.21, 496, 496","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,dementia incl. alzheimers,"290.1, 290.11, 290.11, 290.11, 290.1, 290.16, 290.16, 290.16, 290.16, 290.16, 290.16, 290.1, 290.1, 290.1, 290.3, 290.1, 290.1, 290.11, 290.11, 290.11, 290.11, 290.11","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,diabetes mellitus,"250.23, 250.24, 250.2, 250.2, 250.23, 250.24, 250.2, 250.2, 250.2, 250.2, 250.23, 250.2, 250.24, 250.2, 250.2, 250.2, 250.2, 250.2, 250.2","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,epilepsy,NA,"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,gout,"274.1, 274.11, 274.11, 274.11, 588, 274.1, 274.1","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,heart failure,"428.2, 428.1, 428.2, 428.2","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,HIV/AIDS,NA,"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,hypertension,"401.1, 401.21, 401.21, 401.21, 401.22","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,ischemic heart disease,"411.3, 411.1, 411.3, 411.3, 411.3, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.2, 411.4, 411.2, 411.8, 411.4, 411.2, 411.8, 411.8, 411.8, 411.8","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,mood and anxiety disorders,"296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.1, 296.22, 296.22, 296.22, 296.22, 296.22, 296.22, 296.22, 296, 301, 296, 296, 296, 296, 296, 296, 300.12, 300.12, 300.12, 300.11, 300.1, 300.1, 300.1, 300.1, 300.3, 300.3, 300.3, 300.3, 300.3, 300.3, 295, 303.4, 303.4, 303.4, 295, 303.4, 303.4, 303.4, 303.4, 303.3, 303.4, 303.3, 303.4, 300, 300, 300, 301, 301","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,multiple sclerosis,NA,"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,osteoarthritis,"740.2, 740.2, 740.2, 740.9, 740.9, 740.1, 740.11, 740.11, 740.1, 740.1, 716.9, 716.9, 740.11, 716.9, 740.11, 740.11, 740.1, 740.9, 716.9, 716.9","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,osteoporosis,NA,"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,parkinsons,"332, 349, 349, 349, 349, 349, 349","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,rheumatoid arthritis,NA,"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,schizophrenia,"295.1, 295.1, 295.1, 295.1, 295.1, 296.22, 295.1, 295.1, 295.1, 295.1, 295.1, 295.1, 295.1, 295.1, 295.1, 295.1","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,stroke,"433, 430.2, 430.2, 430.2, 430.2, 430.2, 430.2, 430.2, 430.2, 430.2, 430.2, 433.2, 433.21, 433.2, 433.21, 433.21, 433.21, 433.2, 433.21, 433.21, 433.2, 433.21, 433.2","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Absent or infrequent menstruation (626.11, 626.11, 626.11, 626.11, 626.11, 626.11, 626.11)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Acidosis (276.41),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Acne (706.1, 706.1, 706.1, 706.1, 706.1, 706.1, 706.1, 706.1, 706.1, 706.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Acquired spondylolisthesis (738.4, 738.4)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Acute inflammatory pelvic disease (614.31, 614.31)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Acute renal failure (585.1, 585.1, 585.1, 585.1, 585.1, 585.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Acute, but ill-defined cerebrovascular disease (433.6)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Adjustment reaction (304, 304, 304, 304)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Agorophobia, social phobia, and panic disorder (300.12)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Alcohol-related disorders (317, 317, 317, 317, 317, 317, 317, 317)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Alcoholic liver damage (317.11, 317.11, 317.11, 317.11, 317.11, 317.11)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Alcoholism (317.1, 317.1, 317.1, 317.1, 317.1, 317.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Allergic conjunctivitis (371.21),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Althete's foot (110.12),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Antisocial/ borderline personality disorder (301.2, 301.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Anxiety disorder (300.1),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Anxiety, phobic and dissociative disorders (300, 300, 300)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Arthropathy NOS (716.9, 716.9, 716.9, 716.9, 716.9, 716.9)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Atopic/contact dermatitis due to other or unspecified (939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939, 939)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Atrial fibrillation (427.21),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Back pain (760, 760, 760, 760, 760)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Bacterial infection NOS (041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041, 041)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Bacterial pneumonia (480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1, 480.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Benign neoplasm of ovary (220),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Benign neoplasm of skin (216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216, 216)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Candidiasis (112, 112, 112, 112, 112, 112, 112, 112)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Carbuncle and furuncle (686.1, 686.1, 686.1, 686.1, 686.1, 686.1, 686.1, 686.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Cataract (366, 366, 366, 366, 366, 366, 366, 366, 366, 366)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Cerebral atherosclerosis (433.12),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Cerebrovascular disease (433, 433, 433, 433, 433, 433, 433, 433, 433, 433, 433, 433, 433)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Cervicitis and endocervicitis (614.51),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Chronic hepatitis (070.4, 070.4, 070.4, 070.4, 070.4, 070.4, 070.4, 070.4)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Chronic inflammatory pelvic disease (614.32, 614.32, 614.32)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Cirrhosis of liver without mention of alcohol (571.51, 571.51)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Conjunctivitis, infectious (369.5, 369.5, 369.5, 369.5, 369.5, 369.5, 369.5, 369.5)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Conjunctivitis, noninfectious (371.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Constipation (563),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Coronary atherosclerosis (411.4, 411.4)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Cystoid macular degeneration of retina (362.23),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Decubitus ulcer (707.1),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Degeneration of intervertebral disc (722.6, 722.6)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Delirium dementia and amnestic and other cognitive disorders (290, 290)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Depression (296.2),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Dermatophytosis (110.1, 110.1, 110.1, 110.1, 110.1, 110.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Dermatophytosis of nail (110.11),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Dermatophytosis of the body (110.13, 110.13, 110.13)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Diabetes type 2 with peripheral circulatory disorders (250.25),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Disorder of skin and subcutaneous tissue NOS (689, 689, 689, 689, 689, 689, 689, 689, 689)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Disorders of conjunctiva (372, 372, 372, 372, 372, 372, 372, 372, 372)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Disorders of menstruation and other abnormal bleeding from female genital tract (626, 626, 626)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Disorders of the pituitary gland and its hypothalamic control (253, 253, 253, 253)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Disorders resulting from impaired renal function (588, 588, 588, 588)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Displacement of intervertebral disc (722.1),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Dry eyes (375.1),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Duodenal ulcer (531.3, 531.3, 531.3, 531.3, 531.3, 531.3)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Dyshidrosis (705.1),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Dysmenorrhea (626.2, 626.2, 626.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Dyspepsia and other specified disorders of function of stomach (536.8),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,E. coli (041.4),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Ectropion or entropion (374.1, 374.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Endometrial hyperplasia (621, 621)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Endometriosis (615, 615, 615, 615, 615, 615, 615, 615, 615, 615)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Esophageal bleeding (varices/ hemorrhage) (530.2, 530.2, 530.2, 530.2, 530.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Esophagitis, GERD and related diseases (530.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Excessive or frequent menstruation (626.12),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Extrapyramidal disease and abnormal movement disorders (333, 333, 333, 333)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Fasciitis (728.7, 728.7, 728.7)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Fluid overload (276.6),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Functional digestive disorders (564, 564, 564, 564, 564, 564)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Gastric ulcer (531.2, 531.2, 531.2, 531.2, 531.2, 531.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Gastritis and duodenitis, NOS (535.9)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Gastroesophageal laceration- hemorrhage syndrome (530.7),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"GERD (530.11, 530.11)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Gram positive septicemia (038.2, 038.2, 038.2, 038.2, 038.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Hematemesis (578.1),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Hemiplegia (342, 342, 342, 342)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Hemorrhage from gastrointestinal ulcer (531.1, 531.1, 531.1, 531.1, 531.1, 531.1, 531.1, 531.1, 531.1, 531.1, 531.1, 531.1, 531.1, 531.1, 531.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Hemorrhage of gastrointestinal tract (578.9),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Hepatitis NOS (070.9, 070.9, 070.9, 070.9, 070.9, 070.9, 070.9, 070.9, 070.9, 070.9, 070.9, 070.9, 070.9, 070.9)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Hypercholesterolemia (272.11),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Hyperglyceridemia (272.12),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Hyperlipidemia (272.1, 272.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Hyperosmolality and/ or hypernatremia (276.11),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Hyperplasia of prostate (600),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Hyperpotassemia (276.13),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Hypoglycemia (251.1, 251.1, 251.1, 251.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Hypopotassemia (276.14),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Hyposmolality and/or hyponatremia (276.12),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Infertility, female (626.8, 626.8, 626.8, 626.8, 626.8, 626.8, 626.8)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Infertility, female, associated with anovulation (626.15)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Inflammation of eyelids (371.3, 371.3, 371.3, 371.3, 371.3, 371.3)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Inflammatory disease of cervix, vagina, and vulva (614.5, 614.5, 614.5, 614.5, 614.5)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Inflammatory diseases of female pelvic organs (614, 614, 614, 614, 614)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Inflammatory diseases of uterus, except cervix (614.4, 614.4, 614.4)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Insomnia (327.4, 327.4)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Intervertebral disc disorder with myelopathy (722.7),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Iron deficiency anemia secondary to blood loss (chronic) (280.2),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Irregular menstrual bleeding (626.14, 626.14)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Irregular menstrual cycle (626.13),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Irregular menstrual cycle/bleeding (626.1, 626.1, 626.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Irritable Bowel Syndrome (564.1, 564.1, 564.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Keratoconjunctivitis sicca (370.31),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Keratoderma, acquired (701.1, 701.1, 701.1, 701.1, 701.1, 701.1, 701.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Late effects of cerebrovascular disease (433.8, 433.8, 433.8, 433.8, 433.8, 433.8, 433.8)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Liver abscess and sequelae of chronic liver disease (571.8, 571.8, 571.8, 571.8, 571.8, 571.8, 571.8)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Macular degeneration (senile) of retina NOS (362.29),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Macular degeneration, dry (362.21)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Macular degeneration, wet (362.22)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Macular puckering of retina (362.26),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Mixed hyperlipidemia (272.13),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Mood disorders (296),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Myalgia and myositis unspecified (770, 770, 770, 770, 770)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Myocardial infarction (411.2, 411.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Nerve root lesions (353.2, 353.2, 353.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Neuralgia, neuritis, and radiculitis NOS (766, 766)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Noninflammatory disorders of cervix (619.3, 619.3, 619.3, 619.3, 619.3, 619.3)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Noninflammatory disorders of ovary, fallopian tube, and broad ligament (619.1, 619.1, 619.1, 619.1, 619.1, 619.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Noninflammatory female genital disorders (619),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Occlusion and stenosis of precerebral arteries (433.1, 433.1, 433.1, 433.1, 433.1, 433.1, 433.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Occlusion of cerebral arteries (433.2, 433.2, 433.2, 433.2, 433.2, 433.2, 433.2, 433.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Organic or persistent insomnia (327.41),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Osteoarthrosis NOS (740.9),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other and unspecified disc disorder (722.9, 722.9, 722.9, 722.9, 722.9, 722.9, 722.9)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other and unspecified disorders of the nervous system (349, 349, 349, 349, 349, 349, 349, 349, 349, 349)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other anemias (285, 285, 285, 285)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other benign neoplasm of uterus (218.2, 218.2, 218.2, 218.2, 218.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other chronic nonalcoholic liver disease (571.5, 571.5, 571.5)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other disorders of liver (573, 573, 573, 573, 573, 573, 573, 573, 573)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other disorders of the kidney and ureters (586, 586, 586, 586, 586)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other local infections of skin and subcutaneous tissue (686, 686, 686, 686, 686, 686, 686, 686, 686, 686, 686, 686, 686)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other peripheral nerve disorders (351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351, 351)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other persistent mental disorders due to conditions classified elsewhere (290.3, 290.3, 290.3, 290.3, 290.3, 290.3, 290.3, 290.3, 290.3, 290.3, 290.3, 290.3, 290.3, 290.3, 290.3)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Other pulmonary inflamation or edema (505),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other specified diseases of hair and hair follicles (704.8, 704.8, 704.8, 704.8, 704.8, 704.8, 704.8)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Other specified disorders of plasma protein metabolism (270.38),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Other specified gastritis (535.8, 535.8, 535.8)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Ovarian cyst (628, 628, 628)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Ovarian dysfunction (256, 256, 256, 256, 256)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pain and other symptoms associated with female genital organs (625, 625)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Pain in joint (745),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Paranoid disorders (295.2, 295.2, 295.2, 295.2, 295.2, 295.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pelvic inflammatory disease (PID) (614.3, 614.3)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pelvic inflammatory disease, NOS (614.33, 614.33, 614.33)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pelvic peritoneal adhesions, female (postoperative) (postinfection) (614.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Peptic ulcer, site unspecified (531.4, 531.4, 531.4, 531.4, 531.4, 531.4)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Personality disorders (301, 301, 301, 301, 301, 301, 301, 301)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pituitary hyperfunction (253.1, 253.1, 253.1, 253.1, 253.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pleurisy; pleural effusion (507, 507, 507, 507, 507, 507, 507, 507, 507, 507, 507, 507)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pneumonia (480, 480, 480, 480, 480, 480, 480, 480)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Pneumonitis due to inhalation of food or vomitus (501),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Polycystic ovaries (256.4),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Polyneuropathy in diabetes (250.6),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Polyp of corpus uteri (622.1, 622.1, 622.1, 622.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Portal hypertension (571.81),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Premenstrual tension syndromes (626.4),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Presbyopia (367.4),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Protozoan infection (131, 131, 131, 131, 131, 131, 131, 131, 131)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Prurigo and Lichen (695.7, 695.7, 695.7, 695.7, 695.7, 695.7, 695.7, 695.7, 695.7, 695.7, 695.7, 695.7, 695.7, 695.7, 695.7)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pruritus and related conditions (698, 698, 698, 698, 698, 698, 698)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Pseudomonal pneumonia (480.12),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Psychogenic disorder (303.3),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Psychosis (295.3, 295.3, 295.3, 295.3)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pulmonary congestion and hypostasis (503, 503)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Pyoderma (686.5, 686.5)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Reflux esophagitis (530.14),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Respiratory failure (509.1, 509.1, 509.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Respiratory insufficiency (509.2, 509.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Retinal edema (362.9),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Retinal hemorrhage/ ischemia (362.8),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Retinal vascular changes and abnomalities (362.4, 362.4, 362.4, 362.4, 362.4, 362.4, 362.4, 362.4)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Rosacea (695.3, 695.3, 695.3, 695.3, 695.3)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Sciatica (764, 764)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Sebaceous cyst (706.2, 706.2, 706.2, 706.2, 706.2, 706.2, 706.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Seborrhea (706.3),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Seborrheic dermatitis (690.1, 690.1, 690.1, 690.1, 690.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Senile cataract (366.2, 366.2, 366.2, 366.2, 366.2, 366.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Senile dementia (290.13),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Septicemia (038, 038, 038, 038, 038)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Sleep disorders (327, 327, 327, 327, 327, 327)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Spinal stenosis (720, 720, 720, 720)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Spinal stenosis of lumbar region (720.1),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Spondylolisthesis, congenital (754.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Spondylosis with myelopathy (721.2),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Spondylosis without myelopathy (721.1, 721.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Subjective visual disturbances (368.9, 368.9)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Substance addiction and disorders (316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316, 316)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Superficial keratitis (370.2),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Symptoms involving female genital tract (624, 624)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Symptoms of the muscles (772, 772, 772, 772, 772, 772, 772)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Synovitis and tenosynovitis (727.1, 727.1, 727.1, 727.1, 727.1, 727.1, 727.1, 727.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Transient cerebral ischemia (433.31, 433.31, 433.31, 433.31, 433.31, 433.31, 433.31, 433.31)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Type 2 diabetes with neurological manifestations (250.24),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Ulcer of esophagus (530.12),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,Urinary tract infection (591),"ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Urticaria (947, 947, 947, 947, 947, 947, 947, 947, 947, 947, 947)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Uterine leiomyoma (218.1, 218.1, 218.1, 218.1, 218.1)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Vaginitis and vulvovaginitis (614.52, 614.52, 614.52, 614.52)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Viral hepatitis B (070.2, 070.2, 070.2, 070.2, 070.2, 070.2, 070.2)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Viral hepatitis C (070.3, 070.3)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
41,Jiang,2018,NA,"Viral warts & HPV (078, 078)","ICD-9 codes, grouped into disease entities by PheWAS (PheCode) mapping. Phecodes are listed in parentheses here."
42,Jensen,2014,asthma,J45,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,cancer,"C18, C20, C34, C61, C77, C78, C79, C83, C85","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,chronic kidney disease,"N03, N18, N19, N25, N28, N30, N39, N40, N81","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,COPD,"J41, J42, J44","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,dementia incl. alzheimers,F03,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,diabetes mellitus,"E10, E11, E13, E14","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,epilepsy,G40,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,gout,M10,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,heart failure,I50,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,HIV/AIDS,NA,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,hypertension,"I10, I11, I15","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,ischemic heart disease,"I20, I21, I25","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,mood and anxiety disorders,"F32, F33","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,multiple sclerosis,NA,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,osteoarthritis,"M17, M19","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,osteoporosis,"M80, M81","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,parkinsons,G20,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,rheumatoid arthritis,M06,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,schizophrenia,NA,"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,stroke,"I61, I63, I64","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Aplastic and other anaemias (D62, D63, D64)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Cerebrovascular diseases (I65, I69)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Chronic lower respiratory diseases (J47),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Coagulation defects, purpura and other haemorrhagic conditions (D68)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Diseases of arteries, arterioles and capillaries (I70, I71, I73)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Diseases of inner ear (H81),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Diseases of liver (K70, K72, K74)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Diseases of oesophagus, stomach and duodenum (K20, K25, K29, K30)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Diseases of peritoneum (K65),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Disorders of choroid and retina (H33, H35, H36)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Disorders of gallbladder, biliary tract and pancreas (K80, K85, K86)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Disorders of lens (H25, H26, H28)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Disorders of muscles (M62),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Disorders of vitreous body and globe (H43, H45)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Episodic and paroxysmal disorders (G41, G45)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Glomerular diseases (N08),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Hernia (K43),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Infections of the skin and subcutaneous tissue (L02, L08)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Inflammatory polyarthropathies (M14),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Influenza and pneumonia (J14, J15, J18)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Intestinal infectious diseases (A04, A09)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Lung diseases due to external agents (J69),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Mental and behavioural disorders due to psychoactive substance use (F10, F11, F17)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Metabolic disorders (E78, E86, E87)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Neoplasms of uncertain or unknown behaviour (D37, D46)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Nerve, nerve root and plexus disorders (G56)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Noninfective enteritis and colitis (K52),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Noninflammatory disorders of female genital tract (N92, N95)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Nutritional anaemias (D50),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Obesity and other hyperalimentation (E66),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Other acute lower respiratory infections (J22),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Other and unspecified disorders of the circulatory system (I95),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Other bacterial diseases (A41, A46, A49)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Other diseases of intestines (K55, K56, K57, K59, K62)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Other diseases of the digestive system (K92),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Other diseases of the respiratory system (J96),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Other disorders of glucose regulation and pancreatic internal secretion (E15, E16)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Other disorders of the nervous system (G95),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Other disorders of the skin and subcutaneous tissue (L89, L97, L98)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Other dorsopathies (M54),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,"Other forms of heart disease (I35, I44, I46, I48, I49, I51)","ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Other respiratory diseases principally affecting the interstitium (J81),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Papulosquamous disorders (L40),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Polyneuropathies and other disorders of the peripheral nervous system (G62),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Pulmonary heart disease and diseases of pulmonary circulation (I27),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Renal failure (N17),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Renal tubulo-interstitial diseases (N13),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Soft tissue disorders (M62),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Spondylopathies (M47),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Systemic connective tissue disorders (M35),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Viral hepatitis (B18),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
42,Jensen,2014,NA,Visual disturbances and blindness (H54),"ICD-10 codes at 3-digit levels, note that disease names for the additional (not in SR) diseases are the block-level ICD names (not the 3-digit level names)"
43,Giannoula,2018,asthma,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,cancer,"malignant neoplasm of bone, connective tissue, skin, and breast (170-176)
malignant neoplasm of genitourinary organs (179-189)
malignant neoplasm of lymphatic and hematopoietic tissue (200-208)
malignant neoplasm of other and unspecified sites (190-199)
malignant neoplasm of respiratory and intrathoracic organs (160-165)
benign neoplasms (210-229)","ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,chronic kidney disease,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,COPD,chronic obstructive pulmonary disease and allied conditions (490-496),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,dementia incl. alzheimers,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,diabetes mellitus,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,epilepsy,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,gout,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,heart failure,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,HIV/AIDS,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,hypertension,hypertensive disease (401-405),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,ischemic heart disease,ischemic heart disease (410-414),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,mood and anxiety disorders,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,multiple sclerosis,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,osteoarthritis,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,osteoporosis,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,parkinsons,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,rheumatoid arthritis,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,schizophrenia,NA,"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,stroke,cerebrovascular disease (430-438),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,acute respiratory infections (460-466),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,appendicitis (540-543),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,arthropathies and related disorders (710-719),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,chronic rheumatic heart disease (393-398),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,complications mainly related to pregnancy (640-649),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,complications occurring mainly in the course of labor and delivery (660-669),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,complications of the puerperium (670-677),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,"diseases of arteries, arterioles, and capillaries (440-449)","ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,"diseases of esophagus, stomach, and duodenum (530-539)","ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,diseases of male genital organs (600-608),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,"diseases of oral cavity, salivary glands, and jaws (520-529)","ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,diseases of pulmonary circulation (415-417),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,diseases of the ear and mastoid process (380-389),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,"diseases of veins and lymphatics, and other diseases of circulatory system (451-459)","ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,disorders of breast (610-612),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,disorders of the eye and adnexa (360-379),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,disorders of the peripheral nervous system (350-359),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,dorsopathies (720-724),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,ectopic and molar pregnancy (630-633),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,hereditary and degenerative diseases of the central nervous system (330-337),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,hernia of abdominal cavity (550-553),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,"nephritis, nephrotic syndrome, and nephrosis (580-589)","ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,noninfective enteritis and colitis (555-558),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,"normal delivery, and other indications for care in pregnancy, labor, and delivery (650-659)","ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,"osteopathies, chondropathies, and acquired musculoskeletal deformities (730-739)","ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other diseases of digestive system (570-579),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other diseases of intestines and peritoneum  (560-569),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other diseases of respiratory system (510-519),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other diseases of skin and subcutaneous tissue (700-709),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other diseases of upper respiratory tract (470-478),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other diseases of urinary system (590-599),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other disorders of female genital tract (617-629),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other disorders of the central nervous system (340-349),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other forms of heart disease (420-429),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,other pregnancy with abortive outcome (634-639),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,pain (338),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,pneumoconioses and other lung diseases due to external agents (500-508),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,pneumonia and influenza (480-488),"ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
43,Giannoula,2018,NA,"rheumatism, excluding the back (725-729)","ICD-9 codes (3-digit level), however the results are listed in multiple 3-digit blocks.  I've rolled these up into CCDSS categories"
44,Wartelle,2021,asthma,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,cancer,"C15-C26, C76-C80, C81-C96","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,chronic kidney disease,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,COPD,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,dementia incl. alzheimers,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,diabetes mellitus,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,epilepsy,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,gout,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,heart failure,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,HIV/AIDS,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,hypertension,I10-I15,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,ischemic heart disease,I20-I25,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,mood and anxiety disorders,F30-F39,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,multiple sclerosis,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,osteoarthritis,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,osteoporosis,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,parkinsons,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,rheumatoid arthritis,NA,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,schizophrenia,F20-F29,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,stroke,I60-I69,"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Acute upper respiratory infections (J00-J06),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Aplastic and other anaemias (D60-D64),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Arthropathies (M00-M25),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Behavioural and emotional disorders with onset usually occurring in childhood and adolescence (F90-F98),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Behavioural syndromes associated with physiological disturbances and physical factors (F50-F59),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Benign neoplasms (D10-D36),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Bullous disorders (L10-L14),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Burns and corrosions (T20-T32),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Cerebral palsy and other paralytic syndromes (G80-G83),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Certain early complications of trauma (T79-T79),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Certain zoonotic bacterial diseases (A20-A28),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Chondropathies (M91-M94),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Chronic lower respiratory diseases (J40-J47),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Circulatory and respiratory systems (R00-R09),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Coagulation defects, purpura and other haemorrhagic conditions (D65-D69)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Cognition, perception, emotional state and behaviour (R40-R46)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Complications of labour and delivery (O60-O75),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Complications of surgical and medical care, not elsewhere classified (T80-T88)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Complications predominantly related to the puerperium (O85-O92),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Conditions involving the integument and temperature regulation of fetus and newborn (P80-P83),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Congenital malformations and deformations : genital organs (Q50-Q56),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Demyelinating diseases of the central nervous system (G35-G37),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Dermatitis and eczema (L20-L30),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Digestive system and abdomen (R10-R19),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Digestive system disorders of fetus and newborn (P75-P78),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Diseases of appendix (K35-K38),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Diseases of arteries, arterioles and capillaries (I70-I79)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Diseases of external ear (H60-H62),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Diseases of inner ear (H80-H83),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Diseases of liver (K70-K77),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Diseases of male genital organs (N40-N51),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Diseases of middle ear and mastoid (H65-H75),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Diseases of myoneural junction and muscle (G70-G73),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Diseases of oesophagus, stomach and duodenum (K20-K31)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Diseases of oral cavity, salivary glands and jaws (K00-K14)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Diseases of peritoneum (K65-K67),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Disorders of adult personality and behaviour (F60-F69),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Disorders of breast (N60-N64),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Disorders of choroid and retina (H30-H36),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Disorders of conjunctiva (H10-H13),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Disorders of eyelid, lacrimal system and orbit (H00-H06)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Disorders of gallbladder, biliary tract and pancreas (K80-K87)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Disorders of iris and ciliary body (H20-H22),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Disorders of ocular muscles, binocular movement, accommodation and refraction (H53-H54)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Disorders of psychological development (F80-F89),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Disorders of sclera and cornea (H15-H19),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Disorders of vitreous body and globe (H43-H45),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Dorsopathies (M40-M54),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Effects of foreign body entering through natural orifice (T15-T19),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Episodic and paroxysmal disorders (G40-G47),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Extrapyramidal and movement disorders (G20-G26),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,General symptoms and signs (R50-R69),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Glomerular diseases (N00-N08),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Gonads / Estrogen, androgens, testosterone, etc (E28-E30)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Haemolytic anaemias (D55-D59),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Helminthiases (B65-B83),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Hernia (K40-K46),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Ill-defined and unknown causes of mortality (R95-R99),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,In situ neoplasms (D00-D09),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Infections of the skin and subcutaneous tissue (L00-L08),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Infections with a predominantly sexual mode of transmission (A50-A64),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Inflammatory diseases of female pelvic organs (N70-N77),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Inflammatory diseases of the central nervous system (G00-G09),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Influenza and Pneumonia (J09-J18),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Injury : abdomen, lower back, lumbar spine and pelvis (S30-S39)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Injury : ankle and foot (S90-S99),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Injury : elbow and forearm (S50-S59),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Injury : head (S00-S09),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Injury : hip and thigh (S70-S79),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Injury : knee and lower leg (S80-S89),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Injury : neck (S10-S19),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Injury : shoulder and upper arm (S40-S49),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Injury : thorax (S20-S29),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Injury : wrist and hand (S60-S69),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Intestinal infectious diseases (A00-A09),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Lung diseases due to external agents (J60-J70),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Maternal care related to the fetus and amniotic cavity and possible delivery problems (O30-O48),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Mental and behavioural disorders due to psychoactive substance use (F10-F19),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Mycoses (B35-B49),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Neoplasms of uncertain or unknown behaviour (D37-D48),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Nerve, nerve root and plexus disorders (G50-G59)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Nervous and musculoskeletal systems (R25-R29),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Neurotic, stress-related and somatoform disorders (F40-F49)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Noninfective enteritis and colitis (K50-K52),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Noninflammatory disorders of female genital tract (N80-N98),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Nutritional anaemias (D50-D53),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"On diagnostic imaging and in function studies, without diagnosis (R90-R94)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"On examination of blood, without diagnosis (R70-R79)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Organic, including symptomatic, mental disorders (F00-F09)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Osteopathies (M80-M90),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other acute lower respiratory infections (J20-J22),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other and unspecified disorders of the circulatory system (I95-I99),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other and unspecified effects of external causes (T66-T78),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other bacterial diseases (A30-A49),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other diseases of intestines (K55-K64),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other diseases of pleura (J90-J94),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other diseases of the digestive system (K90-K93),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other diseases of the respiratory system (J95-J99),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other diseases of upper respiratory tract (J30-J39),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other diseases of urinary system (N30-N39),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other disorders of ear (H90-H95),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other disorders of eye and adnexa (H55-H59),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other disorders of the musculoskeletal system and connective tissue (M95-M99),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other disorders of the nervous system (G90-G99),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other disorders of the skin and subcutaneous tissue (L80-L99),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other disorders originating in the perinatal period (P90-P96),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other forms of heart disease (I30-I52),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other maternal disorders predominantly related to pregnancy (O20-O29),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other metabolic disorders (E79-E90),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other respiratory diseases principally affecting the interstitium (J80-J84),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other spirochaetal diseases (A65-A69),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Other viral diseases (B25-B34),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Pancreas / Insulin, glucagon (E10-E16)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Papulosquamous disorders (L40-L45),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Pediculosis, acariasis and other infestations (B85-B89)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Persons encountering health services for examination and investigation (Z00-Z13),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Persons encountering health services for specific procedures and health care (Z40-Z54),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Persons encountering health services in circumstances related to reproduction (Z30-Z39),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Persons encountering health services in other circumstances (Z70-Z76),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Persons with potential health hazards related to communicable diseases (Z20-Z29),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z80-Z99),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Persons with potential health hazards related to socioeconomic and psychosocial circumstances (Z55-Z65),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,"Poisoning by drugs, medicaments and biological substances (T36-T50)","ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Polyneuropathies and other disorders of the peripheral nervous system (G60-G64),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Pregnancy with abortive outcome (O00-O08),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Protozoal diseases (B50-B64),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Pulmonary heart disease and diseases of pulmonary circulation (I26-I28),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Radiation-related disorders of the skin and subcutaneous tissue (L55-L59),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Radiation-related disorders of the skin and subcutaneous tissue (L60-L75),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Renal failure (N17-N19),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Renal tubulo-interstitial diseases (N10-N16),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Skin and subcutaneous tissue (R20-R23),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Soft tissue disorders (M60-M79),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Speech and voice (R47-R49),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Thyroid gland / Thyroid (E00-E07),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Toxic effects of substances chiefly nonmedicinal as to source (T51-T65),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Urinary system (R30-R39),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Urolithiasis (N20-N23),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Urticaria and erythema (L50-L54),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Viral hepatitis (B15-B19),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Viral infections characterized by skin and mucous membrane lesions (B00-B09),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
44,Wartelle,2021,NA,Viral infections of the central nervous system (A80-A89),"ICD-10 block disease categories, from select list in Violan, 2018 and meeting inclusion criteria"
45,Violan,2016,asthma,NA,ICD-10 block disease categories
45,Violan,2016,cancer,Malignant neoplasm of breast (C50-C50),ICD-10 block disease categories
45,Violan,2016,chronic kidney disease,NA,ICD-10 block disease categories
45,Violan,2016,COPD,NA,ICD-10 block disease categories
45,Violan,2016,dementia incl. alzheimers,NA,ICD-10 block disease categories
45,Violan,2016,diabetes mellitus,Diabetes mellitus (E10-E14),ICD-10 block disease categories
45,Violan,2016,epilepsy,NA,ICD-10 block disease categories
45,Violan,2016,gout,NA,ICD-10 block disease categories
45,Violan,2016,heart failure,NA,ICD-10 block disease categories
45,Violan,2016,HIV/AIDS,NA,ICD-10 block disease categories
45,Violan,2016,hypertension,Hypertensive diseases (I10-I15),ICD-10 block disease categories
45,Violan,2016,ischemic heart disease,Ischaemic heart diseases (I20-I25),ICD-10 block disease categories
45,Violan,2016,mood and anxiety disorders,Mood [affective] disorders (F30-F39),ICD-10 block disease categories
45,Violan,2016,multiple sclerosis,NA,ICD-10 block disease categories
45,Violan,2016,osteoarthritis,Arthrosis (M15-M19),ICD-10 block disease categories
45,Violan,2016,osteoporosis,NA,ICD-10 block disease categories
45,Violan,2016,parkinsons,NA,ICD-10 block disease categories
45,Violan,2016,rheumatoid arthritis,NA,ICD-10 block disease categories
45,Violan,2016,schizophrenia,"Schizophrenia, schizotypal and delusional disorders (F20-F29)",ICD-10 block disease categories
45,Violan,2016,stroke,Cerebrovascular diseases (I60-I69),ICD-10 block disease categories
45,Violan,2016,NA,other ICD-10 blocks (still need translation from spanish),ICD-10 block disease categories
46,Buja,2018,asthma,asthma/bronchitis,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,cancer,cancer,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,chronic kidney disease,chronic renal disease,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,COPD,chronic obstructive pulmonary disease,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,dementia incl. alzheimers,Alzheimer’s disease,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,diabetes mellitus,diabetes,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,epilepsy,NA,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,gout,NA,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,heart failure,congestive heart failure,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,HIV/AIDS,NA,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,hypertension,high blood pressure (HBP),Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,ischemic heart disease,ischemic heart disease,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,mood and anxiety disorders,depression,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,multiple sclerosis,NA,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,osteoarthritis,NA,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,osteoporosis,osteoporosis,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,parkinsons,NA,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,rheumatoid arthritis,NA,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,schizophrenia,NA,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,stroke,cerebrovascular disease,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,NA,atrial fibrillation,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,NA,depression,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,NA,hyperlipidemia,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
46,Buja,2018,NA,hypothyroidism,Subset (15) of EDC AGCs/Pharmacy morbidity marker groups
47,Collerton,2016,asthma,Asthma,GP diagnoses from medical charts
47,Collerton,2016,cancer,Cancer within previous 5 years,GP diagnoses from medical charts
47,Collerton,2016,chronic kidney disease,Renal impairment,GP diagnoses from medical charts
47,Collerton,2016,COPD,Chronic obstructive pulmonary disease,GP diagnoses from medical charts
47,Collerton,2016,dementia incl. alzheimers,NA,GP diagnoses from medical charts
47,Collerton,2016,diabetes mellitus,Diabetes mellitus,GP diagnoses from medical charts
47,Collerton,2016,epilepsy,NA,GP diagnoses from medical charts
47,Collerton,2016,gout,NA,GP diagnoses from medical charts
47,Collerton,2016,heart failure,Heart failure,GP diagnoses from medical charts
47,Collerton,2016,HIV/AIDS,NA,GP diagnoses from medical charts
47,Collerton,2016,hypertension,Hypertension,GP diagnoses from medical charts
47,Collerton,2016,ischemic heart disease,Ischaemic heart disease,GP diagnoses from medical charts
47,Collerton,2016,mood and anxiety disorders,NA,GP diagnoses from medical charts
47,Collerton,2016,multiple sclerosis,NA,GP diagnoses from medical charts
47,Collerton,2016,osteoarthritis,Osteoarthritis,GP diagnoses from medical charts
47,Collerton,2016,osteoporosis,Osteoporosis,GP diagnoses from medical charts
47,Collerton,2016,parkinsons,NA,GP diagnoses from medical charts
47,Collerton,2016,rheumatoid arthritis,NA,GP diagnoses from medical charts
47,Collerton,2016,schizophrenia,NA,GP diagnoses from medical charts
47,Collerton,2016,stroke,Cerebrovascular disease,GP diagnoses from medical charts
47,Collerton,2016,NA,Atrial fibrillation or flutter,GP diagnoses from medical charts
47,Collerton,2016,NA,Cognitive impairment,GP diagnoses from medical charts
47,Collerton,2016,NA,Falls,GP diagnoses from medical charts
47,Collerton,2016,NA,Hearing impairment,GP diagnoses from medical charts
47,Collerton,2016,NA,Inflammatory arthritis,GP diagnoses from medical charts
47,Collerton,2016,NA,Peripheral vascular disease,GP diagnoses from medical charts
47,Collerton,2016,NA,Thyroid disease,GP diagnoses from medical charts
47,Collerton,2016,NA,Urinary incontinence,GP diagnoses from medical charts
47,Collerton,2016,NA,Visual impairment,GP diagnoses from medical charts
48,Diaz,2015,asthma,Asthma,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,cancer,Prostate cancer; colorectal cancer; breast cancer,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,chronic kidney disease,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,COPD,COPD,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,dementia incl. alzheimers,Dementia,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,diabetes mellitus,Diabetes,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,epilepsy,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,gout,Gout,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,heart failure,Congestive heart failure,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,HIV/AIDS,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,hypertension,Hypertension,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,ischemic heart disease,Ischemic heart disease; Myocardial Infarction,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,mood and anxiety disorders,Depression; Anxiety,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,multiple sclerosis,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,osteoarthritis,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,osteoporosis,Osteoporosis,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,parkinsons,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,rheumatoid arthritis,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,schizophrenia,Schizophrenia,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,stroke,NA,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Anxiety,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Arrythmia,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Arthropathy,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,BPH (not defined?),"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Breast cancer,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Cardiovascular disease,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Cataracts,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Cervical Pain,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Chronic Ulcer,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Colorectal cancer,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Deafness,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Depression,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Dermatitis,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Hematologic,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Hyperlipidemia,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Hypothyroidism,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Iron Deficiency,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Low back pain,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Malignant neoplasm,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Neuritis,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Other cardiovascular disease,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Other Endocrine,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Peripheral Vascular disease,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Prostate Cancer,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Substance use,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Thrombophlebitis,"EDC AGCs, chronic conditions defined by Salisbury list"
48,Diaz,2015,NA,Valvulopathy,"EDC AGCs, chronic conditions defined by Salisbury list"
49,Foguet-Boreu,2015,asthma,NA,NA
49,Foguet-Boreu,2015,cancer,Melanoma and other malignant neoplasms of skin (C43-C44),ICD-10 block disease categories
49,Foguet-Boreu,2015,chronic kidney disease,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,COPD,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,dementia incl. alzheimers,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,diabetes mellitus,Diabetes mellitus (E10-E14),ICD-10 block disease categories
49,Foguet-Boreu,2015,epilepsy,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,gout,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,heart failure,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,HIV/AIDS,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,hypertension,Hypertensive diseases (I10-I15),ICD-10 block disease categories
49,Foguet-Boreu,2015,ischemic heart disease,Ischaemic heart diseases (I20-I25),ICD-10 block disease categories
49,Foguet-Boreu,2015,mood and anxiety disorders,Mood [affective] disorders (F30-F39),ICD-10 block disease categories
49,Foguet-Boreu,2015,multiple sclerosis,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,osteoarthritis,Arthrosis (M15-M19),ICD-10 block disease categories
49,Foguet-Boreu,2015,osteoporosis,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,parkinsons,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,rheumatoid arthritis,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,schizophrenia,NA,ICD-10 block disease categories
49,Foguet-Boreu,2015,stroke,Cerebrovascular diseases (I60-I69),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Acute upper respiratory infections (J00-J06),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Aplastic and other anaemias (D60-D64),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Behavioural syndromes associated with physiological disturbances and physical factors (F50-F59),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Benign neoplasms (D10-D36),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Chronic lower respiratory diseases (J40-J47),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Coagulation defects, purpura and other haemorrhagic conditions (D65-D69)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Deforming dorsopathies (M40-M43),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Dermatitis and eczema (L20-L30),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Digestive organs (C15-C26),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Diseases of arteries, arterioles and capillaries (I70-I79)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Diseases of external ear (H60-H62),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Diseases of inner ear (H80-H83),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Diseases of liver (K70-K77),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Diseases of male genital organs (N40-N51),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Diseases of oesophagus, stomach and duodenum (K20-K31)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Diseases of oral cavity, salivary glands and jaws (K00-K14)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (DG99 I80-I89)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Disorders of bone density and structure (M80-M85),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Disorders of breast (N60-N64),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Disorders of choroid and retina (H30-H36),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Disorders of conjunctiva (H10-H13),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Disorders of eyelid, lacrimal system and orbit (H00-H06)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Disorders of gallbladder, biliary tract and pancreas (K80-K87)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Disorders of lens (H25-H28),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Disorders of skin appendages (L60-L75),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Disorders of synovium and tendon (M65-M68),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Disorders of thyroid gland (E00-E07),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Episodic and paroxysmal disorders (G40-G47),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Extrapyramidal and movement disorders (G20-G26),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Falls (W00-W19),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Glaucoma (H40-H42),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Hernia (K40-K46),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Inflammatory polyarthropathies (M05-M14),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Injuries to the shoulder and upper arm (S40-S49),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Injuries to unspecified part of trunk, limb or body region (T08-T14)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Intestinal infectious diseases (A00-A09),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Mental and behavioural disorders due to psychoactive substance use (F10-F19),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Metabolic disorders (E70-E90),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Mycoses (B35-B49),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Nerve, nerve root and plexus disorders (G50-G59)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Neurotic, stress-related and somatoform disorders (F40-F48)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Noninfective enteritis and colitis (K50-K52),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Noninflammatory disorders of female genital tract (N80-N98),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Nutritional anaemias (D50-D53),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Obesity and other hyperalimentation (E65-E68),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,"Organic, including symptomatic, mental disorders (F00-F09)",ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other acute lower respiratory infections (J20-J22),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other degenerative diseases of the nervous system (G30-G32),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other diseases of blood and blood-forming organs (D70-D77),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other diseases of intestines (K55-K63),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other diseases of upper respiratory tract (J30-J39),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other diseases of urinary system (N30-N39),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other disorders of ear (H90-H95),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other disorders of kidney and ureter (N25-N29),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other disorders of the skin and subcutaneous tissue (L80-L99),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other dorsopathies (M50-M54),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other forms of heart disease (I30-I52),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other joint disorders (M20-M25),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Other soft tissue disorders (M70-M79),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Polyneuropathies and other disorders of the peripheral nervous system (G60-G64),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Radiation-related disorders of the skin and subcutaneous tissue (L55-L59),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Renal failure (N17-N19),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Skin (C43-C44),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Spondylopathies (M45-M49),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Systemic connective tissue disorders (M30-M36),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Urinary tract (C64-C68),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Urolithiasis (N20-N23),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Urticaria and erythema (L50-L54),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Viral hepatitis (B15-B19),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Viral infections characterized by skin and mucous membrane lesions (B00-B09),ICD-10 block disease categories
49,Foguet-Boreu,2015,NA,Visual disturbances and blindness (H53-H54),ICD-10 block disease categories
50,Forslund,2021,asthma,"Asthma (current) (J45, J46)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,cancer,Cancer (new diagnosis in last five years) (C01-C97),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,chronic kidney disease,"Chronic renal disease (N18, N19, I12)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,COPD,"Chronic obstructive pulmonary disease (J41, J42, J43, J44)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,dementia incl. alzheimers,"Dementia (F00, F01, F02, F03)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,diabetes mellitus,"Diabetes (E10, E11, E12, E13, E14)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,epilepsy,Epilepsy (current) (G40),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,gout,NA,"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,heart failure,NA,"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,HIV/AIDS,NA,"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,hypertension,"Hypertension (I10, I119, I12, I13, I15)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,ischemic heart disease,"Coronary heart disease (I20, I21, I22, I23, I24, I25)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,mood and anxiety disorders,"Anxiety & other neurotic, stress related & somatoform disorders (F40, F41, F42, F43, F32, F33, F34, F38, F39); Depression (F40, F41, F42, F43, F32, F33, F34, F38, F39)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,multiple sclerosis,Multiple sclerosis (G359),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,osteoarthritis,NA,"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,osteoporosis,NA,"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,parkinsons,Parkinson's disease (G20),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,rheumatoid arthritis,NA,"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,schizophrenia,NA,"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,stroke,"Stroke & transient ischaemic attack (I60, I61, I62, I63, I64, I65, I66, I67, I68, I69)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Alcohol problems (F10),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Anorexia or bulimia (F50),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Atrial fibrillation (I48),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Blindness & low vision (H54),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Bronchiectasis (J47),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Chronic liver disease (K70, K72.1, K72.9, K74, K75, K76, K77)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Chronic sinusitis (J32),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Constipation (current) (K59.0),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Diverticular disease of intestine (K52),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Dyspepsia (current) (K30, K29.7, K29.6, K29.5, K29.4, K 29.3)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Glaucoma (H40, H42)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Hearing loss (H91, H92)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Heart failure (I110, I50)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Inflammatory bowel disease (K50, K51)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Irritable bowel syndrome (K58),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Learning disability (F81),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Migraine (current) (G43),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Painful condition (K580, K589, M797, R521, R522, R522A, R522B, R522C B022 G500, E104 E114 E124 E134 E144, G099 G359, G500 G508 G509 G530 G540 G541 G542 G543 G544 G545 G546 G548 G549 ¬†G551 G552 G553 G558 G560 G561 G562 G562B G562C G562D G562X G563 G563B G563C G563D G563X, G564 G568 G569 G570 G571 G572 G573 G574 G575 G576 G578 G579 G580 G587 G588 G589 G590 G598, G600 G601 G602 G603 G608 G609 G618 G619 G620 G621 G622 G628 G629 G630 G631 G632 G633 G634, G635 G636 G638, G952, B02- B91- G35- G500 G546 G549P G560 G573 G58-P G621 G629P I69-, E108P E118P F454, B02- B91- G35- G500 G546 G549P G560 G573 G58-P G621 G629P I69-)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,Peripheral vascular disease (I73),"ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Prostate disorders (N40, N41, N42)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Psoriasis or eczema (L20, L23, L24, L25, L26, L30, L40)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Rheumatoid arthritis, other inflammatory polyarthropathies & systematic connective tissue disorders (M05, M06, M07, M08, M09, M10, M11, M12, M30, M31, M32, M33, M34, M35)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Schizophrenia (and related non-organic psychosis) or bipolar disorder (F20, F30, F31)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Substance misuse (psychoactive not alcohol) (F11, F12, F13, F14, F15, F16, F18, F19)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Thyroid disorders (E01, E02, E03, E04, E05, E06, E07)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
50,Forslund,2021,NA,"Viral Hepatitis (B15, B16, B17, B18, B19)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
51,Guisado-Clavero,2018,asthma,Asthma (R96),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,cancer,"Malignancy NOS (A79), Malignant neoplasm, colon/rectum (D75), Malignant neoplasm, digestive other/NOS (D77), Malignant neoplasm, bronchus, lung (R84), Malignant neoplasm of skin (S77), Malignant neoplasm, bladder (U76), Malignant neoplasm, genital, female, other (X77)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,chronic kidney disease,NA,"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,COPD,Chronic obstructive pulmonary disease (R95),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,dementia incl. alzheimers,Dementia (P70),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,diabetes mellitus,"Diabetes, non-insulin dependent (T90)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,epilepsy,Epilepsy (N88),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,gout,Gout (T92),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,heart failure,Heart failure (K77),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,HIV/AIDS,NA,"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,hypertension,"Hypertension, uncomplicated (K86), Hypertension, complicated (K87)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,ischemic heart disease,"Acute myocardial infarction (K75), Ischaemic heart disease with angina (K74), Ischaemic heart disease without angina (K76)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,mood and anxiety disorders,"Anxiety disorder/anxiety state (P74), Depressive disorder (P76)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,multiple sclerosis,NA,"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,osteoarthritis,"Osteoarthritis of hip (L89), Osteoarthritis of knee (L90), Osteoarthritis, other (L91)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,osteoporosis,Osteoporosis (L95),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,parkinsons,Parkinsonism (N87),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,rheumatoid arthritis,NA,"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,schizophrenia,NA,"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,stroke,Stroke/cerebrovascular accident (K90),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Acquired deformity of spine (L85),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Anaemia, other/unspecified (B82)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Anaemia, Vit B12/folate deficiency (B81)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Forslund,2022,NA,"Anxiety & other neurotic, stress related & somatoform disorders (F40, F41, F42, F43, F32, F33, F34, F38, F39)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
51,Guisado-Clavero,2018,NA,Anxiety disorder/anxiety state (P74),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Atherosclerosis/peripheral vascular disease (K92),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Atrial fibrillation/flutter (K78),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Back syndrome with radiating pain (L86),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Back syndrome without radiating pain (L84),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Benign prostatic hypertrophy (Y85),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Benign/unspecified neoplasm, blood (B75)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Cardiac arrhythmia NOS (K80),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Carpal tunnel syndrome (N93),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Cataract (F92),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Cerebrovascular disease (K91),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Cholecystitis/cholelithiasis (D98),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Chronic alcohol abuse (P15),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Congenital anomaly, digestive system (D81)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Deafness (H86),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Forslund,2022,NA,"Depression (F40, F41, F42, F43, F32, F33, F34, F38, F39)","ICD-10 codes, grouped by established case definitions and dentified as clinically important in Barnett, 2012. I reported top 3 highest prevalence diseases for each cluster."
51,Guisado-Clavero,2018,NA,Depressive disorder (P76),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Dermatitis, seborrhoeic (S86)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Dermatitis/atopic eczema (S87),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Disease digestive system, other (D99)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Diverticular disease (D92),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Duodenal ulcer (D85),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Endocrine/metabolic/nutritional disease, other (T99)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Genital disease, other (X99)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Glaucoma (F93),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Goitre (T81),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Heart disease, other (K84)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Heart valve disease NOS (K83),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Heart/arterial murmur NOS (K81),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Hyperthyroidism/thyrotoxicosis (T85),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Irritable bowel syndrome (D93),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Lipid disorder (T93),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Liver disease NOS (D97),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Musculoskeletal disease, other (L99)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Neck syndrome (L83),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Neurological disease, other (N99)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Obesity (T82),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Oesophagus disease (D84),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Organic psychosis, other (P71)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Paroxysmal tachycardia (K79),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Peptic ulcer, other (D86)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Peripheral neuritis/neuropathy (N94),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Phlebitis/thrombophlebitis (K94),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Postural hypotension (K88),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Presbycusis (H84),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Psoriasis (S91),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Pulmonary embolism (K93),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Purpura/coagulation defects (B83),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Respiratory disease, other (R99)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Retinopathy (F83),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Rheumatic fever/heart disease (K71),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Shoulder syndrome (L92),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Skin disease, other (S99)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Tennis elbow (L93),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Transient cerebral ischaemia (K89),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Tuberculosis (A70),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Urinary disease, other (U99)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Varicose veins of leg (K95),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Vertiginous syndrome (H82),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,Viral hepatitis (D72),"ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
51,Guisado-Clavero,2018,NA,"Weakness/tiredness, general (A04)","ICPC-2 codes, from ﻿O’Halloran, 2004 list, with prevalence >1%"
53,Haug,2020,asthma,NA,ICD-10 block disease categories
53,Haug,2020,cancer,NA,ICD-10 block disease categories
53,Haug,2020,chronic kidney disease,NA,ICD-10 block disease categories
53,Haug,2020,COPD,NA,ICD-10 block disease categories
53,Haug,2020,dementia incl. alzheimers,NA,ICD-10 block disease categories
53,Haug,2020,diabetes mellitus,Diabetes mellitus (E10-E14),ICD-10 block disease categories
53,Haug,2020,epilepsy,NA,ICD-10 block disease categories
53,Haug,2020,gout,NA,ICD-10 block disease categories
53,Haug,2020,heart failure,NA,ICD-10 block disease categories
53,Haug,2020,HIV/AIDS,NA,ICD-10 block disease categories
53,Haug,2020,hypertension,Hypertensive diseases (I10-I15),ICD-10 block disease categories
53,Haug,2020,ischemic heart disease,Ischaemic heart diseases (I20-I25),ICD-10 block disease categories
53,Haug,2020,mood and anxiety disorders,Mood [affective] disorders (F30-F39),ICD-10 block disease categories
53,Haug,2020,multiple sclerosis,NA,ICD-10 block disease categories
53,Haug,2020,osteoarthritis,NA,ICD-10 block disease categories
53,Haug,2020,osteoporosis,NA,ICD-10 block disease categories
53,Haug,2020,parkinsons,NA,ICD-10 block disease categories
53,Haug,2020,rheumatoid arthritis,NA,ICD-10 block disease categories
53,Haug,2020,schizophrenia,"Schizophrenia, schizotypal and delusional disorders (F20-F29)",ICD-10 block disease categories
53,Haug,2020,stroke,Cerebrovascular diseases (I60-I69),ICD-10 block disease categories
53,Haug,2020,NA,Acute upper respiratory infections (J00-J06),ICD-10 block disease categories
53,Haug,2020,NA,Arthropathies (M00-M25),ICD-10 block disease categories
53,Haug,2020,NA,Behavioural and emotional disorders with onset usually occurring in childhood and adolescence (F90-F98),ICD-10 block disease categories
53,Haug,2020,NA,Benign neoplasms (D10-D36),ICD-10 block disease categories
53,Haug,2020,NA,Chronic lower respiratory diseases (J40-J47),ICD-10 block disease categories
53,Haug,2020,NA,Dermatitis and eczema (L20-L30),ICD-10 block disease categories
53,Haug,2020,NA,Diseases of appendix (K35-K38),ICD-10 block disease categories
53,Haug,2020,NA,"Diseases of arteries, arterioles and capillaries (I70-I79)",ICD-10 block disease categories
53,Haug,2020,NA,Diseases of inner ear (H80-H83),ICD-10 block disease categories
53,Haug,2020,NA,Diseases of liver (K70-K77),ICD-10 block disease categories
53,Haug,2020,NA,Diseases of male genital organs (N40-N51),ICD-10 block disease categories
53,Haug,2020,NA,Diseases of middle ear and mastoid (H65-H75),ICD-10 block disease categories
53,Haug,2020,NA,"Diseases of oesophagus, stomach and duodenum (K20-K31)",ICD-10 block disease categories
53,Haug,2020,NA,"Diseases of oral cavity, salivary glands and jaws (K00-K14)",ICD-10 block disease categories
53,Haug,2020,NA,"Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89)",ICD-10 block disease categories
53,Haug,2020,NA,Disorders of breast (N60-N64),ICD-10 block disease categories
53,Haug,2020,NA,Disorders of choroid and retina (H30-H36),ICD-10 block disease categories
53,Haug,2020,NA,"Disorders of eyelid, lacrimal system and orbit (H00-H06)",ICD-10 block disease categories
53,Haug,2020,NA,"Disorders of gallbladder, biliary tract and pancreas (K80-K87)",ICD-10 block disease categories
53,Haug,2020,NA,Disorders of lens (H25-H28),ICD-10 block disease categories
53,Haug,2020,NA,"Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52)",ICD-10 block disease categories
53,Haug,2020,NA,Disorders of skin appendages (L60-L75),ICD-10 block disease categories
53,Haug,2020,NA,Disorders of thyroid gland (E00-E07),ICD-10 block disease categories
53,Haug,2020,NA,Dorsopathies (M40-M54),ICD-10 block disease categories
53,Haug,2020,NA,Episodic and paroxysmal disorders (G40-G47),ICD-10 block disease categories
53,Haug,2020,NA,Hernia (K40-K46),ICD-10 block disease categories
53,Haug,2020,NA,In situ neoplasms (D00-D09),ICD-10 block disease categories
53,Haug,2020,NA,Infections of the skin and subcutaneous tissue (L00-L08),ICD-10 block disease categories
53,Haug,2020,NA,Infections with a predominantly sexual mode of transmission (A50-A64),ICD-10 block disease categories
53,Haug,2020,NA,Inflammatory diseases of female pelvic organs (N70-N77),ICD-10 block disease categories
53,Haug,2020,NA,Influenza and pneumonia (J09-J18),ICD-10 block disease categories
53,Haug,2020,NA,Intestinal infectious diseases (A00-A09),ICD-10 block disease categories
53,Haug,2020,NA,Malignant neoplasms (C00-C97),ICD-10 block disease categories
53,Haug,2020,NA,Mental and behavioural disorders due to psychoactive substance use (F10-F19),ICD-10 block disease categories
53,Haug,2020,NA,Metabolic disorders (E70-E90),ICD-10 block disease categories
53,Haug,2020,NA,Neoplasms of uncertain or unknown behaviour (D37-D48),ICD-10 block disease categories
53,Haug,2020,NA,"Nerve, nerve root and plexus disorders (G50-G59)",ICD-10 block disease categories
53,Haug,2020,NA,"Neurotic, stress-related and somatoform disorders (F40-F48)",ICD-10 block disease categories
53,Haug,2020,NA,Noninfective enteritis and colitis (K50-K52),ICD-10 block disease categories
53,Haug,2020,NA,Noninflammatory disorders of female genital tract (N80-N98),ICD-10 block disease categories
53,Haug,2020,NA,Obesity and other hyperalimentation (E65-E68),ICD-10 block disease categories
53,Haug,2020,NA,"Organic, including symptomatic, mental disorders (F00-F09)",ICD-10 block disease categories
53,Haug,2020,NA,Osteopathies and chondropathies (M80-M94),ICD-10 block disease categories
53,Haug,2020,NA,Other acute lower respiratory infections (J20-J22),ICD-10 block disease categories
53,Haug,2020,NA,Other and unspecified disorders of the circulatory system (I95-I99),ICD-10 block disease categories
53,Haug,2020,NA,Other bacterial diseases (A30-A49),ICD-10 block disease categories
53,Haug,2020,NA,Other diseases of intestines (K55-K63),ICD-10 block disease categories
53,Haug,2020,NA,Other diseases of upper respiratory tract (J30-J39),ICD-10 block disease categories
53,Haug,2020,NA,Other diseases of urinary system (N30-N39),ICD-10 block disease categories
53,Haug,2020,NA,Other disorders of ear (H90-H95),ICD-10 block disease categories
53,Haug,2020,NA,Other disorders of the musculoskeletal system and connective tissue (M95-M99),ICD-10 block disease categories
53,Haug,2020,NA,Other disorders of the skin and subcutaneous tissue (L80-L99),ICD-10 block disease categories
53,Haug,2020,NA,Other forms of heart disease (I30-I52),ICD-10 block disease categories
53,Haug,2020,NA,Other viral diseases (B25-B34),ICD-10 block disease categories
53,Haug,2020,NA,Renal failure (N17-N19),ICD-10 block disease categories
53,Haug,2020,NA,Renal tubulo-interstitial diseases (N10-N16),ICD-10 block disease categories
53,Haug,2020,NA,Soft tissue disorders (M60-M79),ICD-10 block disease categories
53,Haug,2020,NA,Urolithiasis (N20-N23),ICD-10 block disease categories
53,Haug,2020,NA,Urticaria and erythema (L50-L54),ICD-10 block disease categories
53,Haug,2020,NA,Viral infections characterized by skin and mucous membrane lesions (B00-B09),ICD-10 block disease categories
54,Juul-Larsen,NA,asthma,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,cancer,Cancer,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,chronic kidney disease,Chronic kidney disease,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,COPD,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,dementia incl. alzheimers,Dementia,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,diabetes mellitus,Diabetes,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,epilepsy,epilepsy,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,gout,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,heart failure,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,HIV/AIDS,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,hypertension,Hypertension,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,ischemic heart disease,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,mood and anxiety disorders,Depression,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,multiple sclerosis,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,osteoarthritis,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,osteoporosis,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,parkinsons,Parkinsons disease,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,rheumatoid arthritis,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,schizophrenia,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,stroke,Brain infarction/hemmorhage,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,Arthritis,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,cardiac disease,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,COPD/asthma,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,Dementia,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,Disability,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,Disorders of lipoprotein metabolism,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,Disorders of the eyes and ears,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,gastritis,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,Genitourinary diseases,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,mental disorders due to alcohol,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,obesity,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,osteoporosis/osteoarthritis,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,thyroid dysfunction,"ICD codes, grouped by the Chronic Condition Measurement Guide"
54,Juul-Larsen,NA,NA,Ulcers of the skin,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,asthma,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,cancer,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,chronic kidney disease,Chronic kidney disease,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,COPD,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,dementia incl. alzheimers,Dementia,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,diabetes mellitus,Diabetes,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,epilepsy,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,gout,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,heart failure,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,HIV/AIDS,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,hypertension,Hypertension,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,ischemic heart disease,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,mood and anxiety disorders,Depression,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,multiple sclerosis,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,osteoarthritis,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,osteoporosis,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,parkinsons,Parkinsons disease,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,rheumatoid arthritis,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,schizophrenia,NA,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,stroke,Brain infarction/hemmorhage,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,Arthritis,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,cardiac disease,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,Colitis ulcerosa/Chron's disease,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,COPD/asthma,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,Dementia,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,Disability,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,Disorders of lipoprotein metabolism,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,Disorders of the eyes and ears,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,gastritis,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,Genitourinary diseases,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,mental disorders due to alcohol,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,Mental disorders due to tobacco,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,Neuropathy,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,obesity,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,osteoporosis/osteoarthritis,"ICD codes, grouped by the Chronic Condition Measurement Guide"
55,Juul-Larsen,NA,NA,thyroid dysfunction,"ICD codes, grouped by the Chronic Condition Measurement Guide"
56,Lai,2021,asthma,Asthma,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,cancer,"Cancer, lymphoma; Cancer, metastatic; cancer, non-metastatic","ICD codes grouped by Tonelli, 2015"
56,Lai,2021,chronic kidney disease,Chronic kidney disease,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,COPD,NA,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,dementia incl. alzheimers,Dementia,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,diabetes mellitus,Diabetes,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,epilepsy,Epilepsy,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,gout,NA,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,heart failure,Chronic heart failure,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,HIV/AIDS,NA,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,hypertension,Hypertension,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,ischemic heart disease,Myocardial infarction,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,mood and anxiety disorders,Depression,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,multiple sclerosis,Multiple sclerosis,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,osteoarthritis,NA,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,osteoporosis,NA,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,parkinsons,Parkinson’s disease,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,rheumatoid arthritis,Rheumatoid arthritis,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,schizophrenia,Schizophrenia,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,stroke,Stroke or TIA,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Alcohol misuse,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Atrial fibrillation,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,"Cancer, lymphoma","ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,"Cancer, metastatic","ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,"Cancer, non-metastatic (breast, cervical, colorectal, lung, prostate)","ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Chronic pain,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Chronic pulmonary disease,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Chronic viral hepatitis B,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Cirrhosis,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Depression,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Hypothyroidism,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Inflammatory bowel disease,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Irritable bowel syndrome,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Peptic ulcer disease,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Peripheral vascular disease,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Psoriasis,"ICD codes grouped by Tonelli, 2015"
56,Lai,2021,NA,Severe constipation,"ICD codes grouped by Tonelli, 2015"
57,Marengoni,2009,asthma,NA,Custom ICD-9 groupings
57,Marengoni,2009,cancer,malignancy,Custom ICD-9 groupings
57,Marengoni,2009,chronic kidney disease,NA,Custom ICD-9 groupings
57,Marengoni,2009,COPD,chronic obstructive pulmonary disease,Custom ICD-9 groupings
57,Marengoni,2009,dementia incl. alzheimers,dementia,Custom ICD-9 groupings
57,Marengoni,2009,diabetes mellitus,diabetes mellitus,Custom ICD-9 groupings
57,Marengoni,2009,epilepsy,NA,Custom ICD-9 groupings
57,Marengoni,2009,gout,NA,Custom ICD-9 groupings
57,Marengoni,2009,heart failure,heart failure,Custom ICD-9 groupings
57,Marengoni,2009,HIV/AIDS,NA,Custom ICD-9 groupings
57,Marengoni,2009,hypertension,hypertension,Custom ICD-9 groupings
57,Marengoni,2009,ischemic heart disease,coronary heart disease,Custom ICD-9 groupings
57,Marengoni,2009,mood and anxiety disorders,depression,Custom ICD-9 groupings
57,Marengoni,2009,multiple sclerosis,NA,Custom ICD-9 groupings
57,Marengoni,2009,osteoarthritis,NA,Custom ICD-9 groupings
57,Marengoni,2009,osteoporosis,NA,Custom ICD-9 groupings
57,Marengoni,2009,parkinsons,NA,Custom ICD-9 groupings
57,Marengoni,2009,rheumatoid arthritis,NA,Custom ICD-9 groupings
57,Marengoni,2009,schizophrenia,NA,Custom ICD-9 groupings
57,Marengoni,2009,stroke,cerebrovascular disease,Custom ICD-9 groupings
57,Marengoni,2009,NA,anemia,Custom ICD-9 groupings
57,Marengoni,2009,NA,atrial fibrillation,Custom ICD-9 groupings
57,Marengoni,2009,NA,deafness,Custom ICD-9 groupings
57,Marengoni,2009,NA,depression,Custom ICD-9 groupings
57,Marengoni,2009,NA,hip fracture,Custom ICD-9 groupings
57,Marengoni,2009,NA,thyroid dysfuncitons,Custom ICD-9 groupings
57,Marengoni,2009,NA,visual impairments,Custom ICD-9 groupings
58,Marengoni,2013,asthma,NA,Custom ICD-9 groupings
58,Marengoni,2013,cancer,"malignancy (140–165, 170–175, and 179–208)",Custom ICD-9 groupings
58,Marengoni,2013,chronic kidney disease,chronic renal failure (585),Custom ICD-9 groupings
58,Marengoni,2013,COPD,chronic obstructive pulmonary disease (490–496),Custom ICD-9 groupings
58,Marengoni,2013,dementia incl. alzheimers,dementia (290 and 331),Custom ICD-9 groupings
58,Marengoni,2013,diabetes mellitus,diabetes mellitus (250),Custom ICD-9 groupings
58,Marengoni,2013,epilepsy,NA,Custom ICD-9 groupings
58,Marengoni,2013,gout,NA,Custom ICD-9 groupings
58,Marengoni,2013,heart failure,heart failure (428),Custom ICD-9 groupings
58,Marengoni,2013,HIV/AIDS,NA,Custom ICD-9 groupings
58,Marengoni,2013,hypertension,hypertension (401–405),Custom ICD-9 groupings
58,Marengoni,2013,ischemic heart disease,coronary heart disease (410–414),Custom ICD-9 groupings
58,Marengoni,2013,mood and anxiety disorders,anxiety (300),Custom ICD-9 groupings
58,Marengoni,2013,multiple sclerosis,NA,Custom ICD-9 groupings
58,Marengoni,2013,osteoarthritis,arthritis (715),Custom ICD-9 groupings
58,Marengoni,2013,osteoporosis,NA,Custom ICD-9 groupings
58,Marengoni,2013,parkinsons,NA,Custom ICD-9 groupings
58,Marengoni,2013,rheumatoid arthritis,NA,Custom ICD-9 groupings
58,Marengoni,2013,schizophrenia,NA,Custom ICD-9 groupings
58,Marengoni,2013,stroke,cerebrovascular diseases (430–438),Custom ICD-9 groupings
58,Marengoni,2013,NA,anxiety (300),Custom ICD-9 groupings
58,Marengoni,2013,NA,atrial fibrillation (427),Custom ICD-9 groupings
58,Marengoni,2013,NA,dyslipidemia (272),Custom ICD-9 groupings
58,Marengoni,2013,NA,gastric diseases (530–536),Custom ICD-9 groupings
58,Marengoni,2013,NA,intestinal diseases (560–569),Custom ICD-9 groupings
58,Marengoni,2013,NA,liver cirrhosis (571),Custom ICD-9 groupings
58,Marengoni,2013,NA,prostate hypertrophy (600),Custom ICD-9 groupings
58,Marengoni,2013,NA,thyroid diseases (240–246),Custom ICD-9 groupings
59,Prasad,2022,asthma,NA,Charlson's classification
59,Prasad,2022,cancer,"Any Malignancy, Metatatic solid tumour",Charlson's classification
59,Prasad,2022,chronic kidney disease,Renal Disease,Charlson's classification
59,Prasad,2022,COPD,NA,Charlson's classification
59,Prasad,2022,dementia incl. alzheimers,Dementia,Charlson's classification
59,Prasad,2022,diabetes mellitus,Diabetes with/out chronic complications,Charlson's classification
59,Prasad,2022,epilepsy,NA,Charlson's classification
59,Prasad,2022,gout,NA,Charlson's classification
59,Prasad,2022,heart failure,Congestive heart failure,Charlson's classification
59,Prasad,2022,HIV/AIDS,AIDS/HIV,Charlson's classification
59,Prasad,2022,hypertension,NA,Charlson's classification
59,Prasad,2022,ischemic heart disease,Myocardial infarction,Charlson's classification
59,Prasad,2022,mood and anxiety disorders,NA,Charlson's classification
59,Prasad,2022,multiple sclerosis,NA,Charlson's classification
59,Prasad,2022,osteoarthritis,NA,Charlson's classification
59,Prasad,2022,osteoporosis,NA,Charlson's classification
59,Prasad,2022,parkinsons,NA,Charlson's classification
59,Prasad,2022,rheumatoid arthritis,NA,Charlson's classification
59,Prasad,2022,schizophrenia,NA,Charlson's classification
59,Prasad,2022,stroke,Cerebrovascular disease,Charlson's classification
59,Prasad,2022,NA,Chronic pulmonary disease,Charlson's classification
59,Prasad,2022,NA,Hemiplegia or Paraplegia,Charlson's classification
59,Prasad,2022,NA,Mild liver disease,Charlson's classification
59,Prasad,2022,NA,Moderate or severe liver disease,Charlson's classification
59,Prasad,2022,NA,Peptic ulcer disease,Charlson's classification
59,Prasad,2022,NA,Peripheral vascular disease,Charlson's classification
59,Prasad,2022,NA,Rheumatic Disease,Charlson's classification
60,Ruiz,2015,asthma,NA,Charlson/Elixhauser
60,Ruiz,2015,cancer,Cancer; Malignant neoplasm,Charlson/Elixhauser
60,Ruiz,2015,chronic kidney disease,Renal failure,Charlson/Elixhauser
60,Ruiz,2015,COPD,NA,Charlson/Elixhauser
60,Ruiz,2015,dementia incl. alzheimers,Dementia and Alzheimer’s,Charlson/Elixhauser
60,Ruiz,2015,diabetes mellitus,Diabetes With  complications,Charlson/Elixhauser
60,Ruiz,2015,epilepsy,NA,Charlson/Elixhauser
60,Ruiz,2015,gout,NA,Charlson/Elixhauser
60,Ruiz,2015,heart failure,Heart failure (incl. congestive),Charlson/Elixhauser
60,Ruiz,2015,HIV/AIDS,NA,Charlson/Elixhauser
60,Ruiz,2015,hypertension,Hypertension,Charlson/Elixhauser
60,Ruiz,2015,ischemic heart disease,Myocardial infarction,Charlson/Elixhauser
60,Ruiz,2015,mood and anxiety disorders,Depression,Charlson/Elixhauser
60,Ruiz,2015,multiple sclerosis,NA,Charlson/Elixhauser
60,Ruiz,2015,osteoarthritis,NA,Charlson/Elixhauser
60,Ruiz,2015,osteoporosis,Osteoporosis,Charlson/Elixhauser
60,Ruiz,2015,parkinsons,NA,Charlson/Elixhauser
60,Ruiz,2015,rheumatoid arthritis,Rheumatoid arthritis,Charlson/Elixhauser
60,Ruiz,2015,schizophrenia,NA,Charlson/Elixhauser
60,Ruiz,2015,stroke,Cerebrovascular disease (stroke),Charlson/Elixhauser
60,Ruiz,2015,NA,Bladder disorders,Charlson/Elixhauser
60,Ruiz,2015,NA,Connective tissue (incl. arthritis),Charlson/Elixhauser
60,Ruiz,2015,NA,Depression,Charlson/Elixhauser
60,Ruiz,2015,NA,Drug abuse (incl. tobacco),Charlson/Elixhauser
60,Ruiz,2015,NA,Glaucoma,Charlson/Elixhauser
60,Ruiz,2015,NA,Lung (including chronic pulmonary) conditions -asthma,Charlson/Elixhauser
60,Ruiz,2015,NA,"Neurological conditions (including Parkinson’s, Epilepsy, MS)",Charlson/Elixhauser
60,Ruiz,2015,NA,Obesity,Charlson/Elixhauser
60,Ruiz,2015,NA,Paraplegia,Charlson/Elixhauser
60,Ruiz,2015,NA,Peripheral vascular disease,Charlson/Elixhauser
61,Schramm,2022,asthma,J45,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,cancer,"C43, C50, C15-C26, C51-C58, C60-C63, C30-C39, C00-C14, C40-C41, C45-C49, C64-C68, C69-C72, C73-C75, C81-C96","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,chronic kidney disease,N18,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,COPD,"J40, J41, J42, J43, J44, J47, J96","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,dementia incl. alzheimers,"F00, F01, F02, F03, G30, G31.0B, G31.8B, G31.8E, G31.9","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,diabetes mellitus,"E10, E11","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,epilepsy,"G40, G41","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,gout,NA,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,heart failure,NA,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,HIV/AIDS,"B20, B21, B22, B23, B24","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,hypertension,"I10, I12, I15","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,ischemic heart disease,NA,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,mood and anxiety disorders,"F40.1, F41.1, F06.32, F32, F33, F34.1","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,multiple sclerosis,G35,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,osteoarthritis,"M15, M16, M17, M18, M19","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,osteoporosis,"M80, M81, M82","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,parkinsons,"F02.3, G20, G21, G22","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,rheumatoid arthritis,NA,"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,schizophrenia,"F20, F21, F22, F25, F28, F29","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,stroke,"G45, G46, I60, I61, I62, I63, I64, I65, I66, I67, I68, I69","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Alcohol attributable diseases (G31.2, G62.1, G72.1, K29.2, K70, K86.0)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Stafford,2020,NA,Allergy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
61,Schramm,2022,NA,"Anxiety (F40.1, F41.1)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Aortic and mitral valve disease (I05, I06, I34, I35)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,Atherosclerosis (I70),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,Atrial fibrillation and flutter (I48),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Bipolar affective disorder (F30, F31)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,Blindness (H54),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Crohns‚Äôs disease and ulcerative colitis (K50, K51)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Depression (F06.32, F32, F33, F34.1)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Diseases of liver, biliary tract and pancreas (K71, K72, K73, K74, K75, K76, K77, K86.1, K87)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Disorders of lipoprotein metabolism and other lipidaemias (E78.0, E78.2, E78.4, E78.5)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,Eating disorders (F50),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,Fibromyalgia (M79.7),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Inflammatory polyarthropathies (M05, M06.0, M06.8, M07.0, M07.1, M07.3, M10.0, M10.9)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Injuries of nerves and spinal cord and paralytic syndromes (G81, G82, G83, S14, S24, S34, T09.3)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,Irritable bowel disease (K58),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Ischemic heart disease and heart failure (I11, I13, I20, I21, I23, I24, I25, I50)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Migraine and other headache syndromes (G43, G44)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,Obsessive-compulsive disorder (F42),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,Phlebitis and thrombophlebitis (I80),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,PTSD (F43.1),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Pulmonary heart disease and diseases of pulmonary circulation (I26, I27, I28)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Respiratory allergy (J30.1, J30.2, J30.3, J30.4)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Spondylopathies and other dorsopathies (M40, M41, M42, M43, M45, M46, M47, M48, M49, M50, M51, M53, M54)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,"Thyroid diseases (E00, E01, E02, E03, E04, E05, E06, E07)","ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
61,Schramm,2022,NA,Tinnitus (H93.1),"ICD-10 codes, grouped by established case definitions, I reported top 3 highest prevalence diseases for each cluster."
62,Stafford,2021,asthma,Asthma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,cancer,solid neoplasms,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,chronic kidney disease,Chronic kidney diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,COPD,"COPD, Emphysema, Chronic Bronchitis","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,dementia incl. alzheimers,Dementia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,diabetes mellitus,Diabetes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,epilepsy,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,gout,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,heart failure,heart failure,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,HIV/AIDS,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,hypertension,Hypertension,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,ischemic heart disease,Ischemic heart disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,mood and anxiety disorders,Depression and mood diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,multiple sclerosis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,osteoarthritis,Osteoarthritis and other degenerative joint disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,osteoporosis,Osteoporosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,parkinsons,Parkinson and parkinsonism,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,rheumatoid arthritis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,schizophrenia,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,stroke,cerebrovascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,Anemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,Atrial fibrillation,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,Autoimmune diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,cardiac valve diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,chronic liver diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,colitis and related diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,dorsopathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,dyslipidemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,"ear, nose, throat diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,"﻿esophagus, stomach and duodenum diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,glaucoma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,inflammatory arthropathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,migraine and facial pain syndromes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,other eye diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,﻿other genitourinary diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,﻿other metabolic diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,﻿other musculoskeletal and joint diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,﻿other neurological diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,﻿other psychiatric and behavioral diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,other psychiatric and behavioral diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,﻿peripheral neuropathy,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,peripheral vascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,prostate diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,﻿sleep disorders,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,thyroid diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
62,Stafford,2021,NA,﻿venous and lymphatic diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
63,Fortuna,2021,asthma,Asthma,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,cancer,Neoplasms,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,chronic kidney disease,Chronic renal failure,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,COPD,Chronic Obstructive Pulmonary Disease,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,dementia incl. alzheimers,Dementia,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,diabetes mellitus,Diabetes mellitus,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,epilepsy,Epilepsy,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,gout,Gout,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,heart failure,Heart failure,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,HIV/AIDS,HIV,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,hypertension,Hypertension,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,ischemic heart disease,Ischemic heart disease,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,mood and anxiety disorders,Depression,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,multiple sclerosis,NA,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,osteoarthritis,NA,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,osteoporosis,NA,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,parkinsons,Parkinson disease,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,rheumatoid arthritis,NA,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,schizophrenia,NA,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,stroke,Cerebrovascular disease,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Stafford,2022,NA,Blindness and visual impairment,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. restricted to 36 diseases with drug mapping and >=2% prevalence"
63,Fortuna,2021,NA,Cardiac arrhytmias,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Chronic hepatitis,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Cirrhosis,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Crohn 's disease and ulcerative colitis,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Gastroesophageal disease,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Hearing reduction,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Heart valve diseases,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Hyperlipidemia,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Migraine,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Osteoposis and Paget disease,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Other neurological pathologies,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Peripheral vascular disease,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Prostatic hyperplasia,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Psychiatric disorders,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Reduced vision,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Rheumatologic conditions,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
63,Fortuna,2021,NA,Thyroid disease,"ICD-9 codes, grouped into select list of chronic conditions based on literature review"
64,Tazzeo,2021,asthma,Asthma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,cancer,solid neoplasms,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,chronic kidney disease,Chronic kidney diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,COPD,"COPD, Emphysema, Chronic Bronchitis","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,dementia incl. alzheimers,Dementia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,diabetes mellitus,Diabetes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,epilepsy,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,gout,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,heart failure,heart failure,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,HIV/AIDS,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,hypertension,Hypertension,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,ischemic heart disease,Ischemic heart disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,mood and anxiety disorders,Depression and mood diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,multiple sclerosis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,osteoarthritis,Osteoarthritis and other degenerative joint disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,osteoporosis,Osteoporosis,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,parkinsons,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,rheumatoid arthritis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,schizophrenia,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,stroke,cerebrovascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,Anemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,Atrial fibrillation,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,Autoimmune diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,"Blindness, visual impairment","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,Bradycardias and conduction diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,cardiac valve diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,cataract and other lens diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,colitis and related diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,"deafness, hearing impairment","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,dorsopathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,dyslipidemia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,"﻿esophagus, stomach and duodenum diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,glaucoma,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,inflammatory arthropathies,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,migraine and facial pain syndromes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,"﻿neurotic, stress-related and somatoform diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,obesity,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,﻿other cardiovascular diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,other eye diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,﻿other genitourinary diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,﻿other musculoskeletal and joint diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,﻿other neurological diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,prostate diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,﻿sleep disorders,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
64,Tazzeo,2021,NA,thyroid diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 35 diseases with prevalence >= 2%"
65,Vertrano,2022,asthma,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,cancer,cancer,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,chronic kidney disease,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,COPD,"COPD, Emphysema, Chronic Bronchitis","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,dementia incl. alzheimers,Dementia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,diabetes mellitus,Diabetes,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,epilepsy,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,gout,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,heart failure,heart failure,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,HIV/AIDS,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,hypertension,Hypertension,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,ischemic heart disease,Ischemic heart disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,mood and anxiety disorders,Depression and mood diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,multiple sclerosis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,osteoarthritis,Osteoarthritis and other degenerative joint disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,osteoporosis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,parkinsons,Parkinson and parkinsonism,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,rheumatoid arthritis,NA,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,schizophrenia,﻿schizophrenia and delusional diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,stroke,cerebrovascular disease,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,Arrythmia,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,Atrial fibrillation,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,hearing impairment - deafness,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,hip fracture,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,"﻿neurotic, stress-related and somatoform diseases","ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,﻿other musculoskeletal and joint diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,﻿other neurological diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,skin ulcer,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,thyroid diseases,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
65,Vertrano,2022,NA,visual impairment- blindness,"ICD-10 codes grouped into 60 categories, according to ﻿Calderón-Larrañaga, 2016. Restricted to 22 diseases with >=2% prevalence"
66,Violan,2018,asthma,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,cancer,Malignant neoplasm of breast (C50-C50),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,chronic kidney disease,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,COPD,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,dementia incl. alzheimers,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,diabetes mellitus,Diabetes mellitus (E10-E14),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,epilepsy,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,gout,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,heart failure,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,HIV/AIDS,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,hypertension,Hypertensive diseases (I10-I15),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,ischemic heart disease,Ischaemic heart diseases (I20-I25),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,mood and anxiety disorders,Mood [affective] disorders (F30-F39),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,multiple sclerosis,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,osteoarthritis,Arthrosis (M15-M19),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,osteoporosis,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,parkinsons,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,rheumatoid arthritis,NA,"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,schizophrenia,"Schizophrenia, schizotypal and delusional disorders (F20-F29)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,stroke,Cerebrovascular diseases (I60-I69),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Acute upper respiratory infections (J00-J06),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Aplastic and other anaemias (D60-D64),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Behavioural syndromes associated with physiological disturbances and physical factors (F50-F59),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Benign neoplasms (D10-D36),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Chronic lower respiratory diseases (J40-J47),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Deforming dorsopathies (M40-M43),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Dermatitis and eczema (L20-L30),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Diseases of arteries, arterioles and capillaries (I70-I79)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Diseases of external ear (H60-H62),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Diseases of inner ear (H80-H83),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Diseases of liver (K70-K77),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Diseases of male genital organs (N40-N51),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Diseases of middle ear and mastoid (H65-H75),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Diseases of oesophagus, stomach and duodenum (K20-K31)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Diseases of oral cavity, salivary glands and jaws (K00-K14)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of bone density and structure (M80-M85),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of breast (N60-N64),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of choroid and retina (H30-H36),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of conjunctiva (H10-H13),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Disorders of eyelid, lacrimal system and orbit (H00-H06)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Disorders of gallbladder, biliary tract and pancreas (K80-K87)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of lens (H25-H28),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of muscles (M60-M63),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of other endocrine glands (E20-E35),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of skin appendages (L60-L75),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of synovium and tendon (M65-M68),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Disorders of thyroid gland (E00-E07),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Drugs, medicaments and biological substances causing adverse effects in therapeutic use (Y40-Y59)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Episodic and paroxysmal disorders (G40-G47),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Exposure to animate mechanical forces (W50-W64),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Glaucoma (H40-H42),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Hernia (K40-K46),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Infections of the skin and subcutaneous tissue (L00-L08),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Inflammatory diseases of female pelvic organs (N70-N77),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Inflammatory polyarthropathies (M05-M14),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Influenza and pneumonia (J09-J18),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Injuries to the ankle and foot (S90-S99),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Injuries to the head (S00-S09),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Injuries to the knee and lower leg (S80-S89),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Injuries to the wrist and hand (S60-S69),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Injuries to unspecified part of trunk, limb or body region (T08-T14)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Intestinal infectious diseases (A00-A09),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Mental and behavioural disorders due to psychoactive substance use (F10-F19),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Metabolic disorders (E70-E90),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Mycoses (B35-B49),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Nerve, nerve root and plexus disorders (G50-G59)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,"Neurotic, stress-related and somatoform disorders (F40-F48)","ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Noninfective enteritis and colitis (K50-K52),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Noninflammatory disorders of female genital tract (N80-N98),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Nutritional anaemias (D50-D53),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Obesity and other hyperalimentation (E65-E68),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other acute lower respiratory infections (J20-J22),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other congenital malformations of the digestive system (Q38-Q45),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other diseases of blood and blood-forming organs (D70-D77),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other diseases of intestines (K55-K63),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other diseases of upper respiratory tract (J30-J39),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other diseases of urinary system (N30-N39),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other disorders of ear (H90-H95),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other disorders of eye and adnexa (H55-H59),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other disorders of the skin and subcutaneous tissue (L80-L99),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other dorsopathies (M50-M54),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other forms of heart disease (I30-I52),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other joint disorders (M20-M25),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other soft tissue disorders (M70-M79),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Other viral diseases (B25-B34),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Papulosquamous disorders (L40-L45),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Renal failure (N17-N19),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Spondylopathies (M45-M49),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Toxic effects of substances chiefly nonmedicinal as to source (T51-T65),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Urolithiasis (N20-N23),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Urticaria and erythema (L50-L54),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Viral hepatitis (B15-B19),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Viral infections characterized by skin and mucous membrane lesions (B00-B09),"ICD-10 block disease categories, with >1% prevalence in study sample"
66,Violan,2018,NA,Visual disturbances and blindness (H53-H54),"ICD-10 block disease categories, with >1% prevalence in study sample"
69,Soley-Bori,2024,asthma,asthma,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,cancer,cancer,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,chronic kidney disease,chronic kidney disease (CKD),SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,COPD,chronic obstructive pulmonary disease,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,dementia incl. alzheimers,dementia,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,diabetes mellitus,diabetes mellitus,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,epilepsy,epilepsy,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,gout,NA,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,heart failure,heart failure,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,HIV/AIDS,HIV infection,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,hypertension,hypertension,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,ischemic heart disease,coronary heart disease,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,mood and anxiety disorders,anxiety; depression,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,multiple sclerosis,multiple sclerosis,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,osteoarthritis,osteoarthritis,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,osteoporosis,osteoporosis,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,parkinsons,Parkinson’s disease,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,rheumatoid arthritis,rheumatoid arthritis,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,schizophrenia,NA,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,stroke,stroke or transient ischemic attack,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,anxiety,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,﻿alcohol dependency,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,atrial fibrillation,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,chronic pain,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,depression,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,inflammatory bowel disease,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,learning disability,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,liver disease,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,lupus,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,morbid obesity,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,peripheral artery disease,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,severe mental illness,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,sickle-cell anaemia,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,substance dependency,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
69,Soley-Bori,2024,NA,viral hepatitis,SNODMED codes grouped into UK NHS Quality and Outcomes framework groupings
70,Cho,2024,asthma,asthma,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,cancer,"cancer (breast,  colorectal, endometrial, lung, prostate)","ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,chronic kidney disease,chronic ﻿kidney disease (CKD),"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,COPD,chronic obstructive pulmonary disease (COPD),"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,dementia incl. alzheimers,Alzheimer’s disease and related disorders (ADRD) or senile dementia,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,diabetes mellitus,diabetes,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,epilepsy,NA,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,gout,NA,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,heart failure,acute myocardial infarction; heart failure,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,HIV/AIDS,NA,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,hypertension,hypertension,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,ischemic heart disease,ischemic heart disease,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,mood and anxiety disorders,depression,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,multiple sclerosis,NA,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,osteoarthritis,NA,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,osteoporosis,osteoporosis,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,parkinsons,NA,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,rheumatoid arthritis,NA,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,schizophrenia,NA,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,stroke,stroke/transient ischemic attack,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,NA,rheumatoid arthritis/osteoarthritis,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,NA,﻿acquired hypothyroidism,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,NA,anemia,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,NA,atrial fibrillation,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,NA,benign prostatic hyperplasia,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,NA,glaucoma,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,NA,hip/pelvic fracture,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
70,Cho,2024,NA,hyperlipidemia,"ICD 9/10 codes, grouped into 27 diseases by Centre for Medicare and Medicaid services (CMS) Chronic Conditions Data Warehouse (CCW)"
NA,NA,NA,NA,NA,NA
71,Beaney,2024,asthma,Asthma,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,cancer,"Hodgkin Lymphoma, Leukaemia, Non-Hodgkin Lymphoma, Plasma Cell Malignancy, Primary Malignancy_Biliary Tract, Primary Malignancy_Bladder, Primary Malignancy_Bone, Primary Malignancy_Bowel, Primary Malignancy_Brain, Primary Malignancy_Breast, Primary Malignancy_Cervix, Primary Malignancy_Kidney, Primary Malignancy_Liver, Primary Malignancy_Lung, Primary Malignancy_Melanoma, Primary Malignancy_Mesothelioma, Primary Malignancy_Multiple Sites, Primary Malignancy_Oesophageal, Primary Malignancy_Oropharyngeal, Primary Malignancy_other, Primary Malignancy_Ovary, Primary Malignancy_Pancreas, Primary Malignancy_Prostate, Primary Malignancy_Skin, Primary Malignancy_Stomach, Primary Malignancy_Testis, Primary Malignancy_Thyroid, Primary Malignancy_Uterus, Secondary Malignancy_Adrenal Gland, Secondary Malignancy_Bone, Secondary Malignancy_Bowel, Secondary Malignancy_Brain, Secondary Malignancy_Liver, Secondary Malignancy_Lung, Secondary Malignancy_Lymph Nodes, Secondary Malignancy_other, Secondary Malignancy_Peritoneum, Secondary Malignancy_Pleura",Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,chronic kidney disease,Chronic Kidney Disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,COPD,COPD,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,dementia incl. alzheimers,Dementia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,diabetes mellitus,"Diabetes Mellitus_other or not specified, Diabetic Eye Disease, Diabetic Neuropathy, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus",Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,epilepsy,Epilepsy,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,gout,Gout,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,heart failure,Heart failure,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,HIV/AIDS,HIV,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,hypertension,Hypertension,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,ischemic heart disease,"Coronary Heart Disease (not otherwise specified), Myocardial Infarction, Stable Angina, Unstable Angina",Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,mood and anxiety disorders,"Anxiety disorders, Bipolar affective disorder and mania, Depression, Obsessive-compulsive disorder",Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,multiple sclerosis,Multiple sclerosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,osteoarthritis,Osteoarthritis (excl spine),Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,osteoporosis,Osteoporosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,parkinsons,Parkinson's disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,rheumatoid arthritis,Rheumatoid Arthritis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,schizophrenia,Schizophrenia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,stroke,"Intracerebral haemorrhage, Ischaemic stroke, Stroke_not otherwise specified, Subarachnoid haemorrhage",Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Abdominal Aortic Aneurysm,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Abdominal Hernia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Acne,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Alcohol Misuse,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Alcoholic liver disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Allergic and chronic rhinitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Alopecia areata,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Anaemia_other,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Angiodysplasia of colon,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Ankylosing spondylitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Anterior and Intermediate Uveitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Aplastic anaemias,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Asbestosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Atrial Fibrillation,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Atrioventricular blocks,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Autism and Asperger's syndrome,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Autoimmune liver disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Autonomic Neuropathy,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Barrett's oesophagus,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Benign essential tremor,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Benign Prostatic Hyperplasia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Bronchiectasis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Cardiomyopathy_other,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Cataract,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Cerebral Palsy,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Chronic Cystitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Chronic Fatigue Syndrome,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Chronic primary pain,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Chronic sinusitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Chronic viral hepatitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Cirrhosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Coeliac disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Collapsed vertebra,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Congenital Septal Defect,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Crohn's disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Cystic Fibrosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Dermatitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Diaphragmatic hernia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Dilated cardiomyopathy,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Diverticular Disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Down's syndrome,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Dysmenorrhoea,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Eating Disorders,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Endometrial hyperplasia and hypertrophy,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Endometriosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Enteropathic arthropathy,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Enthesopathy and synovial disorder,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Fatty Liver,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Fibromatosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Folate deficiency anaemia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Gastritis and duodenitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Gastro-oesophageal reflux disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Giant Cell arteritis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Glaucoma,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Glomerulonephritis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Hearing loss,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Hepatic failure,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Hidradenitis suppurativa,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Hyperkinetic disorders,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Hyperparathyroidism,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Hypersplenism,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Hypertrophic Cardiomyopathy,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Hypertrophic Nasal Turbinates,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Hyposplenism,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Idiopathic Intracranial Hypertension,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Immunodeficiencies,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Intellectual disability,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Intervertebral disc disorders,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Irritable bowel syndrome,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Left bundle branch block,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Low HDL-C,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Lupus Erythematosus,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Macular degeneration,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Meniere's Disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Migraine,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Motor neurone disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Multiple valve disorder,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Myasthenia gravis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Myelodysplastic Syndrome,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Neuropathic Bladder,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Nonrheumatic aortic valve disorders,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Nonrheumatic mitral valve disorders,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Obesity,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Obstructive and reflux uropathy,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Oesophageal varices,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Other haemolytic anaemias,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Pancreatitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Pericardial Effusion,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Peripheral Neuropathy,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Peripheral Vascular Disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Personality disorders,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Pleural effusion,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Pleural plaque,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Polycystic ovarian syndrome,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Polycythaemia vera,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Polymyalgia Rheumatica,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Portal hypertension,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Posterior Uveitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Primary pulmonary hypertension,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Primary Thrombocytopaenia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Psoriasis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Psoriatic Arthritis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Pulmonary Fibrosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Raised LDL-C,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Raised Total Cholesterol,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Raised Triglycerides,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Raynaud's syndrome,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Retinal vascular occlusions,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Rheumatic Valve Disorder,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Right bundle branch block combinations,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Rosacea,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Sarcoidosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Scleritis and episcleritis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Scleroderma,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Seborrheic dermatitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Secondary polycythaemia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Secondary pulmonary hypertension,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Secondary Thrombocytopaenia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Sick sinus syndrome,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Sickle Cell Disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Sjogren's Syndrome,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Sleep apnoea,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Spina bifida,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Spinal stenosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Spondylolisthesis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Spondylosis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Substance Misuse,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Supraventricular tachycardia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Thalassaemia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Thrombophilia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Thyroid Disease,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Tinnitus,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Transient ischaemic attack,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Trigeminal neuralgia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Tubulo-interstitial nephritis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Ulcerative colitis,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Urinary Incontinence,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Venous thromboembolic disease (Excl PE),Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Ventricular tachycardia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Visual impairment and blindness,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Vitamin B12 deficiency anaemia,Medcodes grouped to disease entiries based on CALIBER study criteria
71,Beaney,2024,NA,Vitiligo,Medcodes grouped to disease entiries based on CALIBER study criteria
NA,NA,NA,NA,NA,NA
72,Dervic,2024,asthma,J45,3- digit ICD-10 codes
72,Dervic,2024,cancer,C00-C92,3- digit ICD-10 codes
72,Dervic,2024,chronic kidney disease,"I12, I13, N02, N03, N04, N05, N18, N19, N80, N81, N83, N84, N85, N87, N88",3- digit ICD-10 codes
72,Dervic,2024,COPD,"J41, J42, J43, J44",3- digit ICD-10 codes
72,Dervic,2024,dementia incl. alzheimers,"F00, F01, F02, F03, G30",3- digit ICD-10 codes
72,Dervic,2024,diabetes mellitus,"E10, E11, E13, E14",3- digit ICD-10 codes
72,Dervic,2024,epilepsy,G40,3- digit ICD-10 codes
72,Dervic,2024,gout,"M10, M11",3- digit ICD-10 codes
72,Dervic,2024,heart failure,I50,3- digit ICD-10 codes
72,Dervic,2024,HIV/AIDS,"B20, B24",3- digit ICD-10 codes
72,Dervic,2024,hypertension,"I10, I11, I12, I13, I15",3- digit ICD-10 codes
72,Dervic,2024,ischemic heart disease,"I20, I21, I22, I24, I25",3- digit ICD-10 codes
72,Dervic,2024,mood and anxiety disorders,"F31, F32, F33, F34, F40, F41, F42, F44, F45, F48",3- digit ICD-10 codes
72,Dervic,2024,multiple sclerosis,G35,3- digit ICD-10 codes
72,Dervic,2024,osteoarthritis,"M15, M16, M17, M18, M19",3- digit ICD-10 codes
72,Dervic,2024,osteoporosis,"M80, M81",3- digit ICD-10 codes
72,Dervic,2024,parkinsons,"G20, G21",3- digit ICD-10 codes
72,Dervic,2024,rheumatoid arthritis,"M05, M06",3- digit ICD-10 codes
72,Dervic,2024,schizophrenia,"F20, F23, F25",3- digit ICD-10 codes
72,Dervic,2024,stroke,"I60, I61, I63, I64",3- digit ICD-10 codes
72,Dervic,2024,NA,"Acute upper respiratory infections (J03, J06, J01, J02, J04, J00)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Aplastic and other anaemias (D64, D62, D61, D63)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Bacterial, viral and other infectious agents (B96)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Behavioural and emotional disorders with onset usually occurring in childhood and adolescence (F91, F90, F93, F92)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Behavioural syndromes associated with physiological disturbances and physical factors (F55, F54, F51, F52, F50)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Benign neoplasms (D16, D12, D21, D17, D22, D13, D23, D18, D35, D14, D32, D11, D15, D31, D34, D30, D29, D36, D27, D24, D25, D26)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Cerebral palsy and other paralytic syndromes (G80, G82, G81, G83)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Cerebrovascular diseases (I67, I62, I66, I65, I68, I69)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Certain disorders involving the immune mechanism (D86, D89, D80)",3- digit ICD-10 codes
72,Dervic,2024,NA,Certain zoonotic bacterial diseases (A26),3- digit ICD-10 codes
72,Dervic,2024,NA,"Chronic lower respiratory diseases (J47, J40)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Chronic rheumatic heart diseases (I07, I05, I08, I06)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Coagulation defects, purpura and other haemorrhagic conditions (D69, D68)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Deforming dorsopathies (M42, M43, M41, M40)",3- digit ICD-10 codes
72,Dervic,2024,NA,Demyelinating diseases of the central nervous system (G37),3- digit ICD-10 codes
72,Dervic,2024,NA,"Dermatitis and eczema (L20, L21, L23, L27, L30, L28, L25, L29, L24)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of appendix (K35, K37, K36)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of arteries, arterioles and capillaries (I70, I71, I79, I73, I74, I72, I77, I78)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of external ear (H61, H60)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of inner ear (H83, H81, H80, H82)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of liver (K76, K70, K71, K73, K74, K72, K75)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of male genital organs (N47, N48, N41, N40, N43, N45, N42, N50, N49)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of middle ear and mastoid (H65, H66, H70, H72, H74)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of myoneural junction and muscle (G71, G70)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of oesophagus, stomach and duodenum (K25, K26, K29, K31, K20, K21, K22, K28, K27, K30)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of oral cavity, salivary glands and jaws (K01, K07, K09, K02, K04, K08, K12, K03, K11, K13, K06, K14)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of peritoneum (K65, K66)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80, I85, I84, I86, I83, I87, I89, I82, I88, I81)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of adult personality and behaviour (F60, F63, F61)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of breast (N62, N60, N64)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of choroid and retina (H36, H33, H35, H34, H31)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of conjunctiva (H10, H11)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of eyelid, lacrimal system and orbit (H02, H00, H04, H01)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of gallbladder, biliary tract and pancreas (K86, K80, K81, K85, K82, K83)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of lens (H25, H26, H27)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of ocular muscles, binocular movement, accommodation and refraction (H50, H52, H49)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of optic nerve and visual pathways (H47, H46)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of other endocrine glands (E23, E34, E26, E21, E22, E27, E29, E24, E20)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of psychological development (F89, F81, F84)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of sclera, cornea, iris and ciliary body (H16, H21, H17, H18)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of skin appendages (L72, L71, L73, L60, L70)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of thyroid gland (E03, E04, E05, E06, E07, E01)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Disorders of vitreous body and globe (H43, H44)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Episodic and paroxysmal disorders (G47, G45, G41, G43, G46, G44)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Extrapyramidal and movement disorders (G25, G24)",3- digit ICD-10 codes
72,Dervic,2024,NA,Glaucoma (H40),3- digit ICD-10 codes
72,Dervic,2024,NA,"Glomerular diseases (N08, N00)",3- digit ICD-10 codes
72,Dervic,2024,NA,Haemolytic anaemias (D59),3- digit ICD-10 codes
72,Dervic,2024,NA,"Hernia (K40, K42, K43, K46, K44, K45, K41)",3- digit ICD-10 codes
72,Dervic,2024,NA,"In situ neoplasms (D01, D03, D04, D07, D06, D05)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Infections of the skin and subcutaneous tissue (L05, L02, L03, L08)",3- digit ICD-10 codes
72,Dervic,2024,NA,Infections with a predominantly sexual mode of transmission (A63),3- digit ICD-10 codes
72,Dervic,2024,NA,Infectious arthropathies (M00),3- digit ICD-10 codes
72,Dervic,2024,NA,"Inflammatory diseases of female pelvic organs (N73, N70, N71, N76)",3- digit ICD-10 codes
72,Dervic,2024,NA,Inflammatory diseases of the central nervous system (G06),3- digit ICD-10 codes
72,Dervic,2024,NA,"Inflammatory polyarthropathies (M07, M12, M14, M13)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Influenza and pneumonia (J18, J15, J13, J10, J11, J12, J16)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Intestinal infectious diseases (A04, A09, A08, A02)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Lung diseases due to external agents (J69, J61, J62)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Malnutrition (E41, E46)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Mental and behavioural disorders due to psychoactive substance use (F10, F11, F13, F14, F15, F12, F19, F17)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Mental retardation (F70, F79, F71)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Metabolic disorders (E84, E78, E79, E89, E87, E88, E73, E72, E86, E83, E74, E85)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Mycoses (B35, B37, B44, B36, B49)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Neoplasms of uncertain or unknown behaviour (D43, D40, D38, D41, D46, D48, D44, D47, D39, D37)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Nerve, nerve root and plexus disorders (G54, G51, G55, G58, G52, G57, G56, G50)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Neurotic, stress-related and somatoform disorders (F43)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Noninfective enteritis and colitis (K51, K50, K52)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Noninflammatory disorders of female genital tract (N92, N94, N91, N93, N95, N97, N89)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Nutritional anaemias (D50, D53, D52, D51)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Obesity and other hyperalimentation (E66, E68, E65)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Organic, including symptomatic, mental disorders (F05, F07, F06, F09)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Osteopathies and chondropathies (M93, M94, M86, M87, M84, M89, M85, M82)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other acute lower respiratory infections (J20, J22, J21)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other and unspecified disorders of the circulatory system (I99, I98, I97, I95)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other bacterial diseases (A46, A49, A41, A40, A48)",3- digit ICD-10 codes
72,Dervic,2024,NA,Other degenerative diseases of the nervous system (G31),3- digit ICD-10 codes
72,Dervic,2024,NA,"Other diseases of blood and blood-forming organs (D75, D73, D72, D70)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other diseases of intestines (K58, K59, K56, K63, K62, K60, K61, K64, K55, K57)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other diseases of pleura (J93, J90, J91, J94, J92)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other diseases of the digestive system (K90, K92, K91)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other diseases of the respiratory system (J96, J98, J95)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other diseases of upper respiratory tract (J30, J35, J36, J32, J33, J37, J38, J39, J34, J31)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other diseases of urinary system (N39, N31, N32, N30, N35, N34, N36)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other disorders of ear (H91, H93, H90)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other disorders of eye and adnexa (H55, H57, H59)",3- digit ICD-10 codes
72,Dervic,2024,NA,Other disorders of glucose regulation and pancreatic internal secretion (E16),3- digit ICD-10 codes
72,Dervic,2024,NA,"Other disorders of kidney and ureter (N25, N26, N28)",3- digit ICD-10 codes
72,Dervic,2024,NA,Other disorders of the genitourinary system (N99),3- digit ICD-10 codes
72,Dervic,2024,NA,"Other disorders of the musculoskeletal system and connective tissue (M99, M96, M95)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other disorders of the nervous system (G93, G91, G95, G98, G99, G90, G92, G96)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other disorders of the skin and subcutaneous tissue (L97, L98, L89, L80, L81, L95, L85, L82, L84, L93, L90)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other dorsopathies (M51, M53, M54, M50)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other forms of heart disease (I42, I34, I36, I35, I45, I30, I31, I44, I51, I46, I33, I48, I38, I47, I49)",3- digit ICD-10 codes
72,Dervic,2024,NA,Other infectious diseases (B99),3- digit ICD-10 codes
72,Dervic,2024,NA,"Other joint disorders (M21, M23, M24, M25, M22, M20)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other nutritional deficiencies (E53, E61, E51, E55)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Other respiratory diseases principally affecting the interstitium (J82, J80, J81, J84)",3- digit ICD-10 codes
72,Dervic,2024,NA,Other spirochaetal diseases (A69),3- digit ICD-10 codes
72,Dervic,2024,NA,"Other viral diseases (B27, B34, B25)",3- digit ICD-10 codes
72,Dervic,2024,NA,Papulosquamous disorders (L40),3- digit ICD-10 codes
72,Dervic,2024,NA,"Pediculosis, acariasis and other infestations (B86)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Polyneuropathies and other disorders of the peripheral nervous system (G63, G61, G62, G60)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Pulmonary heart disease and diseases of pulmonary circulation (I26, I27)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Radiation-related disorders of the skin and subcutaneous tissue (L57, L58)",3- digit ICD-10 codes
72,Dervic,2024,NA,Renal failure (N17),3- digit ICD-10 codes
72,Dervic,2024,NA,"Renal tubulo-interstitial diseases (N13, N12, N10, N11)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Schizophrenia, schizotypal and delusional disorders (F22)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Sequelae of infectious and parasitic diseases (B94, B90, B91)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Soft tissue disorders (M65, M67, M62, M66, M71, M75, M77, M76, M70, M72, M60, M79)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Spondylopathies (M47, M48, M45, M46)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Suppurative and necrotic conditions of lower respiratory tract (J86, J85)",3- digit ICD-10 codes
72,Dervic,2024,NA,Systemic atrophies primarily affecting the central nervous system (G12),3- digit ICD-10 codes
72,Dervic,2024,NA,"Systemic connective tissue disorders (M35, M31, M32, M34)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Tuberculosis (A16, A18)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Urolithiasis (N20, N23, N21)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Urticaria and erythema (L50, L53)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Viral hepatitis (B17, B18, B16)",3- digit ICD-10 codes
72,Dervic,2024,NA,"Viral infections characterized by skin and mucous membrane lesions (B00, B02, B07)",3- digit ICD-10 codes
72,Dervic,2024,NA,Viral infections of the central nervous system (A84),3- digit ICD-10 codes
72,Dervic,2024,NA,"Visual disturbances and blindness (H53, H54)",3- digit ICD-10 codes
NA,NA,NA,NA,NA,NA
73,Ioakeim-Skoufa,2024,asthma,Asthma,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,cancer,Neoplasms,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,chronic kidney disease,Chronic kidney disease,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,COPD,Chronic obstructive pulmonary disease and bronchiectasis,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,dementia incl. alzheimers,"Delirium, dementia, and amnestic and other cognitive disorders",ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,diabetes mellitus,Diabetes Mellitus,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,epilepsy,Epilepsy; convulsions,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,gout,Gout and other crystal arthropathies,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,heart failure,NA,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,HIV/AIDS,NA,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,hypertension,Hypertension,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,ischemic heart disease,Acute myocardial infarction,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,mood and anxiety disorders,Depression and mood disorders; Anxiety disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,multiple sclerosis,NA,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,osteoarthritis,Osteoarthritis,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,osteoporosis,Osteoporosis,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,parkinsons,NA,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,rheumatoid arthritis,Rheumatoid arthritis and related disease,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,schizophrenia,NA,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,stroke,Acute cerebrovascular disease,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Acquired foot deformities,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Adjustment disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Alcohol-related disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Allergic reactions,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Anxiety disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Blindness and vision defects,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Cardiac dysrhythmias,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Cataract,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Coagulation and hemorrhagic disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Conduction disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Depression and mood disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Diseases of white blood cells,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Disorders of lipid metabolism,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Diverticulosis and diverticulitis,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Esophageal disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Genitourinary symptoms and ill-defined conditions,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Glaucoma,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Headache; including migraine,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Hepatitis,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Hyperplasia of prostate,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Joint disorders and dislocations; trauma-related,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Menopausal disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Menstrual disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Miscellaneous mental health disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Nonmalignant breast conditions,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Obesity,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other acquired deformities,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other circulatory disease,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other congenital anomalies,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other ear and sense organ disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other eye disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other gastrointestinal disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other inflammatory condition of skin,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other liver diseases,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other male genital disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other nervous system disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other non-traumatic joint disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other nutritional; endocrine; and metabolic disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Other upper respiratory disease,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Prolapse of female genital organs,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Residual codes; unclassified,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Retinal detachments; defects; vascular occlusion; and retinopathy,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Sexual disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Spondylosis; intervertebral disc disorders; other back problems,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
73,Ioakeim-Skoufa,2024,NA,Thyroid disorders,ICPC/ICD-9 codes grouped into chronic disease categories by AHQR CCS/CCI list.
NA,NA,NA,NA,NA,NA
74,Stockmarr,2024,asthma,NA,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,cancer,Cancer,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,chronic kidney disease,NA,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,COPD,Chronic obstructive pulmonary disease (COPD),"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,dementia incl. alzheimers,Dementia,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,diabetes mellitus,Diabetes,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,epilepsy,NA,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,gout,NA,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,heart failure,NA,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,HIV/AIDS,NA,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,hypertension,Hypertension,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,ischemic heart disease,Chronic Heart Condition,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,mood and anxiety disorders,Anxiety; Long term use of antidepressants (Depression),"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,multiple sclerosis,NA,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,osteoarthritis,Osteoarthritis,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,osteoporosis,Osteoporosis,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,parkinsons,NA,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,rheumatoid arthritis,Rheumatoid Arthritis,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,schizophrenia,Schizophrenia,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,stroke,Stroke,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,NA,Allergies,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,NA,Anxiety,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,NA,Back pain,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,NA,Hypercholesterolemia,"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
74,Stockmarr,2024,NA,Long term use of antidepressants (Depression),"ICD-10 and ATC codes, grouped based on custom case algorithms (Glostrup University Hospital)"
NA,NA,NA,NA,NA,NA
75,Seghieri,2024,asthma,asthma,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,cancer,cancer,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,chronic kidney disease,chronic kidney disease-renal replacement therapy,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,COPD,chronic obstructive pulmonary disease,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,dementia incl. alzheimers,alzheimer; dementia,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,diabetes mellitus,type 1 diabetes; type 2 diabetes,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,epilepsy,epilepsy,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,gout,NA,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,heart failure,heart failure,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,HIV/AIDS,hiv positive and aids concluded,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,hypertension,hypertension,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,ischemic heart disease,coronary artery disease,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,mood and anxiety disorders,NA,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,multiple sclerosis,multiple sclerosis,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,osteoarthritis,NA,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,osteoporosis,NA,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,parkinsons,parkinson’s disease,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,rheumatoid arthritis,rheumatoid arthritis,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,schizophrenia,NA,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,stroke,stroke,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,ankylosing spondylitis,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,arterial vasculopathy,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,blood and hematopoietic organs diseases,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,chronic hepatitis,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,chronic pancreatitis,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,circulatory system diseases,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,congenital malformations,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,digestive system diseases,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,"endocrine glands, nutrition, metabolism and immune disorders",administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,hashimoto’s thyroiditis,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,hepatic cirrhosis,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,hyper and hypoparathyroidism,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,hypercholesterol,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,hyperthyroidisms,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,hypothyroidism,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,infiammatory bowel disease,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,nervous system and sense organs diseases,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,non-ischemic heart disease,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,osteomuscular system and connective tissue diseases,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,psoriasis and psoriasic arthropathy,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,recent transplants (2 years),administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,respiratory insufficiency / oxygen therapy,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,severe myasthenia,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,sjogren syndrome,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,skin and subcutaneous tissue diseases,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,systemic lupus erythematosus,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,systemic sclerosis,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,transplants (10 years),administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
75,Seghieri,2024,NA,venous vasculopathy,administrative data grouped into Chronic related groups (CReG) system (Italian case algorithms)
NA,NA,NA,NA,NA,NA
76,Jiang,2023,asthma,495,Phecodes
76,Jiang,2023,cancer,"153.2, 165.1, 172.11, 172.2, 174.11, 182, 189.11, 189.21, 198.1, 198.2, 198.4, 198.6, 202.2",Phecodes
76,Jiang,2023,chronic kidney disease,"401.22, 580.14, 585.3, 585.33, 585.2",Phecodes
76,Jiang,2023,COPD,"496.1, 496, 496.21",Phecodes
76,Jiang,2023,dementia incl. alzheimers,NA,Phecodes
76,Jiang,2023,diabetes mellitus,"250.1, 250.2, 250.23, 250.7",Phecodes
76,Jiang,2023,epilepsy,345,Phecodes
76,Jiang,2023,gout,274.10000000000002,Phecodes
76,Jiang,2023,heart failure,"428.1, 428.2",Phecodes
76,Jiang,2023,HIV/AIDS,NA,Phecodes
76,Jiang,2023,hypertension,401.1,Phecodes
76,Jiang,2023,ischemic heart disease,"411.2, 411.9, 411.1, 411.3, 411.4, 411.8",Phecodes
76,Jiang,2023,mood and anxiety disorders,"296.1, 296.22, 300.1",Phecodes
76,Jiang,2023,multiple sclerosis,335,Phecodes
76,Jiang,2023,osteoarthritis,"740.11, 740.1, 740.9, 740.2",Phecodes
76,Jiang,2023,osteoporosis,743.11,Phecodes
76,Jiang,2023,parkinsons,332,Phecodes
76,Jiang,2023,rheumatoid arthritis,"357, 714.1",Phecodes
76,Jiang,2023,schizophrenia,NA,Phecodes
76,Jiang,2023,stroke,433.21,Phecodes
76,Jiang,2023,NA,Abdominal aortic aneurysm (442.11),Phecodes
76,Jiang,2023,NA,Abdominal pain (785),Phecodes
76,Jiang,2023,NA,Acidosis (276.41),Phecodes
76,Jiang,2023,NA,Acquired spondylolisthesis (738.4),Phecodes
76,Jiang,2023,NA,Acquired toe deformities (735.2),Phecodes
76,Jiang,2023,NA,Actinic keratosis (702.1),Phecodes
76,Jiang,2023,NA,Acute appendicitis (540.11),Phecodes
76,Jiang,2023,NA,Acute gastritis (535.1),Phecodes
76,Jiang,2023,NA,Acute pancreatitis (577.1),Phecodes
76,Jiang,2023,NA,Acute pharyngitis (465.2),Phecodes
76,Jiang,2023,NA,Acute renal failure (585.1),Phecodes
76,Jiang,2023,NA,Alcohol-related disorders (317),Phecodes
76,Jiang,2023,NA,Alcoholic liver damage (317.11),Phecodes
76,Jiang,2023,NA,Allergic rhinitis (476),Phecodes
76,Jiang,2023,NA,Anal and rectal conditions (565),Phecodes
76,Jiang,2023,NA,Anal and rectal polyp (565.1),Phecodes
76,Jiang,2023,NA,Aortic valve disease (394.3),Phecodes
76,Jiang,2023,NA,Arrhythmia (cardiac) NOS (427.5),Phecodes
76,Jiang,2023,NA,Arthropathy NOS (716.9),Phecodes
76,Jiang,2023,NA,Atopic/contact dermatitis due to other or unspecified (939),Phecodes
76,Jiang,2023,NA,Atrial fibrillation and flutter (427.2),Phecodes
76,Jiang,2023,NA,Back pain (760),Phecodes
76,Jiang,2023,NA,Bacterial enteritis (8.5),Phecodes
76,Jiang,2023,NA,Bacterial infection NOS (41),Phecodes
76,Jiang,2023,NA,Bacterial pneumonia (480.1),Phecodes
76,Jiang,2023,NA,Barrett's esophagus (530.13),Phecodes
76,Jiang,2023,NA,Benign neoplasm of breast (610.4),Phecodes
76,Jiang,2023,NA,Benign neoplasm of colon (208),Phecodes
76,Jiang,2023,NA,Benign neoplasm of other parts of digestive system (211),Phecodes
76,Jiang,2023,NA,Benign neoplasm of ovary (220),Phecodes
76,Jiang,2023,NA,Benign neoplasm of skin (216),Phecodes
76,Jiang,2023,NA,Bladder neck obstruction (596.1),Phecodes
76,Jiang,2023,NA,Blood in stool (578.2),Phecodes
76,Jiang,2023,NA,Breast cancer [female] (174.1),Phecodes
76,Jiang,2023,NA,Bronchiectasis (496.3),Phecodes
76,Jiang,2023,NA,Bursitis (726.3),Phecodes
76,Jiang,2023,NA,Calculus of bile duct (574.2),Phecodes
76,Jiang,2023,NA,Calculus of kidney (594.1),Phecodes
76,Jiang,2023,NA,Calculus of ureter (594.3),Phecodes
76,Jiang,2023,NA,Cancer of prostate (185),Phecodes
76,Jiang,2023,NA,Candidiasis (112),Phecodes
76,Jiang,2023,NA,Carbuncle and furuncle (686.1),Phecodes
76,Jiang,2023,NA,Cardiac arrest (427.42),Phecodes
76,Jiang,2023,NA,Cardiomegaly (416),Phecodes
76,Jiang,2023,NA,Cataract (366),Phecodes
76,Jiang,2023,NA,Celiac disease (557.1),Phecodes
76,Jiang,2023,NA,Cellulitis and abscess of arm/hand (681.3),Phecodes
76,Jiang,2023,NA,Cerebral ischemia (433.3),Phecodes
76,Jiang,2023,NA,Cerebrovascular disease (433),Phecodes
76,Jiang,2023,NA,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia] (180.3),Phecodes
76,Jiang,2023,NA,Cervicalgia (761),Phecodes
76,Jiang,2023,NA,Cervicitis and endocervicitis (614.51),Phecodes
76,Jiang,2023,NA,Cholecystitis without cholelithiasis (574.3),Phecodes
76,Jiang,2023,NA,Cholelithiasis (574.1),Phecodes
76,Jiang,2023,NA,Cholelithiasis with acute cholecystitis (574.11),Phecodes
76,Jiang,2023,NA,Cholelithiasis with other cholecystitis (574.12),Phecodes
76,Jiang,2023,NA,Chronic cystitis (592.12),Phecodes
76,Jiang,2023,NA,Chronic periodontitis (523.32),Phecodes
76,Jiang,2023,NA,Chronic pharyngitis and nasopharyngitis (472),Phecodes
76,Jiang,2023,NA,Chronic prostatitis (601.12),Phecodes
76,Jiang,2023,NA,Chronic sinusitis (475),Phecodes
76,Jiang,2023,NA,Chronic ulcer of skin (707),Phecodes
76,Jiang,2023,NA,Congenital anomalies of great vessels (747.13),Phecodes
76,Jiang,2023,NA,Contracture of palmar fascia [Dupuytren's disease] (728.71),Phecodes
76,Jiang,2023,NA,"Cyst of kidney, acquired (586.2)",Phecodes
76,Jiang,2023,NA,Cystitis (592.1),Phecodes
76,Jiang,2023,NA,Death (psuedo-disease created from death events) (NA),Phecodes
76,Jiang,2023,NA,Decubitus ulcer (707.1),Phecodes
76,Jiang,2023,NA,Degeneration of intervertebral disc (722.6),Phecodes
76,Jiang,2023,NA,Degenerative disease of the spinal cord (334),Phecodes
76,Jiang,2023,NA,Dental caries (521.1),Phecodes
76,Jiang,2023,NA,Diaphragmatic hernia (550.2),Phecodes
76,Jiang,2023,NA,Disease of tricuspid valve (394.7),Phecodes
76,Jiang,2023,NA,"Diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue (528)",Phecodes
76,Jiang,2023,NA,Disorder of skin and subcutaneous tissue NOS (689),Phecodes
76,Jiang,2023,NA,Disorders of calcium/phosphorus metabolism (275.5),Phecodes
76,Jiang,2023,NA,Disorders of conjunctiva (372),Phecodes
76,Jiang,2023,NA,Disorders of lacrimal system (375),Phecodes
76,Jiang,2023,NA,Disorders of menstruation and other abnormal bleeding from female genital tract (626),Phecodes
76,Jiang,2023,NA,"Disorders of uterus, NEC (619.2)",Phecodes
76,Jiang,2023,NA,Disorders of vitreous body (379.2),Phecodes
76,Jiang,2023,NA,Displacement of intervertebral disc (722.1),Phecodes
76,Jiang,2023,NA,Disturbances in tooth eruption (520.2),Phecodes
76,Jiang,2023,NA,Diverticulosis (562.1),Phecodes
76,Jiang,2023,NA,Duodenal ulcer (531.3),Phecodes
76,Jiang,2023,NA,Duodenitis (535.6),Phecodes
76,Jiang,2023,NA,Dysmenorrhea (626.2),Phecodes
76,Jiang,2023,NA,Dyspareunia (625.1),Phecodes
76,Jiang,2023,NA,E. coli (41.4),Phecodes
76,Jiang,2023,NA,Ectropion or entropion (374.1),Phecodes
76,Jiang,2023,NA,Empyema and pneumothorax (506),Phecodes
76,Jiang,2023,NA,Endometrial hyperplasia (621),Phecodes
76,Jiang,2023,NA,Endometriosis (615),Phecodes
76,Jiang,2023,NA,Enthesopathy (726.1),Phecodes
76,Jiang,2023,NA,Epiphora (375.2),Phecodes
76,Jiang,2023,NA,Esophageal bleeding (varices/hemorrhage) (530.2),Phecodes
76,Jiang,2023,NA,"Esophagitis, GERD and related diseases (530.1)",Phecodes
76,Jiang,2023,NA,Excessive or frequent menstruation (626.12),Phecodes
76,Jiang,2023,NA,Facial nerve disorders [CN7] (352.2),Phecodes
76,Jiang,2023,NA,First degree AV block (426.21),Phecodes
76,Jiang,2023,NA,Functional digestive disorders (564),Phecodes
76,Jiang,2023,NA,Functional disorders of bladder (596.5),Phecodes
76,Jiang,2023,NA,GERD (530.11),Phecodes
76,Jiang,2023,NA,"Ganglion and cyst of synovium, tendon, and bursa (727.4)",Phecodes
76,Jiang,2023,NA,Gastric ulcer (531.2),Phecodes
76,Jiang,2023,NA,Gastritis and duodenitis (535),Phecodes
76,Jiang,2023,NA,Gastrointestinal complications (569.2),Phecodes
76,Jiang,2023,NA,Glaucoma (365),Phecodes
76,Jiang,2023,NA,Gram negative septicemia (38.1),Phecodes
76,Jiang,2023,NA,Hallux rigidus (735.23),Phecodes
76,Jiang,2023,NA,Hallux valgus (Bunion) (735.3),Phecodes
76,Jiang,2023,NA,Hammer toe (acquired) (735.21),Phecodes
76,Jiang,2023,NA,Hearing loss (389),Phecodes
76,Jiang,2023,NA,"Hemangioma and lymphangioma, any site (228)",Phecodes
76,Jiang,2023,NA,Hematemesis (578.1),Phecodes
76,Jiang,2023,NA,Hemiplegia (342),Phecodes
76,Jiang,2023,NA,Hemorrhage of gastrointestinal tract (578.9),Phecodes
76,Jiang,2023,NA,Hemorrhage of rectum and anus (578.8),Phecodes
76,Jiang,2023,NA,Hemorrhoids (455),Phecodes
76,Jiang,2023,NA,Hydrocele (603.1),Phecodes
76,Jiang,2023,NA,Hydronephrosis (595),Phecodes
76,Jiang,2023,NA,Hypercholesterolemia (272.11),Phecodes
76,Jiang,2023,NA,Hyperlipidemia (272.1),Phecodes
76,Jiang,2023,NA,Hyperplasia of prostate (600),Phecodes
76,Jiang,2023,NA,Hyperpotassemia (276.13),Phecodes
76,Jiang,2023,NA,Hypertrophy of breast (Gynecomastia) (612.2),Phecodes
76,Jiang,2023,NA,Hypertrophy of female genital organs (623),Phecodes
76,Jiang,2023,NA,Hypoglycemia (251.1),Phecodes
76,Jiang,2023,NA,Hypopotassemia (276.14),Phecodes
76,Jiang,2023,NA,Hyposmolality and/or hyponatremia (276.12),Phecodes
76,Jiang,2023,NA,Hypotension NOS (458.9),Phecodes
76,Jiang,2023,NA,Hypothyroidism NOS (244.4),Phecodes
76,Jiang,2023,NA,Hypovolemia (276.5),Phecodes
76,Jiang,2023,NA,"Infertility, female (626.8)",Phecodes
76,Jiang,2023,NA,Inflammation of eyelids (371.3),Phecodes
76,Jiang,2023,NA,Inguinal hernia (550.1),Phecodes
76,Jiang,2023,NA,Internal derangement of knee (835),Phecodes
76,Jiang,2023,NA,"Iron deficiency anemias, unspecified or not due to blood loss (280.1)",Phecodes
76,Jiang,2023,NA,Irregular menstrual bleeding (626.14),Phecodes
76,Jiang,2023,NA,Irregular menstrual cycle (626.13),Phecodes
76,Jiang,2023,NA,Irregular menstrual cycle/bleeding (626.1),Phecodes
76,Jiang,2023,NA,Irritable Bowel Syndrome (564.1),Phecodes
76,Jiang,2023,NA,Joint effusions (741.4),Phecodes
76,Jiang,2023,NA,Kyphoscoliosis and scoliosis (737.3),Phecodes
76,Jiang,2023,NA,Late effects of cerebrovascular disease (433.8),Phecodes
76,Jiang,2023,NA,Left bundle branch block (426.32),Phecodes
76,Jiang,2023,NA,Lipoma (214),Phecodes
76,Jiang,2023,NA,Lipoma of skin and subcutaneous tissue (214.1),Phecodes
76,Jiang,2023,NA,Lump or mass in breast (611.3),Phecodes
76,Jiang,2023,NA,Macular degeneration (senile) of retina NOS (362.29),Phecodes
76,Jiang,2023,NA,Malignant neoplasm of ovary (184.11),Phecodes
76,Jiang,2023,NA,"Malignant neoplasm of rectum, rectosigmoid junction, and anus (153.3)",Phecodes
76,Jiang,2023,NA,"Malignant neoplasm, other (195.1)",Phecodes
76,Jiang,2023,NA,Malunion and nonunion of fracture (733.8),Phecodes
76,Jiang,2023,NA,Migraine (340),Phecodes
76,Jiang,2023,NA,Mitral valve disease (394.2),Phecodes
76,Jiang,2023,NA,Mucous polyp of cervix (622.2),Phecodes
76,Jiang,2023,NA,Myalgia and myositis unspecified (770),Phecodes
76,Jiang,2023,NA,Myopia (367.1),Phecodes
76,Jiang,2023,NA,Nasal polyps (471),Phecodes
76,Jiang,2023,NA,Neoplasm of uncertain behavior (199),Phecodes
76,Jiang,2023,NA,Neoplasm of unspecified nature of digestive system (158),Phecodes
76,Jiang,2023,NA,"Neuralgia, neuritis, and radiculitis NOS (766)",Phecodes
76,Jiang,2023,NA,Neutropenia (288.11),Phecodes
76,Jiang,2023,NA,Noninfectious gastroenteritis (558),Phecodes
76,Jiang,2023,NA,Noninflammatory disorders of cervix (619.3),Phecodes
76,Jiang,2023,NA,Noninflammatory disorders of vagina (619.4),Phecodes
76,Jiang,2023,NA,Noninflammatory disorders of vulva and perineum (619.5),Phecodes
76,Jiang,2023,NA,Obesity (Alkesgrp),Phecodes
76,Jiang,2023,NA,Occlusion and stenosis of precerebral arteries (433.1),Phecodes
76,Jiang,2023,NA,Occlusion of cerebral arteries (433.2),Phecodes
76,Jiang,2023,NA,Orthostatic hypotension (458.1),Phecodes
76,Jiang,2023,NA,Osteopenia or other disorder of bone and cartilage (743.9),Phecodes
76,Jiang,2023,NA,Other acquired deformities of limbs (736),Phecodes
76,Jiang,2023,NA,Other and unspecified disc disorder (722.9),Phecodes
76,Jiang,2023,NA,Other anemias (285),Phecodes
76,Jiang,2023,NA,Other chronic nonalcoholic liver disease (571.5),Phecodes
76,Jiang,2023,NA,Other derangement of joint (742.9),Phecodes
76,Jiang,2023,NA,"Other diseases of respiratory system, NEC (519.8)",Phecodes
76,Jiang,2023,NA,Other diseases of the teeth and supporting structures (525),Phecodes
76,Jiang,2023,NA,Other disorders of biliary tract (575.8),Phecodes
76,Jiang,2023,NA,Other disorders of bladder (596),Phecodes
76,Jiang,2023,NA,Other disorders of bone and cartilage (733),Phecodes
76,Jiang,2023,NA,Other disorders of eyelids (374),Phecodes
76,Jiang,2023,NA,Other disorders of gallbladder (575.7),Phecodes
76,Jiang,2023,NA,Other disorders of intestine (569),Phecodes
76,Jiang,2023,NA,Other disorders of liver (573),Phecodes
76,Jiang,2023,NA,Other disorders of male genital organs (608),Phecodes
76,Jiang,2023,NA,Other disorders of prostate (602),Phecodes
76,Jiang,2023,NA,Other disorders of soft tissues (729),Phecodes
76,Jiang,2023,NA,Other disorders of stomach and duodenum (537),Phecodes
76,Jiang,2023,NA,"Other disorders of synovium, tendon, and bursa (727)",Phecodes
76,Jiang,2023,NA,Other disorders of testis (603),Phecodes
76,Jiang,2023,NA,Other disorders of the kidney and ureters (586),Phecodes
76,Jiang,2023,NA,Other forms of chronic heart disease (414),Phecodes
76,Jiang,2023,NA,Other hypertrophic and atrophic conditions of skin (701),Phecodes
76,Jiang,2023,NA,Other inflammatory spondylopathies (715),Phecodes
76,Jiang,2023,NA,Other intestinal obstruction (560.4),Phecodes
76,Jiang,2023,NA,Other local infections of skin and subcutaneous tissue (686),Phecodes
76,Jiang,2023,NA,Other peripheral nerve disorders (351),Phecodes
76,Jiang,2023,NA,Other retinal disorders (362),Phecodes
76,Jiang,2023,NA,Other specified gastritis (535.8),Phecodes
76,Jiang,2023,NA,Other symptoms/disorders or the urinary system (599),Phecodes
76,Jiang,2023,NA,Other tests (1010),Phecodes
76,Jiang,2023,NA,Other upper respiratory disease (479),Phecodes
76,Jiang,2023,NA,Otitis media (381.1),Phecodes
76,Jiang,2023,NA,Ovarian cyst (628),Phecodes
76,Jiang,2023,NA,Pain and other symptoms associated with female genital organs (625),Phecodes
76,Jiang,2023,NA,Pain in joint (745),Phecodes
76,Jiang,2023,NA,Pain in limb (773),Phecodes
76,Jiang,2023,NA,Paroxysmal supraventricular tachycardia (427.11),Phecodes
76,Jiang,2023,NA,Paroxysmal ventricular tachycardia (427.12),Phecodes
76,Jiang,2023,NA,"Pelvic peritoneal adhesions, female (postoperative) (postinfection) (614.1)",Phecodes
76,Jiang,2023,NA,Perforation of tympanic membrane (384.4),Phecodes
76,Jiang,2023,NA,Periapical abscess (522.5),Phecodes
76,Jiang,2023,NA,Pericarditis (420.2),Phecodes
76,Jiang,2023,NA,Peripheral enthesopathies and allied syndromes (726),Phecodes
76,Jiang,2023,NA,"Peripheral vascular disease, unspecified (443.9)",Phecodes
76,Jiang,2023,NA,Peritoneal adhesions (postoperative) (postinfection) (568.1),Phecodes
76,Jiang,2023,NA,Peritonitis and retroperitoneal infections (567),Phecodes
76,Jiang,2023,NA,Phlebitis and thrombophlebitis of lower extremities (451.2),Phecodes
76,Jiang,2023,NA,Pleurisy; pleural effusion (507),Phecodes
76,Jiang,2023,NA,Pneumococcal pneumonia (480.11),Phecodes
76,Jiang,2023,NA,Pneumonia (480),Phecodes
76,Jiang,2023,NA,Polymyalgia Rheumatica (717),Phecodes
76,Jiang,2023,NA,Polyp of corpus uteri (622.1),Phecodes
76,Jiang,2023,NA,Postinflammatory pulmonary fibrosis (502),Phecodes
76,Jiang,2023,NA,Postmenopausal atrophic vaginitis (627.3),Phecodes
76,Jiang,2023,NA,Postmenopausal bleeding (627.1),Phecodes
76,Jiang,2023,NA,Primary open angle glaucoma (365.11),Phecodes
76,Jiang,2023,NA,Primary/intrinsic cardiomyopathies (425.1),Phecodes
76,Jiang,2023,NA,Prolapse of vaginal walls (618.1),Phecodes
76,Jiang,2023,NA,Psoriasis vulgaris (696.41),Phecodes
76,Jiang,2023,NA,Ptosis of eyelid (374.3),Phecodes
76,Jiang,2023,NA,Pulmonary collapse; interstitial and compensatory emphysema (508),Phecodes
76,Jiang,2023,NA,Pulmonary heart disease (415),Phecodes
76,Jiang,2023,NA,Pyelonephritis (590),Phecodes
76,Jiang,2023,NA,Redundant prepuce and phimosis/BXO (604.1),Phecodes
76,Jiang,2023,NA,Reflux esophagitis (530.14),Phecodes
76,Jiang,2023,NA,Regional enteritis (555.1),Phecodes
76,Jiang,2023,NA,Renal colic (594.8),Phecodes
76,Jiang,2023,NA,Respiratory failure (509.1),Phecodes
76,Jiang,2023,NA,Retinal detachment with retinal defect (361.1),Phecodes
76,Jiang,2023,NA,Retinal detachments and defects (361),Phecodes
76,Jiang,2023,NA,Retinal vascular changes and abnomalities (362.4),Phecodes
76,Jiang,2023,NA,Rheumatic disease of the heart valves (394),Phecodes
76,Jiang,2023,NA,"Rheumatism, unspecified and fibrositis (729.1)",Phecodes
76,Jiang,2023,NA,Right bundle branch block (426.31),Phecodes
76,Jiang,2023,NA,Scar conditions and fibrosis of skin (701.2),Phecodes
76,Jiang,2023,NA,Sciatica (764),Phecodes
76,Jiang,2023,NA,Sebaceous cyst (706.2),Phecodes
76,Jiang,2023,NA,Seborrheic keratosis (702.2),Phecodes
76,Jiang,2023,NA,Secondary hypothyroidism (244.1),Phecodes
76,Jiang,2023,NA,Secondary malignant neoplasm (198),Phecodes
76,Jiang,2023,NA,Secondary malignant neoplasm of digestive systems (198.3),Phecodes
76,Jiang,2023,NA,Senile cataract (366.2),Phecodes
76,Jiang,2023,NA,Sepsis (994.2),Phecodes
76,Jiang,2023,NA,Septal Deviations/Turbinate Hypertrophy (470),Phecodes
76,Jiang,2023,NA,Sleep apnea (327.3),Phecodes
76,Jiang,2023,NA,Sleep disorders (327),Phecodes
76,Jiang,2023,NA,Spinal stenosis (720),Phecodes
76,Jiang,2023,NA,Spondylosis and allied disorders (721),Phecodes
76,Jiang,2023,NA,Spondylosis without myelopathy (721.1),Phecodes
76,Jiang,2023,NA,Staphylococcus infections (41.1),Phecodes
76,Jiang,2023,NA,Strabismus (not specified as paralytic) (378.1),Phecodes
76,Jiang,2023,NA,Streptococcus infection (41.2),Phecodes
76,Jiang,2023,NA,Stricture and stenosis of esophagus (530.3),Phecodes
76,Jiang,2023,NA,Stricture of artery (447.1),Phecodes
76,Jiang,2023,NA,Stricture/obstruction of ureter (586.4),Phecodes
76,Jiang,2023,NA,Symptoms and disorders of the joints (741),Phecodes
76,Jiang,2023,NA,Synovitis and tenosynovitis (727.1),Phecodes
76,Jiang,2023,NA,"Thoracic or lumbosacral neuritis or radiculitis, unspecified (763)",Phecodes
76,Jiang,2023,NA,Thrombocytopenia (287.3),Phecodes
76,Jiang,2023,NA,Thyrotoxicosis with or without goiter (242),Phecodes
76,Jiang,2023,NA,Tobacco use disorder (318),Phecodes
76,Jiang,2023,NA,Transient cerebral ischemia (433.31),Phecodes
76,Jiang,2023,NA,Ulcer of esophagus (530.12),Phecodes
76,Jiang,2023,NA,Ulcerative colitis (555.2),Phecodes
76,Jiang,2023,NA,Umbilical hernia (550.4),Phecodes
76,Jiang,2023,NA,Urethral stricture (not specified as infectious) (597.1),Phecodes
76,Jiang,2023,NA,Urinary incontinence (599.4),Phecodes
76,Jiang,2023,NA,Urinary tract infection (591),Phecodes
76,Jiang,2023,NA,Uterine leiomyoma (218.1),Phecodes
76,Jiang,2023,NA,Uterine/Uterovaginal prolapse (618.2),Phecodes
76,Jiang,2023,NA,Varicose veins of lower extremity (454.1),Phecodes
76,Jiang,2023,NA,Ventral hernia (550.5),Phecodes
76,Jiang,2023,NA,Viral Enteritis (8.6),Phecodes
76,Jiang,2023,NA,Viral infection (79),Phecodes
76,Jiang,2023,NA,Viral warts & HPV (78),Phecodes
76,Jiang,2023,NA,Visual disturbances (368),Phecodes
NA,NA,NA,NA,NA,NA
77,Alvarez-Galvez,2023,asthma,Asthma,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,cancer,"Breast cancer, Colorectal cancer, Other cancer, Prostate cancer",ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,chronic kidney disease,Chronic renal failure,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,COPD,COPD,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,dementia incl. alzheimers,Dementia,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,diabetes mellitus,Diabetes,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,epilepsy,Epilepsy,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,gout,Gout and other arthropathies,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,heart failure,Heart failure,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,HIV/AIDS,HIV,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,hypertension,Hypertension,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,ischemic heart disease,Ischemic heart disease,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,mood and anxiety disorders,"Anxiety disorder, Mood disorder",ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,multiple sclerosis,NA,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,osteoarthritis,NA,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,osteoporosis,Osteoporosis,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,parkinsons,Parkinson's disease,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,rheumatoid arthritis,Rheumatoid arthritis,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,schizophrenia,Schizophrenic disorder,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,stroke,Cerebrovascular disease sequel,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Acquired valve disease,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Adolescence childhood start disorder,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Adult personality and behavior disorder,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Another arthropathy,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Another organic mental disorder,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,"Aorta, peripheral and visceral arteries aneurysm",ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,"Arthrosis, spondylosis",ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Atopic dermatitis,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Atrial fibrillation,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Badly defined cerebrovascular disease,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Collagen and vasculitis disease,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Dependence (Alcohol or Drugs),ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Dyslipidemia,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Extrapyramidal syndrome,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Extremities arteriopathy,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Fibromyalgia,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Food intolerance syndrome,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Gastroesophageal reflux disease,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Glaucoma,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Hepatic steatosis,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Hypothyroidism,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Intellectual disability,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Liver disease,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Macular degeneration associated with age,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Neurological disease with non-stroke motor deficit,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Obesity,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Precerebrak arteries occlusion,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Psoriasis,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Regional enteritis and ulcerative colitis,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Retinopathy,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Tobacco dependence,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Urinary lithiasis,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
77,Alvarez-Galvez,2023,NA,Uterine cancer,ICD 9/10 codes grouped into case algorithms developed by the Andalusian health services
NA,NA,NA,NA,NA,NA
78,Eto,2023,asthma,Asthma,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,cancer,"Cervical carcinoma in situ, Hodgkin Lymphoma, Leukaemia, Non-Hodgkin Lymphoma, Primary malignancy biliary tract, Primary malignancy bladder, Primary malignancy bone and articular cartilage, Primary malignancy brain, other CNS and intracranial, Primary malignancy breast, Primary malignancy cervical, Primary malignancy colorectal and anus, Primary malignancy kidney and ureter, Primary malignancy liver, Primary malignancy lung and trachea, Primary malignancy malignant melanoma, Primary malignancy mesothelioma, Primary malignancy oesophageal, Primary malignancy oro-pharyngeal, Primary malignancy other skin and subcutaneous tissue, Primary malignancy others, Primary malignancy ovarian, Primary malignancy pancreatic, Primary malignancy prostate, Primary malignancy stomach, Primary malignancy testicular, Primary malignancy thyroid, Primary malignancy uterine","READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,chronic kidney disease,"Chronic Kidney Disease, End stage renal disease","READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,COPD,Chronic obstructive pulmonary disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,dementia incl. alzheimers,Dementia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,diabetes mellitus,"Diabetic eye disease, Diabetic neurological complications, Type 1 Diabetes, Type 2 Diabetes","READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,epilepsy,Epilepsy,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,gout,Gout,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,heart failure,Heart failure,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,HIV/AIDS,HIV,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,hypertension,Hypertension,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,ischemic heart disease,Coronary heart disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,mood and anxiety disorders,"Anxiety and phobia, Bipolar affective disorder and mania, Depression","READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,multiple sclerosis,Multiple sclerosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,osteoarthritis,Osteoarthritis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,osteoporosis,Osteoporosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,parkinsons,Parkinson's disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,rheumatoid arthritis,Rheumatoid Arthritis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,schizophrenia,Schizophrenia and non-organic psychosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,stroke,"Cerebrovascular disease, Intracerebral haemorrhage, Subarachnoid haemorrhage","READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,ADHD and hyperkinetic disorders,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Adrenal insufficiency and Addison's disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Alcohol dependence and related disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Allergic and chronic rhinitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Alopecia areata and scarring alopecia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Ankylosing spondylitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Aortic aneurysm,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Aplastic anaemias,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Asbestosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Atrial fibrillation and flutter,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Autism and Asperger's syndrome,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Autoimmune liver disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Barrett's oesophagus,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Blistering autoimmune skin conditions,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Bronchiectasis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Cardiac conduction defects,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Cardiomyopathy other,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Cerebral Palsy,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Cholelithiasis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Chronic fatigue,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Chronic sinusitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Chronic ulcer of the skin,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Chronic viral hepatitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Coeliac disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Collapsed vertebra,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Congenital cardiac disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Constipation,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Crohn's disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Cystic Fibrosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Cystic renal disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Dermatitis (atopic/contact/other/unspecified),"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Disorders of autonomic nervous system,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Diverticular disease of intestine,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Down's syndrome,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Dysmenorrhoea,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Eating disorders,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Endometriosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Enteropathic arthropathy,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Enthesopathies and synovial disorders,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Erectile dysfunction,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Female genital prolapse,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Female infertility,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Fibromyalgia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,"Folate deficiency, with and without anaemia","READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Fracture of hip,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Gastritis and duodenitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Gastro-oesophageal reflux disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Gastrointestinal angiodysplasia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Giant Cell arteritis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Glaucoma,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Glomerulonephritis and other nephritides,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Hearing loss,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Heart valve disease non-rheumatic,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Hidradenitis suppurativa,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Hyperparathyroidism,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Hyperplasia of prostate,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Hyperprolactinaemia and prolactinoma,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Hypertrophic Cardiomyopathy,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Hypertrophy of nasal turbinates,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Hypopituitarism,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Hyposplenism,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Immunodeficiencies,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Infection of bones and joints,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Intervertebral disc disorders,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Intracranial hypertension,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Iron deficiency with and without anaemia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Irritable bowel syndrome,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Juvenile arthritis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Learning disability,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Lichen planus,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Liver failure and transplant,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,"Liver fibrosis, sclerosis and cirrhosis","READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Lupus erythematosus (local and systemic),"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Macular degeneration,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Male infertility,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Meniere disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Menorrhagia and polymenorrhoea,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Migraine,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Motor neuron disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Multiple myeloma and malignant plasma cell neoplasms,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Myasthenia gravis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Myelodysplastic syndromes,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Nasal polyp,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Neuromuscular dysfunction of bladder,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Non-acute cystitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Non-alcoholic fatty liver disease and steatohepatitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Non-diabetic peripheral neuropathies (excluding cranial nerves and carpal tunnel syndrome),"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,"Non-malignant tumour of brain, central nervous system and pituitary","READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Obesity,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Obsessive-compulsive disorder,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Obstructive and reflux uropathy,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Oesophagitis and oesophageal ulcer,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Other anaemias,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Other haemolytic anaemias,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Other interstitial pulmonary diseases with fibrosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Other psychoactive substance misuse,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Painful conditions,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Pancreatitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Peptic ulcer disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Peripheral arterial disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Peripheral venous and lymphatic disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Personality disorder,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Polycystic ovarian syndrome,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Polycythaemia vera,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Polymyalgia Rheumatica,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Portal hypertension and oesophageal varices,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Post-traumatic stress and stress-related disorders,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Psoriasis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Psoriatic arthropathy,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Ptosis of eyelid,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Pulmonary hypertension,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Respiratory failure,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Retinal detachments and breaks,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Retinal vascular occlusions,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Rheumatic valve disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Rosacea,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Sarcoidosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,SARS-CoV-2,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Scoliosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Seborrheic dermatitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Secondary malignancy and metastasis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Secondary polycythaemia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Sick sinus syndrome,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Sickle-cell anaemia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Sjogren's disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Sleep apnoea,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Somatoform and dissociative disorders,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Spina bifida,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Spinal stenosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Spondylolisthesis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Spondylosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Subdural haematoma,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Supraventricular tachycardia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Systemic sclerosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Thalassaemia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,"Thrombocytopenia primary, secondary and other","READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Thrombophilia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Thyroid disease,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Tinnitus,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Trigeminal neuralgia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Tuberculosis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Ulcerative colitis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Unspecified or Rare Diabetes,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Urinary Incontinence,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Urolithiasis,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Urticaria,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Venous thromboembolism,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Visual impairment and blindness,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Vitamin B12 deficiency with and without anaemia,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
78,Eto,2023,NA,Vitiligo,"READ, ICD, OPSC, and gemscript codes grouped with case algorithms developed in the MULTIPLY-Initiative"
79,Nishida,2023,asthma,J45,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,cancer,"C16, C18, C20, C25, C67, C73, C77, C78, C79, C85, C34, C50, C53, C54, C56, C61",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,chronic kidney disease,N18,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,COPD,"J42, J43, J44",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,dementia incl. alzheimers,NA,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,diabetes mellitus,"E11, E14",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,epilepsy,G40,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,gout,NA,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,heart failure,I50,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,HIV/AIDS,NA,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,hypertension,"I10, I11",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,ischemic heart disease,"I20, I21, I25",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,mood and anxiety disorders,"F31, F32, F41, F45, F48",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,multiple sclerosis,NA,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,osteoarthritis,NA,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,osteoporosis,M81,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,parkinsons,NA,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,rheumatoid arthritis,NA,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,schizophrenia,F20,ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,stroke,"I61, I63, I65, I67, I69",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Acute pancreatitis (K85),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Alcoholic liver disease (K70),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Arrhythmia (I47, I48, I49)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Arteriosclerosis (I70, I71, I73, I74)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Autonomic neuropathy (G90),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Benign tumor (D18, D25, D27, D37, D38, D39, D41, D43, D44, D48)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Blood disease (D64, D65, D68, D69, D70)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Breast disorders (N63, N64)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Calculus of kidney and ureter (N20),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Chronic disease of load-bearing joints (M16, M17, M47, M51)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Chronic inflammation of the upper and lower airways (J30, J31, J32, J34, J37, J38, J40)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Cirrhosis / Liver failure / Liver cancer (C22, K72, K74)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Connective tissue disease (M06, M32, M35)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Dyslipidemia (E78),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Ear disease (H60, H61, H65, H66, H68, H81, H90, H91, H93)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Eye disease (H00, H01, H02, H04, H10, H11, H16, H18, H20, H25, H26, H33, H35, H40, H43, H52, H53)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Gallbladder/Biliary tract disease (K80, K81, K82)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Gastric ulcer/Duodenal ulcer (K25, K26)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Gastritis (K29),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Hemorrhage in early pregnancy (O20),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Hemorrhoid (I84),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Hyperuricemia/Gout (E79, M10)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Ileus (K56),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Inflammatory diseases of female pelvic organs (N72, N76)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Interstitial pneumonia (J84),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Iron deficiency anemia (D50),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Male genital disorders (N40, N41)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Noninflammatory disorders of female genital tract (N80, N92, N93, N94, N95, N97, N85, N86, N87)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Oral disease (K02, K05, K03, K04, K06, K07, K08, K12)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Other cardiovascular diseases (I34, I38, I51, I95)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Other disorders of nervous system (G98),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Other endocrine, nutritional and metabolic diseases (E03, E04, E05, E06, E07, E10, E21, E22, E23, E28, E53, E56, E66, E83, E86, E87, E88)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Other gastrointestinal disorders (K30, K31, K52, K57, K58, K59, K60, K62, K63, K75, K86, K92)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Other infectious diseases (A04, A09, A41, A49, A53, A56, B00, B02, B07, B35, B37, B48)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Other kidney diseases (N05, N12, N19, N28, Q61)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Other liver diseases (K76, K73)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Other locomotor disorders (M19, M13, M25, M43, M48, M50, M53, M54, M62, M65, M72, M75, M77, M79)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Other urinary disorders (N30, N31, N13, N32, N39)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Peripheral neuropathy (G56, G62, G64)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Phlebitis and thrombophlebitis (I80),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Reflux esophagitis (K21),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Skin and subcutaneous tissue (L01, L02, L03, L08, L20, L21, L25, L27, L29, L30, L40, L50, L70, L72, L73, L81, L84, L85, L91, L98, Q82)",ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Sleep disorder (G47),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Tuberculosis of lung (A16),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,Ulcerative colitis (K51),ICD 10 codes grouped into diseases by  expert consensus
79,Nishida,2023,NA,"Viral hepatitis (B16, B18, B19)",ICD 10 codes grouped into diseases by  expert consensus
